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reaction center form an electron transport chain that converts the energy of a central, light-activated
pigment into a reductant at one end and an oxidant at the other. The central aim of this thesis is to
reproduce the charge separating function of photosystem II in a comparatively simple de novo designed
protein maquette. The maquette effectively eliminates the complexity contributed by parts of
photosystem II that are not directly involved in charge separation and facilitates a streamlined
investigation of fundamental factors essential to this function. Previous work has produced lightactivatable maquettes that are competent for electron transfer between tetrapyrroles but are unable to
trap a charge separated state that is necessary for fuel generation.
This thesis details the design, structure, and action of MZH3, a multi-cofactor maquette that stabilizes a
long-lived charge separated state. X-ray crystallographic structures of MZH3 are solved in complex with
heme B, a synthetic zinc porphyrin, and metal ion cofactors. Despite sharing low sequence identity with
natural proteins, MZH3 exhibits significant structural similarity to cytochrome b at the heme site and
bacterioferritin at the metal site. Transient absorption spectroscopy shows that the reduced state of
heme B is stabilized in the presence of a tyrosine residue for 150 ms after light absorption at pH 9.5. The
binding of ferrous iron extends the charge separated state lifetime to 300 ms at pH 7.5. Providing the
tyrosine with a hydrogen bond to histidine increases the yield of the charge separated state but decreases
its lifetime. Mutation of a heme-ligating histidine to alanine gives rise to an unexpected oxygen binding
function with an oxyferrous lifetime of 38 hours, comparable to natural oxygen transport proteins. These
results show that MZH3 is a uniquely structured, functional reaction center maquette that is readily
adapted to new functions. Continuing development will be directed toward multinuclear metal cluster
assembly and in vivo generation of solar fuel from water.
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ABSTRACT

DESIGN, STRUCTURE, AND ACTION OF AN
ARTIFICIAL PHOTOSYNTHETIC REACTION CENTER
Nathan Ennist
P. Leslie Dutton

At the heart of photosystem II is the reaction center, where solar energy is used to
separate charge. Set within a large and highly complex protein system, the handful of redox
cofactors that make up the reaction center form an electron transport chain that converts the
energy of a central, light-activated pigment into a reductant at one end and an oxidant at the
other. The central aim of this thesis is to reproduce the charge separating function of
photosystem II in a comparatively simple de novo designed protein maquette. The maquette
effectively eliminates the complexity contributed by parts of photosystem II that are not directly
involved in charge separation and facilitates a streamlined investigation of fundamental factors
essential to this function. Previous work has produced light-activatable maquettes that are
competent for electron transfer between tetrapyrroles but are unable to trap a charge
separated state that is necessary for fuel generation.
This thesis details the design, structure, and action of MZH3, a multi-cofactor maquette
that stabilizes a long-lived charge separated state. X-ray crystallographic structures of MZH3 are
solved in complex with heme B, a synthetic zinc porphyrin, and metal ion cofactors. Despite
sharing low sequence identity with natural proteins, MZH3 exhibits significant structural
similarity to cytochrome b at the heme site and bacterioferritin at the metal site. Transient
v

absorption spectroscopy shows that the reduced state of heme B is stabilized in the presence of
a tyrosine residue for 150 ms after light absorption at pH 9.5. The binding of ferrous iron
extends the charge separated state lifetime to 300 ms at pH 7.5. Providing the tyrosine with a
hydrogen bond to histidine increases the yield of the charge separated state but decreases its
lifetime. Mutation of a heme-ligating histidine to alanine gives rise to an unexpected oxygen
binding function with an oxyferrous lifetime of 38 hours, comparable to natural oxygen
transport proteins. These results show that MZH3 is a uniquely structured, functional reaction
center maquette that is readily adapted to new functions. Continuing development will be
directed toward multinuclear metal cluster assembly and in vivo generation of solar fuel from
water.
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Chapter 1: Thesis statement and introduction
Given that nature conducts light driven water oxidation and hydrogenase activities using
proteins, we know that in vivo enzymatic conversion of water and light to oxygen and hydrogen
is possible. Whether it is feasible to engineer a living system that generates large quantities of
clean-burning fuel efficiently enough to compete with the price of fossil fuels remains an open
question. While it is sometimes taken for granted that an organic system is too susceptible to
oxidative damage to be useful in the high potential oxidation of water, an in vivo protein system
has several unique advantages over other catalysts. For instance, enzymes can create
microenvironments with precise interactions that afford lower overpotentials and faster
reaction kinetics than chemical reactions in solution. The ability to create these
microenvironments precludes the need for non-aqueous solvents and extremes of temperature
and pH. Damaged protein can be replaced by a host organism, allowing for “self-healing”
capabilities. In addition, natural enzymes demonstrate that difficult high-energy reactions can
be catalyzed using inexpensive, Earth-abundant elements. With these advantages, proteins
designed for solar-to-fuel energy conversion could become a significant contributor to a future
alternative energy economy.
In support of my thesis, I will present the design, characterization, and crystal structure
of a highly soluble, thermostable, de novo maquette protein that expresses in high yield in E.
coli, assembles a redox-active cofactor tetrad, and traps a long-lived charge-separated state
when exposed to visible light. This represents a first step toward artificial photosynthesis in a
protein system. Despite low sequence similarity to natural proteins, this maquette bears
1

striking structural similarity to natural proteins that were used to guide its design, suggesting
that the engineering of some enzymes with sophisticated functions may be more facile than
once thought.

1.1 Photosynthesis, natural and artificial
New technologies are needed to increase production of clean-burning, high-energy fuels
that can compete economically with fossil fuels to mitigate the environmental impact of climate
change and lessen the social and political burden of meeting our energy needs (1-9). Society’s
energy demands come in different forms, but fuels account for roughly 80% of global energy
consumption, and approximately 20% is satisfied by electrical energy (2). Unlike electrical
energy, fuel can be readily stored and transported to allow energy to be released on demand,
which is one reason why the dominant fraction of our energy needs are met by fossil fuel
combustion (6). Electrical energy is generated by numerous alternative energy technologies
including photovoltaics, wind turbines, nuclear, and hydropower, but currently, no satisfactory
method of generating renewable fuel can be relied upon to supplant fossil fuels (2).
When averaged over a year, photosynthetic organisms convert about 100 TW of solar
power into chemical energy (9). For comparison, the combined rate of energy consumption by
humans in 2010 was 16.3 TW and is expected to rise to at least 30 TW by 2050 (5, 10), but the
total power of sunlight reaching the Earth’s surface is about 120,000 TW, making solar the most
abundant form of renewable energy (4, 6, 7, 11). The scientific community is looking to the
potential of artificial photosynthesis to provide solar fuels on a large scale (1-9). Because of the
potentially transformative impact of efficient solar-to-fuel energy conversion, Faunce et al.
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argue that, “Developing and globally deploying artificial photosynthesis . . . is one of the great
scientific and moral challenges of our time . . .” (1).

1.1.1 Structure and function of photosystem II and its reaction center
An in-depth understanding of photosystem II structure and function will be instrumental
in the development of artificial photosynthetic technologies. Photosystem II is nature’s solar
powered water oxidase and the only enzyme in biology capable of forming an oxygen-oxygen
bond from two water molecules (12). The study of photosystem II is difficult owing to its size,
complexity, and fragility. This membrane protein complex resides in the thylakoid membrane in
cyanobacteria, algae, and plants, and it can function as either a monomer or a dimer (13). Each
monomer has a mass of about 350 kDa depending on the species, and is composed of upwards
of 20 subunits and 50 cofactors including chlorophylls, pheophytins, β-carotenes,
plastoquinones, hemes, non-heme iron, bicarbonate, chlorides, and a Mn4CaO5 oxygen evolving
complex (OEC) (14). In addition, an intricate network of channels conduct water, oxygen, and
protons to and from the OEC (15).
Despite this complexity, researchers have succeeded in crystallizing photosystem II from
thermophilic cyanobacteria Thermosynechococcus vulcanus and Thermosynechococcus
elongatus (14, 16-19). In 2011, the T. vulcanus photosystem II was solved to 1.9 Å resolution, a
breakthrough that yielded unprecedented insight into the structure-function relationship in the
enzyme (14). The overall structure of the photosystem II dimer is shown in the top left of Figure
1.1 (14). Continued progress on elucidation of photosystem II structure comes from recent freeelectron laser X-ray crystallography that provides “radiation damage-free” cyanobacterial
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structures at cryogenic (20) and room temperature (21), as well as studies of eukaryotic
photosystem II complexes using X-ray crystallography (22) and cryo-electron microscopy (23).
While the overall complexity of photosystem II is impressive, the reaction center is
conceptually simple (Figure 1.1, right). The reaction center is essentially a string of redox-active
cofactors that includes a light absorber in the middle (P680), electron donors on one end
(tyrosine Z and the OEC), and electron acceptors on the other end (pheophytin and
plastoquinones QA and QB) (24). When P680 absorbs a photon, it enters a highly reducing singlet
excited state (P680*) that has a midpoint potential Em(P680*/P680•+) value between −0.57 and
−0.58 V vs SHE, and it initiates an electron transfer cascade (25, 26). Within picoseconds of
activation, P680* reduces the nearby pheophytin (Pheo in Figure 1.1), which passes the electron
to plastoquinone QA on a hundreds of picoseconds timescale. QA then reduces QB within
hundreds of microseconds. When a second photon absorption causes QB to be reduced a
second time, QB dissociates from photosystem II and is replaced by an oxidized quinone from
the quinone pool in the thylakoid membrane (24, 27). Meanwhile, on the electron donating side
of the reaction center, P680•+, which has an Em(P680/P680•+) of 1.25 to 1.26 V (25, 26), oxidizes
tyrosine Z, with an Em(YZ/YZ•) of about 1.2 V (25), within tens of nanoseconds (28-30). This
oxidation is followed by slower conformational rearrangement steps around tyrosine Z (31-33),
which take tens of microseconds. YZ•, in turn, oxidizes the OEC on a tens of microseconds to
milliseconds timescale, depending on the oxidation state of the OEC (34-36). When the OEC is
oxidized four times, it oxidizes two water molecules to make O2 and returns to its initial state.
These reaction kinetics are reviewed in more detail in Vinyard et al., 2013 (37). (All midpoint
potentials in this thesis are measured against the standard hydrogen electrode (SHE), unless
otherwise noted).
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Figure 1.1: Photosystem II crystal structure
Structure at 1.9 Å resolution from (PDB ID:
3WU2) (14). Top left: Overall structure of the
photosystem II dimer The protein backbone is
shown as ribbons, organic cofactors are
shown as sticks, and the Mn4CaO5 oxygen
evolving complex (OEC) is shown as spheres.
Right: Reaction center of photosystem II
showing light absorption and electron transfer
pathway. Substituent groups of chlorophylls,
pheophytins, and quinones that do not
directly participate in electron transfer are
removed for clarity.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

The extreme potentials necessary for water oxidation are dangerous in an organic
scaffold such as a protein. Water oxidation in a protein has been likened to “setting a fire in a
wicker basket, without burning the basket” (38). However, photosynthetic organisms are able
to manage the risk. Replacement of the D1 polypeptide that houses the OEC occurs as
frequently as every 30 minutes in full sunlight due to oxidative damage (39).
One peculiarity of the photosystem II reaction center is the nature of P680, the lightabsorbing pigment. P680 consists of four weakly coupled monomeric chlorophyll a molecules.
In the excited singlet P680* state, the excitation energy is delocalized across the chlorophylls.
The special properties of the P680 chlorophylls give them exceedingly high midpoint potentials
5

and cause their absorbance spectra to shift to longer wavelengths. Typical antenna chlorophylls
have an absorbance peak in the range of 670 to 675 nm and use energy transfer to pass photon
energy to the reaction center, but in P680, this absorbance peak shifts to 680 nm. This red shift
creates an “exciton trap” that is unable to transfer energy from P680* to other chlorophylls in
photosystem II, because the other chlorophylls absorb higher energy light (40). The unusual
association of the four chlorophylls of P680 does not necessarily need to be reproduced in order
to create a working reaction center.
Despite detailed knowledge of photosystem II structure from high-resolution structures
and decades of intense research, many important facets of photosystem II function remain
elusive. As with any complex natural protein, different parts of photosystem II have
interconnected and overlapping functions (41). Practical limitations have often lead researchers
to make compromises such as conducting experimental studies on tyrosine Z using photosystem
II in its manganese-depleted form, even though it is well known that manganese depletion
affects the properties of tyrosine Z (32, 42, 43). As a result, the unraveling of mechanistic details
of photosystem II has been painstaking. Debates continue with regard to the proton transfer
pathway of tyrosine Z, the function of tyrosine D, the steps of the photoactivation process that
assembles the OEC, the mechanism of water oxidation at the OEC, and even which water
molecules and/or hydroxide/oxide ligands are the substrates of the oxygen evolving reaction
(21, 31, 44-46). These shortfalls open the door to model systems to pave the way toward a
deeper understanding of photosystem II functions.
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1.1.2 Photosynthetic reactions and the potential for improvement
By developing the ability to extract electrons from water as a widely available substrate,
the advent of oxygenic photosystem II roughly 2.5 billion years ago gave way to a “big bang of
evolution” and a new age of abundant life under an oxidizing atmosphere (9, 24, 44). Electrons
and protons abstracted from water could be used to convert a substrate (carbon dioxide) to a
fuel (carbohydrates). The four-electron oxidation of water requires an energy input equivalent
to 0.82 V vs. SHE per electron at pH 7 (47). The water oxidation half reaction of photosystem II
is catalyzed upon absorption of four photons and is given below in Reaction 1.1:
Em,7 = +0.82 V

2H2O → O2 + 4H+ + 4e-

Reaction 1.1

In oxygenic photosynthetic organisms (plants, algae, and cyanobacteria), the second half
reaction is the reduction of carbon dioxide to make carbohydrates (24). In place of
carbohydrates, artificial photosynthesis seeks to produce a high energy density fuel such as
hydrogen. In this case, the protons and electrons released by water oxidation could be
combined, as shown in Reaction 1.2:
Em,7 = −0.41 V

2H+ + 2e- → H2

Reaction 1.2

All oxygenic photosynthetic organisms use two separate photosystems in the oxidation
of water and reduction of carbon dioxide (48). Photosystem II carries out water oxidation, while
photosystem I generates NADPH to drive the carbon dioxide fixation process (9). In theory,
however, only a single photosystem is necessary. The energy gap between the water oxidizing
half reaction at 0.82 V (Reaction 1) and the proton reducing half reaction at −0.41 V (Reaction 2)
is 1.23 eV, which is ~67% of the energy of the 680 nm (1.8 eV) photon used by P680 to enter the
excited state and begin charge separation in photosystem II. This shows that photosynthetic
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water oxidation and hydrogen evolution could conceivably be conducted using only a single
photosystem (3). Figure 1.2 illustrates that the two half reactions fall within the range of
potentials used in photosystem II. Some of the initial photon energy will need to be used to
stabilize the charge separated state and allow for catalysis, but in principle, a second
photosystem is not required; there is enough energy in a single photon to be used for evolution
of both oxygen and hydrogen in the same reaction center. To do this, however, would require a
new reaction center with inter-cofactor distances and potentials optimized to facilitate energy
conversion.

Figure 1.2: Energy diagram of photosystem II
Cofactors in the photosystem II reaction center are placed according to the scale on the left.
Potentials are measured against SHE. The blue box represents the potential range where
water oxidation occurs (Reaction 1), and the green dotted line represents the potential of the
hydrogen evolution half reaction (Reaction 2). Modified from Vinyard, et al., 2013 (37).
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1.1.3 The oxygen evolving complex (OEC) of photosystem II
In photosystem II, the water oxidation half reaction (Reaction 1.1) is catalyzed at the
oxygen evolving complex (OEC), a Mn4Ca oxo-bridged cubane-like structure (14). The OEC is the
terminal cofactor on the electron donating end of the photosystem II reaction center. With
each photon absorption, the OEC is progressively oxidized through the S-state cycle (Kok cycle)
from S0 (most reduced) to S4 (most oxidized). At S4, the OEC converts two water molecules to
dioxygen and returns to the reduced S0 state (44, 49). In this way, the OEC couples the
sequential one-electron reactions of the reaction center to the four-electron reaction of water
oxidation by storing oxidizing equivalents until the OEC is oxidized four times.
The OEC catalyzes one of the most difficult reactions in biology with a low overpotential,
high turnover frequency, and high turnover number and uses only Earth-abundant metals (12,
50). However, the structure of the OEC does not need to be reproduced exactly in order to
achieve water oxidation. The catalyst remains functional if the calcium ion is replaced by
strontium (51, 52), and most of the highly conserved amino acid ligands of the OEC can be
removed by mutation without abolishing water oxidation (although the rate of the reaction is
usually decreased) (44). Some small molecule manganese-containing mimics of the OEC have
been shown to be capable of oxygen evolution (53-55), and various metal oxides have been
used as heterogeneous water oxidation catalysts including manganese, cobalt, ruthenium, and
iridium oxides (56). While iridium and ruthenium complexes can be used for impressive water
oxidation activity (57, 58), the low abundance of these elements means that they are not useful
as fuel generating catalysts in the long run. The Nocera group has reported a film for
heterogeneous water oxidation composed of Earth-abundant cobalt oxide (59, 60). These
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studies show that many different oxo-bridged metal compounds can be useful for water
oxidation.

1.1.4 Photoassembly of the oxygen evolving complex (OEC)
The Mn4Ca OEC cluster is not chemically stable when released from its binding site in
photosystem II (37), and it must be assembled in place by a process known as photoactivation
(61). During photoactivation, manganese ions (initially in the Mn(II) state) are oxidized using the
same process of light-driven charge separation that the reaction center uses for normal water
oxidation activity. It may seem counterintuitive that increasing the charge of the manganese
ions would help bring them together in the OEC, but manganese oxidation is accompanied by
proton release from Mn-ligating water and hydroxide ligands, exposing negatively charged
oxygens that are capable of forming additional ligands to create bridging μ-hydroxo or μ-oxo
ligands to multiple manganese ions (45). In the photoactivated state, five μ-oxo bridges bind
the manganese and calcium ions together in the fully assembled OEC (14).
Photoactivation begins with the binding of a single Mn(II) ion to the OEC site in photosystem
II with a dissociation constant of ~40-50 μM (45, 62). The Mn(II) ion is believed to bear a water
ligand, and oxidation to Mn(III) by YZ• causes a charge-compensating release of a proton,
allowing the ligating hydroxide anion to form a bridging ligation to a second metal ion (45, 62).
A second oxidation event leads to a more stable state, and the cluster continues to iteratively
reduce YZ•, release protons, and bind additional metal ions until the cluster is fully assembled, as
illustrated in Figure 1.3 (45, 63).
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Figure 1.3: Photoactivation of the oxygen evolving complex
Left: OEC photoassembly process prepares the metal cluster for the oxygen evolving reaction.
Right: Photoactivated OEC is competent for water oxidation (Reaction 1.1), and proceeds
through the S-state cycle (Kok cycle). Figure adapted from Burnap, 2004 (63).

Ca(II) binds to the photoassembling OEC in the early steps of photoactivation and is
required for proper formation of the Mn4Ca cluster. In the absence of Ca(II), a runaway
photoassembly of oxidized manganese ions takes place, building up to 5-10 manganese ions per
photosystem II (64). The resulting cluster is not a functional OEC, but the fact that
photoassembly proceeds without calcium suggests that it might be possible to engineer a similar
photoassembly mechanism in a simpler protein system that is able to trap a charge separated
state and bind metal ions. This would afford a path toward building an OEC in a new protein
designed for artificial photosynthesis.

1.1.5 Redox active tyrosines of photosystem II: YD and YZ
In the de novo design of a reaction center protein, tyrosine has the supreme advantage
of being a covalently attached amino acid cofactor; a specialized binding site is not needed to
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pluck the cofactor out of solution and hold onto it tightly. High affinity cofactor binding sites can
be difficult to engineer in de novo proteins, and a non-covalently bound cofactor in an in vivo
system may require a separate cofactor production pathway to generate stoichiometric
quantities of cofactor. In addition, tyrosine has a high midpoint potential, and photosystem II
demonstrates the applicability of tyrosine redox reactions to water oxidation.
The oxidation and reduction of tyrosine at neutral pH is a proton coupled electron
transfer (PCET) reaction. This is because the pKa of tyrosine changes dramatically from ~10 in
the reduced state to ~−2 when oxidized (65, 66).
There are two redox active tyrosine residues in photosystem II, YZ (D1-Tyr161) and YD
(D2-Tyr160) that have symmetrically-related positions in the homologous D1 and D2
polypeptides (see Figure 1.1, right). Both of these tyrosines can participate in light-activated
electron transfer reactions, are universally conserved, and lie within 9.0 to 9.3 Å of P680
according to recent crystal structures (14, 20, 21). However, only one of them, YZ, is critical to
the function of photosystem II, as YD is not required for water oxidation (46, 67, 68). YZ plays an
instrumental role as it directly reduces P680•+ and directly oxidizes the OEC during normal
oxygen evolving activity (46).
Despite their analogous positions in homologous polypeptides, YZ and YD have very
different oxidation/reduction kinetics, midpoint potentials, and local environments. Tyrosine Z
is a powerful oxidant, with a midpoint potential of 1.2 V (25), significantly higher than the 700800 mV potential of YD (69). In the fully operational photosystem II, YZ is oxidized by P680•+
through a PCET reaction that takes tens of nanoseconds (28, 29), exhibits no deuterium isotope
effect on the kinetics (30), and is rate-limited by electron transfer (70). It has been speculated
that the oxidation of YZ by P680•+, which must involve a proton transfer that takes less than 20
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ns, might be the fastest PCET reaction in nature (46). Reduction of YZ• by the OEC takes longer,
up to 1.4 ms, depending on the S-state of the OEC (34-36). YD is also capable of fast reduction of
P680•+ on the nanoseconds timescale (71), but reduction of YD• takes all day; the YD• radical is
highly stable and remains in the oxidized state during illumination, only going reduced again
when it oxidizes the OEC from the S0 to the S1 state after hours in the dark (46, 69, 72).
These differences in the driving forces and kinetics of YZ and YD PCET reactions can be
attributed to the local environments of the residues. YD is located in a hydrophobic pocket that
might restrict its ability to become protonated once oxidized, while YZ is positioned near the
opening of a solvent channel that leads to the thylakoid lumen and is surrounded by water in an
extensive hydrogen-bonding network that connects it to the OEC (14). Both YZ and YD make
hydrogen bonds to nearby histidines that are important for modulating electron transfer
function (14). D1-His190 (His-Z), which hydrogen bonds YZ using its imidazole Nε atom, donates
a second hydrogen bond to an asparagine oxygen with the Nδ atom. In contrast, D2-H189 (HisD), which hydrogen bonds YD with its Nε atom, accepts a hydrogen bond from an arginine N-H
group at the imidazole Nδ atom (Figure 1.4) (14).

Figure 1.4: Redox active tyrosines of photosystem II
Hydrogen bonding networks around Tyr-Z (left) and
Tyr-D (right) in photosystem II crystal structure (PDB
ID: 3WU2) (14). Images rendered using The PyMOL
Molecular Graphics System, Version 1.7 Schrödinger,
LLC.
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Upon oxidation, YZ is known to pass its proton to His-Z (32, 33, 42, 43, 46, 73). This
proton transfer might be promoted by the conserved residue D1-Asn298, which accepts a
hydrogen bond from the Nδ-H group of His-Z, thereby stabilizing the protonated form of the HisZ Nδ atom (14, 42, 43, 74). If the His-Z Nδ atom is protonated, then the neutral form of His-Z
must accept a hydrogen bond from YZ. In this way, D1-Asn298 might force His-Z into a
protonation state that is capable of accepting a proton from YZ when YZ becomes oxidized (see
Figure 1.4, left). An exhaustive mutagenesis study of D1-Asn298 showed that all 19 possible
mutations of D1-Asn298 resulted in either total abolition of oxygen evolving activity or a
significantly decreased rate of oxygen evolution combined with a marked increase in
photosensitivity (74). This supports the hypothesis that D1-Asn298 plays an important role in
the electron transfer pathway of the photosystem II reaction center.
Although it has been suggested that YD similarly donates its proton to His-D upon
oxidation to YD• (46, 69), it seems that the arginine would prevent this from happening, because
the neutral state of His-D must accept a hydrogen bond from D2-Arg294, meaning that its Nε
atom is protonated and donating a hydrogen bond to the YD phenolic oxygen; the His-D state in
the crystal structure is not competent to accept a proton from YD (see Figure 1.4, right) (14).
Indeed, a study by Nakamura et al., 2014 provides evidence by Fourier transform infrared
spectroscopy that His-Z accepts a proton when YZ is oxidized, but YD oxidation leads to proton
release into a hydrogen bonding network around YD rather than protonation of His-D (43). This
supports the hypothesis that the water molecule that hydrogen bonds YD in Figure 1.4 (right) is
the likely proton donor and acceptor in YD PCET reactions, and not His-D. This water molecule
only has partial occupancy in some crystal structures and is absent from others (14, 20, 21); the
absence of a proton donor might restrict PCET reaction rates of YD and help give rise to its
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observed hours-timescale stability in the oxidized state (46, 69, 72). Regardless of the precise
mechanisms of proton transfer, the distal hydrogen bonds of D1-Asn298 to D1-His190 and D2Arg294 to D2-His189 appear to play important roles in dictating PCET reaction rates of YZ and YD.
Therefore, a model system involving tyrosine oxidation and reduction should use an extended
hydrogen bonding network to modulate PCET properties of the tyrosine.

1.1.6 Functions of YD and YZ
When considering how to build a new reaction center for artificial photosynthesis, it is
constructive to examine the purpose of including YD and YZ in photosystem II. YD is not
necessary for oxygen-evolving activity, but it is completely conserved (46, 67, 68). No single
function of YD stands out as obviously necessary, but some important roles have been identified.
The ability of YD to store an oxidizing equivalent for extended periods (75) supports
photoassembly of the OEC (76). In addition, if P680•+ formation outpaces S-state cycling, or if
the OEC is not assembled, YD can reduce P680•+ and prevent a damaging side reaction (71, 77).
In contrast to YD, YZ is essential to water oxidation in photosystem II, and it serves as an
intermediate electron donor between the OEC and P680 (46). Since YZ bridges the gap between
the OEC and P680, YZ allows the OEC to be positioned further from P680 than it would otherwise
need to be for rapid electron transfer. The distance between cofactors decreases electron
transfer rates by a factor of 10 for every additional ~1.6 Å of distance (78, 79), so the extension
of the P680-OEC distance by YZ may inhibit reduction of the OEC by P680*. Furthermore, the
increased distance may decrease quenching of the P680* excited state by manganese ions of
the OEC (80). Another function of YZ is to quickly reduce P680•+ on a nanoseconds timescale (2830), which helps avoid short circuiting charge recombination and damaging side reactions. The
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OEC undergoes relatively slow structural reorganization steps between different S-states that
result in electron transfer rates as slow as milliseconds (34-36); if P680•+ routinely persisted for
milliseconds, the turnover number and quantum yield of photosystem II would be greatly
diminished. As a result, YZ couples the fast initial charge separation events to the slower S-state
cycling of the OEC. In addition, the proton coupling of YZ oxidation and reduction might serve to
raise the activation energy barrier to charge recombination (81, 82).
The hydrogen abstraction model of YZ function offers another possible function (65, 83,
84). In this model, the reduction of the deprotonated YZ• radical occurs with concomitant
protonation by a water molecule in the hydrogen bonding network that connects YZ to the OEC.
In this way, YZ might help to extract protons from substrate water molecules to facilitate water
oxidation and deliver protons to a solvent channel. Alternatively, the proton rocking model
argues that YZ• receives its proton from His-Z upon reduction and does not participate in proton
transfer with the surrounding water (85-87). YZ does not necessarily behave the same way in
every S-state transition (46), and it has been suggested that hydrogen abstraction may occur
between some S-state transitions, such as S2 to S3, but that proton rocking may be used in
others (43).
A simplified reaction center protein may benefit from the use of a tyrosine residue for
extension of the distance between the pigment and metal cluster, rapid reduction of the
pigment radical cation, and raising the energy barrier to charge recombination by coupling
electron transfer to proton transfer. Hydrogen abstraction is probably too advanced for a small,
simple protein, especially if the metal binding site is exposed to bulk solvent.
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1.1.7 Tyrosine Z model systems
Many different molecular mimics of YZ have been produced to probe mechanistic details
of tyrosine PCET reactions, investigate whether the YZ to His-Z proton transfer can be
reproduced easily, and begin developing bio-inspired artificial photosynthetic units. In one
example, the Hammarström group synthesized a series of four different YZ mimics in which a
phenolic proton made a hydrogen bond to a benzimidazyl or pyridyl group, and light driven
phenol oxidation was carried out by an attached ruthenium tris-bipyridine moiety (88). This
study showed nearly a 1000-fold decrease in the phenol oxidation rate for every ~0.2 Å increase
in hydrogen bond length. Evidently, hydrogen bond lengths play an important role in PCET
rates, which helps explain the short hydrogen bond between YZ and His-Z of about 2.5 Å and the
fast PCET reduction of P680•+ by YZ in tens of nanoseconds (14, 20, 21, 28-30, 42, 46).
The Moore group and collaborators have developed small molecule mimics of YZ and YD
using hydrogen bonding phenol-benzimidazole pairs with the goal of developing an artificial
photosynthetic unit. They showed that the irreversible oxidation of a phenol lacking a hydrogen
bond in aprotic solvent can be made reversible by creating a hydrogen bond to a benzimidazole.
The reversibility was attributed to the proton being able to shuttle between the phenol and
benzimidazole groups depending on the oxidation state, instead of being lost to the solvent
upon phenol oxidation (89). This proton shuttling is reminiscent of the proton rocking
mechanism proposed for YZ oxidation and reduction in photosystem II (85-87). In another mimic
of YZ and YD, the Moore group showed that low temperature phenol oxidation at 13 K led to an
intermediate radical state that was only able to donate its proton to the benzimidazole when
warmed to 100 K (90). This is very similar to the behavior of YD, which was shown to be trapped
in an intermediate at 1.8 K that relaxed with a proton transfer at 77 K (81). The phenol17

benzimidazole pair was incorporated into a redox triad to trap a charge separated state. Using a
di-pentafluorophenyl porphyrin as the pigment, the phenol-benzimidazole as the electron
donor, and a tetracyanoporphyrin as the electron acceptor, the triad was able to convert light
energy to a charge separated state that persisted for 3.8 μs (82). This short lifetime isn’t long
enough to support water oxidation chemistry, which takes milliseconds in photosystem II (3436, 50), but it approaches the longest recorded charge separation lifetime in a synthetic triad of
34 μs (91). Small molecule tetrads can trap a charge separated state for much longer, but they
must be frozen or embedded in nanoparticles to prevent intermolecular charge recombination,
and their synthesis is extremely costly and time-consuming (92, 93).
The synthetic complexity and intermolecular charge recombination limitations of small
molecules can be avoided through the use of proteins. Proteins can protect redox centers from
recombination by shielding them in the hydrophobic core, and sometimes they can be
expressed in high yield in bacteria. The Barry group and collaborators synthesized a β-hairpin
peptide to study tyrosine oxidation in the presence and absence of a nearby histidine. The
histidine was shown to accelerate tyrosine oxidation at pH 9, but not pH 11, consistent with
PCET facilitated by the histidine. While the histidine was shown not to make a hydrogen bond
to the tyrosine or affect the tyrosine pKa, it was speculated that a proton could be passed from
the oxidized tyrosine to the histidine through hydrogen bonding water molecules (94, 95). The
Tommos group and collaborators designed a three-helix bundle protein to study tyrosine
oxidation (96). The protein was expressible in E. coli, and the deeply buried tyrosyl radical was
highly stable for seconds when oxidized photochemically (97). The reversibility of the tyrosine
oxidation allowed detailed study of midpoint potentials (0.92 V at pH 8.4 and 1.07 V at pH 5.5)
(98), and insertion of histidines in different positions was shown to modulate tyrosine
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fluorescence (99). However, as with the Barry β-hairpin peptide, no conclusive evidence of a
His-Tyr hydrogen bond was found.
These model systems have advanced our understanding of tyrosine oxidation and the
influence of hydrogen bonds. Small molecules have reproduced the phenol-imidazole hydrogen
bonds of photosystem II and demonstrated their power in influencing PCET reactions, but direct
tyrosine-histidine hydrogen bonds have not been inserted into protein frameworks, and no
model system has produced an extended hydrogen bonding network such as the tyrosinehistidine-asparagine network involving YZ. If a protein could be tailored to exert precise control
over tyrosine PCET reactions, a tyrosine residue might be a useful electron donor in a de novo
designed reaction center protein for artificial photosynthesis.

1.1.8 Hydrogen evolution in artificial photosynthesis
The reducing end of a reaction center protein designed for artificial photosynthesis
needs to include an active site that can reduce a substrate to make fuel such as hydrogen, as in
Reaction 1.2. Natural hydrogenase enzymes demonstrate the feasibility of this approach; they
exhibit efficient, reversible proton reduction with low overpotentials at neutral pH using Earthabundant elements including nickel and iron (100). A molecular mimic of the hydrogen evolving
cofactor of [Fe-Fe] hydrogenases has been shown to be capable of proton reduction activity
when incorporated into different natural protein scaffolds (101-103).
Another method of generating hydrogen in a protein framework involves the use of
cobalt tetrapyrroles, which have been shown to be capable of hydrogen evolution in
electrocatalytic and photocatalytic systems (104, 105). Recent work has demonstrated that
hydrogen production may be attainable in natural tetrapyrrole-binding proteins with modified
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cofactors, such as a cobinamide cofactor in ethanolamine ammonia lyase (106) or a cobalt
protoporphyrin IX cofactor in cytochrome b562 (107) or myoglobin (108). Proton reduction may
proceed from either the Co(I) or Co(0) state of a cobalt porphyrin (109). Midpoint potentials of
cobalt protoporphyrin IX in myoglobin have been reported with Em(Co(III)Mb/Co(II)Mb) of 100
mV (110) and Em(Co(II)Mb/Co(I)Mb) of −610 mV vs SHE (111). Unfortunately, Co(III)
protoporphyrin IX reduction to the Co(II) state in proteins is slow (110-112), which may mean
that a structural rearrangement occurs in the transition. However, it may be possible to adapt
the local environment of the cofactor in order to facilitate faster electron transfer.

1.1.9 Reengineering natural proteins for artificial photosynthesis
One approach to artificial photosynthesis is to reengineer natural proteins with the aim
of exploiting solar energy to drive proton reduction and water oxidation. For example, multiple
groups have directly coupled photosystem I to a cobalt catalyst or a [Ni-Fe] or [Fe-Fe]
hydrogenase in order to generate solar hydrogen (113-116). This demonstrates the feasibility of
solar-to-hydrogen energy conversion in a biological system; photosystem II and the modified
photosystem I could work together in vivo to produce hydrogen and oxygen from sunlight and
water. An in vivo system allows for the possibility of a self-repairing mechanism in which the cell
replaces protein as it becomes damaged.
However, reengineering of a photosystem I-hydrogenase complex would probably have
to be done without the aid of high resolution structural characterization, because this complex
is too big for NMR and crystallography would be extremely difficult. Without a precise
understanding of how changes to the system improve or inactivate function, progress may not
yield insights into the inner workings of the photosynthetic machinery or how best to develop
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an artificial photosynthetic system. In addition, repurposing such large, complicated, and
delicate proteins for a new function is no simple task. Moreover, as explained in section 1.1.2,
natural photosynthetic efficiency is not as high as it could be. The efficiency of photosynthesis
could be increased by covering the solar spectrum with different pigments, or by integrating
both the water oxidizing and fuel generating half reactions into a single photosystem (3).
A natural reaction center protein that is not involved in oxygenic photosynthesis was
reengineered by Allen, Williams, and colleagues. In this body of work, a bacterial reaction
center was modified for tyrosine oxidation (117) and manganese(II) oxidation (118). The Mnbound complex was structurally characterized by X-ray crystallography (119), and has even been
used as a light-driven superoxide dismutase to convert superoxide to oxygen (120).
In another example of protein reengineering to build a reaction center, the Wydrzynski
group modified the natural four-helix bundle protein bacterioferritin to bind the lightactivatable zinc chlorin e6 (ZnCe6) in place of the natural cofactor heme B. The modified
bacterioferritin was assembled with manganese instead of the natural iron cofactor. Under
illumination, ZnCe6 photo-oxidized Mn(II) to Mn(III), and three nearby tyrosine residues were
found to participate in electron transfer (121-123). However, no electron acceptor was
incorporated into the modified bacterioferritin reaction center, so it is unclear how the excited
state of ZnCe6 became oxidized.
These successes pave the way for the design of other reaction centers from scratch.
When the protein scaffold is designed de novo, the designer has more control over the
parameters that govern electron transfer rates. In order to avoid the complexities of natural
proteins, the Dutton group has produced a series of de novo designed protein maquettes. In
one example, the maquette BT6 was used for light-driven electron transfer from a zinc
21

tetrapyrrole to a heme B. However, because the maquette lacked an electron donor such as a
metal ion or a tyrosine residue, the charge separated state could not be trapped; the reduced
state of the electron acceptor was only observed when a sacrificial electron donor was
introduced into the system (124). In order to improve upon this result, this thesis is aimed at
stabilizing a charge separated state in a new maquette that extends the electron transfer chain
so that it includes a tyrosine residue and a metal center akin to the donor side of the
photosystem II reaction center. The next section will outline the design rules for four-helix
bundles with a focus on the goal of building a new reaction center protein for artificial
photosynthesis.

1.2 Four-helix bundle design
The field of de novo protein design, that is, protein design from first principles, has
progressed steadily since its inception in the 1980s. Today, basic design rules for four helix
bundles are firmly established. A protein designer who is well versed in the literature can
readily produce an amino acid sequence with a high likelihood of folding into a stable four helix
bundle. Ensuring a singular structure, however, requires some finesse, and imparting a highlevel function to a de novo designed protein remains a challenge (125).
Four-helix bundles are very common in nature, and they perform a wide variety of
functions: electron transfer using heme (cytochromes b (126), b6 (127), b562 (128), C′ (129),
bacterioferritin (130)), redox chemistry of carboxylate-bridged diiron and dimanganese proteins
(ribonucleotide reductase (131), alternative oxidase (132), methane monooxygenase (133),
bacterioferritin (130)), signaling (cytokines (134), growth hormone (135)), and protein
oligomerization (Lac repressor) (136). All of these four-helix bundle examples have an
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antiparallel helical topology, meaning that each helix is oriented antiparallel to its two adjacent
helices and parallel to the one diagonally across the bundle on the other side. The abundance of
antiparallel four-helix bundles in nature attests to the “designability” of this protein fold (137,
138).
Extensive work has been done on designed four-helix bundle proteins that bind heme
and other tetrapyrroles (112, 124, 139-144). Heme is one of the most common and most
versatile cofactors in nature, with functions that include quinone oxidation and reduction
(redox) activity (cytochrome bc1 complex) (145), electron transport (cytochrome c) (146), small
molecule binding (guanylate cyclase, myoglobin) (147, 148), and carbon hydroxylation
(cytochrome P450) (149). The field of de novo protein design has produced many proteins that
can bind different tetrapyrroles like heme and use them for an impressive array of functions, but
de novo proteins seldom rival the catalytic performance of their natural counterparts (125), and
despite our progress, no high-resolution structure of a de novo designed protein with a
tetrapyrrole cofactor has yet been solved. This limits our understanding of the structurefunction relationship and makes it all the more difficult to engineer proteins with sophisticated
functions.
Much of the background presented in this section was instructive in the creation of
MZH3, whose design and characterization is the focus of this thesis. MZH3 was designed for
high affinity binding of heme B, a zinc tetrapyrrole, and a di-metal center in an antiparallel fourhelix bundle in order to absorb light and separate charge.

23

1.2.1 Introduction to protein maquettes
A protein maquette is a de novo designed functional protein that avoids reference to
natural protein sequences and is minimalistic in the complexity of its design (41). Four-helix
bundle maquettes use basic principles of binary patterning of polar and nonpolar amino acids to
produce robust protein folds that can tolerate successive iterations of redesign without
significant loss of secondary or tertiary structure (150, 151).
Four-helix bundle protein scaffolds are well suited for the design of an electron
transport chain. Their elongated rod-like structure enforces a linear arrangement of the
cofactors, which works in favor of charge separation, because it maximizes the distance
between the electron donating and accepting ends of the maquette, thereby limiting intraprotein recombination of electrons and holes. Inter-protein collisional recombination is also
restricted because cofactors are insulated within the protein frame, which prevents close
contact between redox centers from different maquettes. The medium between cofactors is a
dry, nonpolar core that facilitates efficient electron transfer by ensuring a low reorganization
energy despite being surrounded by aqueous solvent. A coiled coil platform also allows for
modularity of design. Modifying one cofactor binding site to bind a different type of cofactor
typically has minimal effects on the properties of the other cofactors and the overall maquette
structure (124). Distances between cofactors can be adjusted in quantized steps of 1 α-helical
turn (about 5 Å) to maximize charge separation efficiency. Furthermore, while addition of
cofactors to a pre-existing globular protein would typically necessitate a difficult redesign, a
helical bundle can often accommodate more cofactors by a simple extension of each helix (152),
and increasing the length tends to stabilize the fold (153).
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Some maquettes can bind iron tetrapyrroles and zinc tetrapyrroles with high affinity.
Iron tetrapyrroles are stabilized by hexacoodinate ligation of the iron ion; they prefer two axial
ligands, usually histidine. Zinc tetrapyrroles, in contrast, prefer a pentacoodinate zinc ion that
only requires one axial histidine (144). The special advantage of a zinc tetrapyrrole is that, like
chlorophyll in photosynthetic proteins, it can absorb light to enter a high-energy excited state
that is a strong reductant. Once oxidized, the zinc tetrapyrrole radical cation is a powerful
oxidizing agent. If cofactors are arranged favorably, as they are in photosystem II, light
activation can lead to electron transfer and trapping of the charge separated state. While
maquettes that bind zinc and iron tetrapyrroles have been made to catalyze light-driven
electron transfer (124), none can stabilize a charge-separated state for long enough to catalyze
chemical reactions for solar energy conversion. To do so efficiently would require at least three
cofactors: an electron acceptor, a pigment, and an electron donor.
Unfortunately, no highresolution structures of
tetrapyrrole binding maquettes
have yet been reported in holostate, although apo-state
structures of de novo proteins do
exist (154-157). Some
tetrapyrrole binding maquettes

Figure 1.5: Four-helix bundle topologies

from the Dutton laboratory have

Antiparallel (left, in green), and parallel/antiparallel (right,
in red) helix threading topologies. Helices are represented
as cylinders with arrows pointing from N- to C-terminus.
Antiparallel four-helix bundles are more common in
nature.

been shown to fold into an
unusual mixed
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parallel/antiparallel topology (Figure 1.5, right) rather than the more common antiparallel
topology (Figure 1.5, left) (150, 154). Heme binding is accompanied by a significant structural
rearrangement in which the helices rotate to ligate the heme and bury some polar groups in the
process (158). Without high-resolution structures in the active holo-state, the structurefunction relationship remains uncertain, and it is unclear what mutations might lead to
improved function. This limits the effectiveness of the iterative redesign approach to maquette
development, which is one of the prime selling points of the technique.

1.2.2 Coiled coils
In a low-energy conformation, an α-helix has approximately 3.6 residues per turn, but in
coiled coils, α-helices twist together like a rope, creating a left-handed supercoil that lowers the
periodicity of the right-handed α-helices to 3.5 residues per turn (150). This high-affinity
wrapping of the helices is driven by “knob-into-hole” interactions, first predicted by Francis
Crick, in which amino acid side chains (the knobs) pack into spaces between side chains on
adjacent helices (the holes) (159). With only 3.5 amino acids per turn, a repeating unit is
completed every two turns, or seven residues. This means that α-helical folds can be stabilized
by a binary pattern of polar and hydrophobic amino acids arranged into repeating heptads, as
demonstrated by a large library of designed proteins that follow the heptad repeat pattern
(160). Following the convention set by McLachlan and Stewart (161), the seven positions in the
heptad are designated a through g, where positions a and d are the most buried, e and g are
interfacial, and b, c, and f are located on the exterior. Natural coiled coils do not always follow
these coiled coil guidelines perfectly. Occasionally coiled coils have “stutters” or “skips” in the
heptad pattern that can be compensated by local structural distortions; sometimes the
26

distinction between a coiled coils and other structures with helix-helix interactions cannot be
made unambiguously (162, 163).
A common example of a dimeric coiled coil found in nature is the leucine zipper, which
contains highly-conserved leucines in most d-positions (164). Leucine zippers provided an early
platform for exploring the fundamental design rules that govern coiled coil structure.
Mutagenesis studies on leucine zippers showed that the preference of a particular heptad
repeat sequence to fold as a 2-, 3-, or 4-helix coiled coil is sometimes difficult to predict, as even
volume-conserving mutations from Leu to Ile at a- and d-positions in leucine zippers can result
in dramatic switches between oligomerization states or between native-like and molten globular
states, as observed in the classic example of GCN4 (165). For this reason, accurate prediction of
coiled coil folding generally requires a broader consideration of inter-helical interactions in
different possible structures. In particular, a wider surface on each helix becomes buried in a
four-helix bundle compared to a two-stranded coiled coil, which means that interfacial residues
can play a key role in dictating the fold. The role of interfacial residues is demonstrated in
studies of various coiled coil mutants in which charged amino acids at e- and g-positions favor a
two-stranded coiled coil, whereas nonpolar amino acids such as alanine at e- and g-positions
stabilize four-helix bundles (166, 167).

1.2.3 Layers of hydrophobic amino acids in the core
Complementary core packing is a hallmark of native-like, uniquely-structured proteins,
and the hydrophobic effect is usually the most important driving force in protein folding (168).
However, hydrophobic contacts can be difficult to design, and inadequate core packing can
easily lead to a molten globular fold if there is not a large enough free energy gap between the
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native and non-native folded states relative to thermal energy, kBT (138, 169). In antiparallel
four-helix bundles, core a- and d-position side chains can be thought of as forming “layers”
where each layer consists of two a- and two d-position hydrophobic residues, with each helix
contributing one residue to each layer (Figure 1.6) (170-172). Complementarity of packing is
maximized when each layer has roughly the same total volume so that helices are not pushed
apart to create pockets that destabilize the protein by decreasing van der Waals contact and
possibly even allowing water to
penetrate into the core. The
crystal structure of the antiparallel
four-helix bundle Rop provides a
clear example of layers that has
been used to guide de novo
protein design (170, 171, 173,
174). When core d-positions are
consistently large and core apositions are consistently small, a
regular packing arrangement
facilitates good van der Waals
contact between hydrophobic side

Figure 1.6: Helical wheel diagram
One heptad of an antiparallel four-helix bundle protein.
The distance of an amino acid from the view is
represented by the size of the heptad letter designation.
Dotted lines represent hydrophobic interactions within a
layer. In helices, thick ribbons connect α-carbons, while
thinner lines represent Cα-Cβ bonds. Image rendered
using The PyMOL Molecular Graphics System, Version
1.7 Schrödinger, LLC.

chains (168).
Natural four-helix bundle proteins frequently have clearly segregated layers in the
hydrophobic core. Figure 1.7 shows the structures of the Lac repressor tetramerization domain
(136), bacterioferritin (175), and cytochrome b (176). Layers are shown as spheres with each
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layer colored differently to distinguish them. The layers are sometimes more disorganized at
the ends of the bundles where the four-helix bundle structure is breaking down, but in the
center, the idea of layering can be a useful tool for thinking about core packing in four-helix
bundles. The corresponding green layers of a bacterioferritin-like four-helix bundle and a
cytochrome b-like bundle design can be matched up to create an extended bundle that
assembles two tetrapyrroles and a di-metal center with an associated tyrosine.

Lac repressor
tetramerization domain

bacterioferritin monomer

cytochrome b subunit of
cytochrome bc1

Figure 1.7: Layers in natural proteins
Structure of the Lac repressor tetramerization domain (PDB ID: 1LBI) is shown at left (136).
Bacterioferritin monomer is shown at middle with Mn(II) ions represented as mauve spheres
in the center and tyrosine residues in yellow layers (PDB ID: 1BCF) (175). Structure of
cytochrome b subunit from cytochrome bc1 complex is shown at right with heme B cofactors
represented as sticks (PDB ID: 1EZV) (176). Core a- and d-position amino acid side chains are
represented as spheres. These residues segregate into layers which are distinguished by
color. Images rendered using The PyMOL Molecular Graphics System, Version 1.7
Schrödinger, LLC.
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Different studies have argued for the usefulness of a layering approach to four-helix
bundle core design (168, 170-172, 177, 178). One study by the Regan group showed that after
substituting all eight layers of the Rop hydrophobic core with Ala in a-positions and Leu in dpositions, respectively, the protein denaturation curves exhibited signs of native-like structure,
and the mutant had a 27°C increase in the thermal stability over that of wild-type Rop (172). In
some cases, however, the intrinsic flexibility of leucine side chains can make a leucine-rich core
dynamic, even if all the layers have the same size; it is often necessary to include some inflexible
amino acids in the core such as aromatic and β-branching residues in addition to small or flexible
amino acids in order to achieve a native-like structure (169). In one example, a multi-structured
heme-binding four-helix bundle maquette was used as a scaffold to investigate the effects of
combinations of substitutions of four d-position Leu residues for Ile, Val, and Phe. Six of the
twenty mutants had a stable, unique structure as assayed by one-dimensional proton NMR, and
some of these singularly-structured mutants were actually less stable than the original leucinerich precursor (151). While not fail-safe, the layering method of hydrophobic core design offers
a simple, intuitive method of building the core of a four-helix bundle.
It should be noted that not all four-helix coiled coils are said to have discreet layers.
Ferritin-like Alacoils such as the Lac repressor tetramerization domain (Figure 1.7, left), which
have alanine residues in e-positions, have been described as having interdigitated a- and dpositions, as measured by the relative positions of Cα atoms (179-181). It has even been argued
that the idea of layers in antiparallel four-helix bundles is faulty, because a- and d-positions
rarely align exactly in antiparallel coiled coils (182). However, the stringent requirement of
exact alignment may be a red herring to the protein designer seeking to fill gaps in the core to
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avoid destabilizing a maquette; the layering concept can still be applied even if layers appear
slanted (Figure 1.7, middle). A four-helix bundle should pack well as long as there is consistency
in the total volumes of the layers and in the relative sizes of adjacent a- and d-position amino
acids. Layers give the designer a framework for predicting specific hydrophobic contacts in the
core and the overall alignment of the helices. As with any aspect of protein design, however,
the designer must be conscientious of nuances of the sequence and structure that may
confound attempts to control core packing; the layering approach will not necessarily trump all
other determinants of core packing. In this regard, properties of well-characterized natural
proteins that are similar to the protein being designed can serve to guide the design process.

1.2.4 Heme binding in natural four-helix bundles
Both the antiparallel four-helix bundle fold and the heme cofactor are highly abundant
in nature, and there is no shortage of examples of heme-binding antiparallel four-helix bundles.
The cytochrome b subunit of mitochondrial respiration protein cytochrome bc1 and the
analogous photosynthetic protein cytochrome b6 from the cytochrome b6f complex are
transmembrane antiparallel four-helix bundles that bind two hemes B (126, 127). Other
examples of heme B-binding antiparallel four-helix bundles include cytochrome b562 (128),
succinate dehydrogenase (183), and bacterioferritin (175). All of these four-helix bundle
cytochromes are antiparallel and bind heme B so that the plane of the porphyrin ring is parallel
to the g-g interface and cuts through the e-e interface. This may be due to inherent structural
differences between the e-e and g-g interfaces. The Cα-to-Cβ bond of an amino acid in an eposition points away from the hydrophobic core, while the Cα-to-Cβ bond in a g-position points
into the core, making it easier for e-position amino acids to move out of the way of the bulky
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heme cofactor to avoid steric clashing. In addition, in all of these cases that use histidine to
ligate the heme iron, the Nε atom of the imidazole ring is used to ligate the iron, probably
because an iron-Nδ ligation may cause steric clashing between the porphyrin ring and the His Cβ
atom or the helical backbone.
Of the four-helix bundle cytochromes mentioned above, cytochromes b and b6 are the
most relevant to the artificial photosynthetic maquette that is the centerpiece of this
dissertation. This is because they each bind two B-type hemes non-covalently with an edge-toedge distance of about 12 Å (176, 184), which is close enough for electron transfer to occur but
far enough to slow electron-hole recombination, and they have a designable, layered
antiparallel fold that has already been reproduced in soluble proteins by several different
groups, despite the fact that cytochromes b and b6 are transmembrane proteins (140, 141).
A few details of the structure of cytochromes b and b6 appear to be very important to its
electron transfer function. Most importantly, bis-histidine ligation of the heme iron ion is used
for high-affinity binding. In addition, the four-helix bundle has binding pockets for the hemes
carved out to allow space for the bulky heme cofactor (185, 186). For each pair of ligating
histidines, there is also a pair of universally conserved “notch” glycines that have been shown to
be essential to high-affinity heme binding; even a conservative mutation of one of these glycine
residues to alanine can strain the bis-histidine coordination of the heme and inactivate the
cytochrome bc1 complex (187). These His and Gly residues form the red layers in Figure 1.7
(right panel). Helical glycines are better tolerated in a membrane environment than in solution,
but active site glycines have been shown to aid metal binding in di-metal-binding maquettes as
well (188, 189). Similarly, a maquette designed for anesthetic binding showed an increased
affinity for halothane when four Leu residues surrounding the binding site were mutated to Ala
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(190, 191). Glycines may provide space and flexibility to accommodate subtle structural
rearrangements induced by cofactor binding.
Cytochromes b and b6 also have second-shell Ser and Thr residues that make hydrogenbonds to the heme-ligating His residues. These second-shell Thr contacts have been reproduced
previously in de novo-designed proteins (139). The end layers (green in Figure 1.7, right panel)
of cytochromes b and b6 contain conserved arginine amino acids that make hydrogen bonds
with the propionate groups of heme B (126, 184).
The core of the cytochrome b and b6 four helix bundle can be said to have five layers
between and including the layers that each contain two heme-ligating histidines and two notch
glycines (red layers in Figure 1.7, right panel). The middle layer (yellow in Figure 1.7) is bulky,
because it needs to fill the same volume as the layers that contain heme and two histidines;
sequence alignments show that the middle layer usually contains exactly one phenylalanine and
an assortment of mostly bulky hydrophobic residues that may include isoleucine, leucine,
methionine, valine, and/or threonine. Layers between the heme-ligating and middle layers
(blue in Figure 1.7) have part of the heme projecting into them, so they tend to have smaller and
more flexible amino acids such as alanine, proline, glutamine, leucine, valine, threonine, and
methionine. The presence of polar and helix-breaking amino acids may be more tolerable in a
membrane than in solvent. Therefore, a- and d-positions in a water-soluble maquette should
avoid these residues with the exception of the notch glycines, which appear to be critical to the
heme B affinity and electron transfer function of cytochromes b and b6.
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1.2.5 The role of the apo-state in heme binding
It is intuitive that a heme-binding protein should have hydrophobic core packing that
complements the shape of the heme cofactor to produce a native-like holo-state, but it is also
instructive to consider the structure of the apo-state in the absence of heme and how it might
transition to the heme-bound holo-state. Should an apo-hemoprotein be rigidly structured
before the heme arrives, should folding be driven by heme binding, or is the apo-state structure
irrelevant to heme binding? Studies of natural hemoproteins in the apo-state shed light on the
structural requirements of the apo-state of a high-affinity heme binding structure.
One of the best-studied natural hemoproteins is myoglobin. Apo-myoglobin has
relatively low stability and in some ways resembles a molten globule, but it has ordered
secondary structure as well as specific and stable tertiary interactions that show it is a nativelike globular protein (192). However, apo-myoglobin does have a highly plastic apo-state
structure, which has led to the suggestion that heme binding drives a final transition to a stable,
highly-structured, native-like holo-state (193). A similar native-like structure with folding
intermediate-like properties has been observed in other apo-state B-type hemoproteins
including apo-cytochrome P450 (194), apo-cytochrome b562 (195), and apo-cytochrome b5 (196).
It should be noted, however, that proteins that bind heme transiently usually have more stable
apo-state folds than proteins that bind heme permanently (197). This may reflect a decreased
pressure for high affinity heme binding and increased pressure for apo-protein resistance to
aggregation and proteolysis in proteins that bind heme transiently. It has been observed that
natural hemoproteins in general are biased toward heme binding sites that have “low
foldability” (198). This pattern suggests that a heme-binding protein, which must accommodate
the bulky hydrophobic porphyrin ring of heme, needs some degree of plasticity to allow the
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entry of heme into a binding pocket. Apo-protein flexibility lowers the enthalpic cost of heme
binding by decreasing the number of protein-protein interactions that must be broken for heme
to enter the binding site, but a partially pre-formed active site with native-like structure lowers
the entropic cost of heme binding by lowering the conformational freedom of the apo-protein.
In their study of cytochrome b5, Falzone et al. termed this the “partial fold option” to convey a
balance of flexibility and native-like structure in the apo-protein that facilitates high-affinity
heme binding (196).
Some support for the partial fold option also comes from studies of de novo-designed
hemoproteins. For example, the HP-1 maquette binds two hemes B with high affinity
(dissociation constants less than 20 nM). HP-1 has a molten-globular apo-state but transitions
to a structurally specific conformation upon the binding of heme B (154). In contrast, a
maquette with a very similar sequence that has a rigid, singularly-structured apo-state
transitions to a molten globular state when heme binding disrupts core packing interactions,
suggesting an advantage for hemoproteins that are flexible in the apo-state (199). However, a
heme maquette that is unfolded in the apo-state may not be ideal either. A D2-symmetrical
tetrameric heme maquette that was unfolded in the apo-state showed very slow heme binding
that required hours to reach completion, and an unusually low extinction coefficient was
reported for its Soret maximum, suggesting incomplete binding even after a day (141).

1.2.6 Due Ferro series of maquettes
A series of maquettes from the DeGrado and Lombardi groups and collaborators called
Due Ferro proteins (200) were used to recapitulate functions of natural binuclear non-heme iron
enzymes such as ferroxidase activity of bacterioferritin (201-205) and quinol oxidase activity of
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alternative oxidase (132, 205, 206). Numerous NMR and X-ray crystallographic structures of
Due Ferro maquettes have shown that the maquettes fold very similarly to the natural proteins
and bind various metal ions with high affinity including Mn(II), Fe(II), Fe(III), Co(II), Zn(II), and
Cd(II) (188, 202, 206-211). These natural and de novo four-helix bundle proteins ligate two
metal ions in a deep water-filled cavity using two histidines, two bridging glutamates, and two
axial glutamate residues. The histidines ligate the metal ions using the Nδ atom and typically
make second shell hydrogen bonds to aspartate residues using the Nε atom. Tyrosines are often
used to make second-shell hydrogen bonds to a bidentate axial glutamates (Figure 1.8).

Figure 1.8: Canonical carboxylate-bridge diiron protein active site
Bacterioferritin monomer (left) and close-up of the active site (right) (PDB ID: 1BCF) (175).
Manganese(II) ions are represented as mauve spheres, and hydrogen bonds between Asp and
His residues and between Glu and Tyr residues are represented by blue dotted lines. Images
rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

Just as notch glycines were found to be important for the function of cytochrome b,
iterative redesigns of the Due Ferro series demonstrated that cofactor binding can be improved
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by using active site glycine residues to make space for the cofactor. DF1 was originally designed
with a set of four leucine residues occluding the di-metal binding site, and it had to be
denatured and refolded in the presence of metal ions before binding could take place (207,
212). In subsequent designs, these Leu residues were changed to smaller amino acids,
progressively trading stability for increasing metal ion affinity and substrate access. DF2, which
had two of the Leu residues mutated to Ala, had high affinity for metal ions without the need for
denaturation. In addition, DF2 exhibited ferroxidase activity, whereas DF1 did not (204, 212). In
DF3, which had all four Leu residues changed to Gly, the affinity for Co(II) and Mn(II) was about
two orders of magnitude higher than in DF2 (189), and DF3 was able to catalyze the oxidation of
bulky phenol compounds (188).
Glycine residues at the opening of the metal site cavity in DF3 also facilitated oxygendriven oxidation of substrate molecules including hydroquinones and anilines (188, 206, 213). A
recent study showed that a semiquinone could be stabilized by binding to a di-Zn(II) site in a Due
Ferro variant that had two glycines and two alanines at the opening of the cavity. Interestingly,
hydrophobic interactions were identified as a critical driving force for the binding and
stabilization of the semiquinone (214). Despite the highly polar contents of the metal binding
cavity, hydrophobic molecules are able to make stabilizing contacts with the glycine and alanine
residues at the opening of the metal site. The site is wide enough that it could conceivably
accommodate a much larger molecule, such as a porphyrin.

1.2.7 Negative design
An important aim of any protein design project is to make a protein with a singular,
native-like conformation. Negative design is necessary to widen the energy gap between the
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intended design and alternative conformations, so that the protein cannot exist in multiple
conformations at once. In a four-helix bundle, the primary concern in that the threading of the
helices, or the helix topology, could be arranged incorrectly; there are many ways for the helices
to align in a four-helix bundle, and in the absence of negative design, they may have similar
energies. While it is true that some functions can be achieved in a protein that exchanges
between multiple conformations, this is not the case for a reaction center maquette that must
site-specifically assemble a di-metal center and two tetrapyrroles into an electron transport
chain. In a Due Ferro-type active site (177, 200, 207), any alternative helix threading topology
other than the intended design would change the organization of metal-ligating histidines and
glutamates such that metal affinity would be greatly reduced. In the tetrapyrrole-binding
section of a reaction center maquette, a reversal of the threading from left-turning antiparallel
to right-turning antiparallel would not affect the geometry of ligation, but a parallel/antiparallel
topology would leave a distorted binding cavity and the histidines would be in the wrong
positions for stable tetrapyrrole ligation. Furthermore, a maquette without a singular, nativelike conformation is not suited for high-resolution structure determination, so it would be
difficult to verify that the protein folded as designed or to ascribe structural features to
functional effects.
We have at our disposal several tools to favor the target design including factors that
can destabilize the unintended helix topology relative to the correctly folded state and factors
that can stabilize the intended topology relative to the misfolded state. For one thing, a singlechain monomeric four-helix bundle would need to have inter-helical loops that are at least as
long as a helix in order to have more than two helices with a parallel orientation. Short loops
obviate the possibility of a topology with all helices parallel or with three helices parallel and
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one antiparallel. Structured loops can be designed to favor a left- or right-turning topology,
although loops usually have a weaker effect on topology than helix-helix interactions. Another
significant factor in determining helix topology is hydrophobic core packing. Four-helix bundle
stability is maximized when hydrophobic contact between helices is complementary, so a loss of
complementarity in an alternative topology favors the intended design (170, 171).
Perhaps the most easily controlled structural element that influences helix topology is
inter-helical charge pairing interactions. Early work on leucine zippers demonstrated the power
of charge pairing in dictating coiled coil folding. Mutagenesis and pH titrations on the
heterodimeric leucine zipper Fos-Jun human oncoprotein showed that charge pairing e- and gpositions destabilized the Fos and Jun homodimers while stabilizing the heterodimeric state
(215). A rigorous study of mutants of the homodimeric VBP leucine zipper showed that altered
charge patterning at e- and g-positions could make VBP fold as a heterodimer of two mutants
with complementary charges (166). Charge patterning was soon leveraged to dictate folding in
simple Rop-like antiparallel de novo four-helix bundle designs (170, 171), and later in more
complicated functional antiparallel four-helix bundles. In a set of tetrameric Due Ferro
maquettes, the DeGrado group used charge pairing interactions at b-, c-, e-, and g-positions to
specify heterotetrameric assembly of metal-binding maquettes. When the component peptides
were kept separate, they did not fold at neutral pH, but when the peptides were mixed together
in the proper stoichiometries circular dichroism measurements showed high α-helical content
(216, 217). Similarly, charge pairing interactions at c-positions were used in a series of
porphyrin array (PA) antiparallel four-helix bundle maquettes to help force the intended
topology, and various methods demonstrated folding and function, but no high-resolution
structures were obtained to verify the structure (139, 142, 152, 218).
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1.2.8 Inter-helical loops
The inter-helical loops of a four-helix bundle protein are usually among the most
dynamic parts of the protein, but they can play a role in determining the structure. A short loop
can force the helices it connects to be antiparallel instead of parallel, and loops can have a
significant influence on the overall stability of the bundle.
A loop that is too long will decrease the stability of the four-helix bundle by raising the
entropic cost of folding. Indeed, a study on the helix-loop-helix Rop protein, which folds into a
homodimeric antiparallel four-helix bundle, showed that when the native Asp-Ala loop was
replaced by a polyglycine linker, increasing the number of glycines in the linker progressively
lowered the melting temperature. The mutant with 10 loop glycines denatured at a
temperature 23°C lower than that of the mutant with a single glycine in the loop. It was
estimated that each loop glycine lowered the stability of Rop by 0.26 kcal/mol (219). A loop that
is very short, however, may sometimes cause misfolding or aggregation, as was observed in the
α2B(P) maquette (220) and Rop variants with altered loops (221). The latter study demonstrated
that the wild-type homodimeric Rop could be converted to a monomeric four-helix bundle by
adding polyglycine loops to connect the helices. While a 3-glycine loop resulted in aggregation,
the variant with 4 loop glycines was monomeric with comparable RNA substrate affinity and
higher stability than the wild-type (221). In a similar manner, the single-chain four-helix bundle
maquette BT6 was developed from a homodimeric helix-loop-helix maquette by rearranging the
loops. In this case, 9-residue glycine-rich linkers were used to produce the single-chain BT6,
which retained its affinity for heme and was expressible in E. coli (124).
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The designed loops described above are all glycine-rich unstructured loops, which are
usually sufficient to make stable, functional maquettes, but a structured loop can add stability to
the protein. However, the design of a stable loop in a four-helix bundle is difficult because it
lacks a stable secondary structure, is highly exposed to solvent, and is located at the ends of the
helices where the protein is most dynamic. The DeGrado group has explored the use of loop
structures that are found in natural proteins to connect the helices of four-helix bundles. In the
di-metal maquette DF2t, a structured loop was found to increase stability and expression yield
(222), and a similar maquette, DF3, used a different loop conformation to confer even greater
stability and solubility (188). X-ray crystal and NMR structures demonstrated that the loops
folded as designed. While a structured loop sometimes can impart subtle improvements to a
protein’s structure, unstructured loops are generally sufficient, because four-helix bundle
folding and function is dictated primarily by the α-helices.

1.2.9 Four-helix bundle length
Natural four-helix bundles usually have a length of about 15 to 24 residues per α-helix
(223), but longer four-helix bundle proteins have been reported, and several natural 2-helix and
3-helix coiled coils are considerably longer. In 2008, a de novo-designed two-porphyrin array
(2PA) four-helix bundle maquette with 34 residues per helix was lengthened by duplicating a
three-heptad sequence (and introducing a total of five mutations per helix to ensure the correct
charge pairing interactions) to make a four-porphyrin array (4PA) maquette with 55 residues per
helix. The extension of the helices raised the holo-state melting temperature by 24°C (139,
152). In a systematic study of four-helix bundle length and stability, a peptide sequence based
on the Lac repressor tetramerization domain was extended from 21 to 28 to 35 amino acids, and
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its four-helix bundle stability increased by approximately 16 kcal/mol for each heptad added
(153). The increased stabilization due to lengthening is an effect of the increased burial of
hydrophobic surface area.

1.2.10 Caps at helical termini
The termini of α-helices in four-helix bundles tend to fray, making them among the least
stable parts of the protein (218, 224), which means that end caps can play a significant role in
stability despite their small size. For example, when a single 5-residue MTPEQ N-cap was added
to the N-terminus of BT6, the apo-state melting temperature increased from 37 to about 45°C
(124). Similarly, when the tetrameric four-helix bundle maquette 4PA was given four SLEEA Ncaps and four FQKFQKYG C-caps, they increased the apo-state melting temperature by about
57°C; the caps had a greater stabilizing effect than the lengthening of 2PA by three heptads to
make 4PA (152).
N- and C-termini are unstable because the absence of a continuing bundle leaves them
solvent-exposed, and the absence of a connecting loop leaves their motion largely unrestricted.
An analysis of N-caps in nature shows a significant preference for proline in the N-cap (225).
This is because proline addresses both the solvent exposure and conformational freedom of
helical termini: proline is the most water soluble of all natural amino acids, and it is constrained
to an α-helical conformation (226). In addition, the absence of a hydrogen-bond acceptor for Nterminal backbone amine groups is not an issue for proline, because it has a pyrrolidine side
chain in place of an N-H bond. Outside of an N-cap, however, proline is a strong helix breaker
because the pyrrolidine group blocks the preceding residue from adopting an α-helical
conformation (226). Unfortunately, an N-terminal proline presents a problem for TEV protease,
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which is inhibited by a proline residue close to its site of cleavage (227). N-caps in natural
proteins also show a preference for Asn, Asp, Gly, and Ser residues immediately before the Pro
(225, 228). These residues can adopt non-helical conformations that can hydrogen bond
backbone amines at the N-terminus of the helix (225). In addition, natural N-caps frequently
contain negatively charged residues, because these help stabilize the helix dipole moment which
runs from N- to C- terminus, in the direction of backbone C=O bonds and against backbone N-H
bonds. In the same way, C-caps can stabilize helices by using positive charges to align the helix
dipole (229). However, C-caps do not have any other simple rules of thumb. Natural proteins
frequently use Gly at C-caps, but this is because they are often found in the more complicated
Schellman and αL capping motifs (225, 226, 228). While Gly residues are sometimes added to
designed proteins at the C-termini (139, 207, 218), they may not affect stability unless residues
around them cooperate to fold into specific capping motifs (228).

1.2.11 Summary
Taken together, the above considerations provide a framework for designing a fourhelix bundle maquette. The most important tool available to a protein designer is an awareness
of the literature that is relevant to the protein to be designed. The structure and function of a
protein is determined by a complex system of interactions, each of which may vary in strength
depending on contextual details, and intuition alone cannot be relied upon as a robust predictor
of structure; rational design requires guidance from empirical observations.
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Chapter 2: Design and characterization of a reaction center
maquette
In order to stabilize a light-activated charge separated state, a working reaction center
requires, at a minimum, an electron acceptor, a light-absorbing pigment molecule, and an
electron donor. Various cofactors can be used to satisfy these roles, and previous work in de
novo protein design has produced helical bundle maquettes capable of assembling hemes (1-3),
zinc tetrapyrroles (2, 4, 5), redox-active amino acids (6-8), and di-metal centers (9, 10), but no
maquette has been made to assemble all of these cofactors into a single working scaffold. Such
a maquette would have to be larger and more complex than a typical maquette in order to
assemble all of these cofactors. Furthermore, a reaction center maquette has added
constraints; cofactors must be recognized by their respective active sites and not bind to
incorrect sites, and the inter-cofactor distances and local environments need to be tuned to
enable light-driven electron transfer with rates appropriate for charge separation. This chapter
will describe the design and initial characterization of a working reaction center maquette.

2.1 Crystallization trials with BT6, a multifunctional heme-binding maquette
2.1.1: Structure and function of BT6
The de novo-designed four-helix bundle protein BT6, named after its designers Bruce
Lichtenstein and Tammer Farid, is a heme binding maquette from the Dutton lab that is capable
of multiple functions (2). BT6 has demonstrated light-activated electron transfer functions
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involving zinc porphyrins, zinc chlorins, flavins, and heme. It is also capable of electron transfer
to cytochrome c, energy transfer, and oxygen binding (2).
The light-driven electron transfer function of BT6 represents a first step toward a
working reaction center. The wild type form of BT6 has two bis-histidine heme binding sites,
and mutation of one heme-ligating histidine amino acid to alanine in one of the heme sites
renders that site unable to bind heme but still able to bind zinc tetrapyrroles. Light absorption
by the zinc tetrapyrrole (the pigment) creates a high-energy zinc tetrapyrrole excited state that
reduces the heme electron acceptor. Since there is no electron donor in BT6 to trap heme in
the reduced state, the electron quickly tunnels back to the strongly oxidizing zinc tetrapyrrole
radical cation and to regenerate the ground state. If a sacrificial electron donor such as aniline is
added to the solution, it can reduce the zinc tetrapyrrole radical cation before reduced heme
does, which would trap the heme in the reduced state. Since heme is bound to same protein as
the zinc tetrapyrrole ~19 Å away, it usually outcompetes the aniline reaction, but over extended
periods of continuous illumination and at high aniline concentrations, heme can be converted
from the oxidized to the reduced form over several minutes, as shown in Figure 2.1 (2).
Figure 2.1: Charge separation in BT6
using a sacrificial electron donor
A BT6 mutant with heme B and Zn
protoporphyrin IX (ZnP) is able to drive
heme reduction under illumination in
the presence of aniline. This is
observed by a band shift in the
ultraviolet/visible spectrum. The light
minus dark difference spectrum is
identical to a reduced heme minus
oxidized heme difference spectrum.
Figure reproduced from Farid et al.,
2013 (2).
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BT6 is a four-helix bundle but does not appear to be a canonical coiled coil; a precursor
of BT6 with a very similar sequence, L31M, was crystallized in the apo-state and showed very
straight α-helices with a slight right-handed supercoil instead of the typical left-handed twist of
normal coiled coils (11). Also, the helices of BT6 and its precursors rotate to allow heme
binding, which partially buries several glutamic acid residues, giving rise to an unusual, strained
conformation (2, 12). As a result, BT6 in the holo-state might be quite different from the
previously solved apo-state structure of L31M (11). No high-resolution structure of BT6 has
been solved, but the many functions and unusual structural properties of BT6 make it a
worthwhile target of structural studies.
The sequence of BT6 is given below, with each helix on a new line and loops separated
from helical sequences by a space. Heme-ligating histidines are shown in red. The sequences of
all four helices are identical, as are all three flexible 9-residue glycine-rich loops (2):
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQL (C-terminus)

2.1.1 Efforts to crystallize BT6
BT6 has all the requirements for crystallographic structure determination. It binds its
heme B cofactors with high affinity (both heme dissociation constants are less than 2 nM), it is
stable in the holo-state (with a melting temperature close to 80°C), and it has well-dispersed
NMR peaks in the holo-state (2). Unfortunately, its highly repetitive sequence makes structure
determination by NMR extremely difficult. Past attempts at crystallography have shown BT6
and similar maquettes to be recalcitrant to crystallization, possibly because of the long, flexible
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loops and the many charged surface amino acids that give the maquette an overall charge of
about −16 at neutral pH.
Here, another attempt at BT6 crystallization was made. BT6 was expressed in E. coli
with an N-terminal His6 tag and purified by Ni-NTA column chromatography. This His6 tag was
removed by TEV protease, and the TEV protease, His6 tag, and uncleaved maquette were
removed with a second Ni-NTA column. A size exclusion column yielded monomeric BT6
protein, and after adding heme B, BT6 was ready for crystallization trials.
Several months of crystallization trials eventually yielded small red crystals that were
not suitable for diffraction. A 500 μM BT6 stock solution was prepared in 10 mM MgCl2 with 10
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer at pH 7.5. Small,
irregular crystals were grown in hanging drop experiments at 4°C over well solutions of 50-600
mM MgCl2 and ~28-34% w/v polyethylene glycol monomethyl ether with an average molecular
weight of 2000 Da (PEGMME 2000). Well solutions were not buffered, as several different
buffers were found to disrupt crystal formation. Shown below in Figure 2.2 is an example of the
crystals observed. This crystallization drop includes crystals of various morphologies including
needles, semicircular plates, and roughly hexagonal plates. Their red color shows that heme is
present in the crystals. Lengths of BT6 crystals rarely exceeded ~1 μm.
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Figure 2.2: BT6 crystals
not suitable for X-ray
diffraction
Crystals were
photographed after 3
weeks of growth at 4°C.
Well solution was 300
mM MgCl2, 32% w/v
PEGMME 2000, and 1
mM HCl to adjust the pH.
The crystallization drop
contained 2 μL BT6 stock
solution and 2 μL well
solution. (Crystallization
drop is labeled Tray B24,
well D2).

2.1.2 Improved crystal growth in a modified BT6, BT6_2sl
Crystallization is often inhibited by flexible protein domains. The three long, 9-residue
loops of BT6 are designed to be unstructured linkers. This length is unlikely to be necessary, as
previous work has shown that four-helix bundles rarely require more than four residues in interhelical loops for proper folding (13, 14). For this reason, crystallization trials were attempted
with a BT6 variant with shortened loops. The middle loop of BT6 is believed to cross the bundle
diagonally from helix 2 to helix 3, and may need to be longer; the second loop was left at 9
residues. The onerous task of site-directed mutagenesis in a maquette with such a repetitive
sequence was tackled by fellow graduate student Joshua Mancini, who shortened loops 1 and 3
to 5 residues. The resulting sequence of BT6_2sl (also referred to as BT6sloop) is given below.
The BT6_2sl sequence is identical to BT6, except for the two shortened loops.
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGSGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGG
EIWKQHEDALQKFEEALNQFEDLKQL (C-terminus)
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A new round of crystallography with BT6_2sl following the same procedure as with BT6
gave improved results, including X-ray diffraction to ~6-7 Å resolution using rotating copper
anode X-ray generator (see section 7.5 of the appendix for details). However, this resolution is
not high enough to solve the crystal structure. BT6_2sl crystals were grown using a 760 μM
BT6_2sl stock solution in 10 mM MgCl2, 10 mM HEPES buffer at pH 7.5. BT6_2sl crystals grew in
similar conditions to BT6: hanging drops at 4°C over well solutions of 100-600 mM MgCl2 and
~20-34% w/v PEGMME 2000. Crystals grew with an unusual semicylindrical morphology and
were embedded in films that formed on the surface of the drops or on the cover slides and were
somewhat difficult to extract for X-ray diffraction. Shown below in Figure 2.3 are two examples
of BT6_2sl crystals that diffracted to ~6-7 Å resolution using a rotating copper anode X-ray
source. The spacing between reflections was consistent with an asymmetric unit similar to the
expected dimensions of a BT6_2sl monomer. However, many X-ray reflections appeared to be
missing from the diffraction pattern, suggesting significant disorder in the crystals. A full data
set was not collected.
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Figure 2.3: BT6_2sl crystals that diffract X-rays to 6-7 Å resolution
Two examples of BT6_2sl crystals that diffracted to 6-7 Å resolution. Before X-ray diffraction,
crystals were dipped in a cryoprotectant similar to the well solution with increased PEGMME
2000 and MgCl2 concentrations. Left: Three-week old BT6_2sl crystals grown at 4°C over a
well solution of 600 mM MgCl2 and 26% w/v PEGMME 2000. Right: Two-year old BT6_2sl
crystals grown at 4°C over a well solution of 400 mM MgCl2 and 23% w/v PEGMME 2000.

2.1.3 Promising results from BT6_3sl crystallography
Given the impact that shortened loops made on crystal quality in BT6_2sl, it was
hypothesized that shortening the second loop also would further improve the crystal
morphology and diffraction quality. Joshua Mancini used site-directed mutagenesis to shorten
the second loop to create BT6_3sl, in which all three loops are shortened to five residues:
(N-terminus): GEIWKQHEDALQKFEEALNQFEDLKQL GGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGG
EIWKQHEDALQKFEEALNQFEDLKQL GGSGG
EIWKQHEDALQKFEEALNQFEDLKQL (C-terminus)

BT6_3sl was expressed and purified using a similar procedure to BT6. There was no sign
of weakened affinity for heme B in BT6_3sl, and initial attempts at crystallographic structure
determination have been pursued using a stock solution of 870 μM BT6_3sl with 10 mM MgCl2
and 5 mM HEPES buffer at pH 7.5. Like BT6, BT6_3sl crystals grew at 4°C over well solutions of
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~24-30% w/v PEGMME 2000 and 100-600 mM MgCl2. BT6_3sl growth was best when the
crystallization drop had a pH of about 7.0, but crystal growth was disrupted by buffer, as with
other BT6 variants. BT6_3sl crystal morphology is greatly improved relative to BT6_2sl and BT6.
While the crystals remain small (less than 10 μm in length), they tend to grow in the shapes of
hexagonal prisms rather than thin semicylinders. Crystals appeared within a day and continued
growing for about 5 days. Only one crystal so far has been mounted for X-ray diffraction, and it
only diffracted to ~12 Å resolution, but there did not appear to be any missing reflections as
there were with BT6_2sl. The preliminary low resolution of BT6_3sl X-ray diffraction is probably
limited by the small size of the crystals (~1-10 μm in length) rather than problems with disorder
in the crystals. Some examples of BT6_3sl crystals are shown in Figure 2.4.

Figure 2.4: BT6_3sl crystals grow with improved morphology compared to BT6 and BT6_2sl
Left: Five-month old BT6_3sl crystals grown at 4°C over a well solution of 300 mM MgCl2 and
25.5% w/v PEGMME 2000. Right: Five-month old BT6_3sl crystals grown at 4°C over a well
solution of 200 mM MgCl2 and 26% w/v PEGMME 2000.

While the crystal structure of BT6 has not yet been solved, the current results are very
promising. It is interesting to note that the crystallization conditions of BT6 are similar to the
conditions used for crystallization of the apo-state of its precursor, the L31M maquette. L31M
crystals grew from well solutions with 30% w/v PEGMME 2000, similar to BT6. However, the
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L31M condition also had 100 mM HEPES buffer (which disrupts BT6 crystal growth), it did not
contain MgCl2, and the crystals grew at 28°C instead of 4°C. Still, it may be worthwhile to test
the cryoprotectant that was favored for L31M (30% v/v PEG 550 and 30 mM HEPES buffer at pH
7.4) (11). Better crystals might also grow from the use of higher purity protein, such as that
purified by high-performance liquid chromatography (HPLC). Future work is likely to produce a
high-resolution BT6_3sl structure that may elucidate the mechanisms of different functions in
BT6.

2.2 Design of the reaction center maquette MZH3
The trapping of a reduced heme state in BT6 is an important step toward developing an
artificial reaction center maquette, but the ultimate goal is water oxidation and fuel generation.
BT6 is not equipped to incorporate additional cofactor binding sites that will be necessary to
achieve this function.
A new maquette was designed to function as a simplified reaction center by
incorporating electron donors, a pigment, and an electron acceptor. The maquette was named
MZH3 for the cofactors it binds: Metal, Zinc tetrapyrrole, and Heme. The design of MZH3 makes
use of the extensive literature on four-helix bundle design that has been built up since Regan
and DeGrado made their first de novo four-helix bundle protein in 1988 (15). MZH3 was
designed to have an antiparallel topology, which is common to the natural carboxylate-bridged
diiron and dimanganese family of proteins as well as cytochromes b and b6. MZH3 is a 196amino acid protein with an extinction coefficient of 12,490 M-1cm-1 at 280 nm, a molecular
weight of 22.5 kDa, and a theoretical isoelectric point at pH 5.5 in the apo-state (calculations
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performed using ExPASy ProtParam online server) (16). The sequence of MZH3 in its singleletter amino acid code is:

GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEKARNPEKKSVLQKILEDEEKHIELLETLQ
QTGQEAQQLLQELQQTGQELWQLGGSGGPELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETILG
GSGGDELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG

A more informative depiction of the sequence of MZH3 is given in Table 2.1. The
winding “snaked” sequence in the second row, which is written backwards in helices 2 and 4,
shows which amino acids form layers together in the hydrophobic core.
heptad
positions
MZH3
“snaked”
sequence
MZH3 N-toC forward
sequence

(N)Forward: efgabcdefgabcdefgabcdefgabcdefgabcdefgabcdef
(C)
(C)Reverse: gfedcbagfedcbagfedcbagfedcbagfedcbagfedcbagf
(N)
(N-term) →GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN → (C)
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLTELLEIHKEEDELIKQLVSKKEP ← (N)
(N) →
PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG → (C)
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGLQQLERYQKIGQLEGKLLERLED
← (N)
(N-term) GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN
(C)
(N)
PEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQL GGSGG (C)
(N)
PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG
(C)
(N)
DELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLWQLG (C-term)

Table 2.1: Amino acid sequence of MZH3
Coiled coil heptad positions a through g are denoted in the top row for both forward (N- to Cterminus) and reverse (C- to N-terminus) sequences, and they are aligned with corresponding
positions in the MZH3 amino acid sequences. Residues highlighted yellow are a-position
residues. The MZH3 amino acid sequences have each helix written on a new line with loops
separated from the helices by a space. The N- and C-terminal ends of each helix are denoted
by the letter in parentheses at either end of each helix, and “N-term” and “C-term” denote
termini of the protein. Green amino acids belong to the cytochrome b-like tetrapyrrole
binding section of MZH3, whereas blue amino acids belong to the Due Ferro-like di-metal
binding section of the protein. In the MZH3 “snaked” sequence, helices 2 and 4 are written in
reverse so that amino acids that are spatially close together in the folded protein are close
together in the snaked sequence diagram. Red boxes enclose layers of the hydrophobic core,
each of which includes two a- and two d-position residues. The N-to-C forward sequence is
written conventionally, from the N-terminus to the C-terminus.
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2.2.1 Use of the Due Ferro maquette sequences in MZH3
The electron donating section of the photosystem II reaction center has a Mn4Ca water
oxidizing cluster and tyrosine Z, which transfer electrons to the pigment P680 when it becomes
oxidized (17). The design of MZH3 sought to reproduce this electron transfer pathway in a fourhelix bundle, and perhaps the most obvious template for such a design is the family of
carboxylate-bridged diiron and dimanganese proteins that are diverse in function but similar in
structure (18). This scaffold was recreated in the Due Ferro series of maquettes created by the
DeGrado and Lombardi groups and collaborators (9). The carboxylate-bridged diiron fold usually
includes one or two tyrosine amino acids that form hydrogen bonds with glutamates. In some
cases, such as bacterioferritin and ribonucleotide reductase, these tyrosines function as redoxactive cofactors (19, 20). Given the success of the Due Ferro maquettes, the sequence of one of
these proteins was used as the metal and tyrosine section of the protein with some adaptations.
The Due Ferro section of MZH3 was based primarily on the sequence of DF3, a helixloop-helix dimeric 4-helix bundle maquette protein that can bind two metal ions and was
originally used for ferroxidase and phenol oxidase activity (21, 22). DF3 has higher affinity for
metal ions than previous Due Ferro proteins, and its four active site glycines allow for a wide
cavity that facilitates efficient entry and exit of substrate molecules and may allow space for a
larger metal cluster to assemble, such as one close to the size of the oxygen evolving cluster of
photosystem II. However, these helical glycines make DF3 less stable than previous Due Ferro
proteins. The design of MZH3 compensates for this instability with its length and by using a
single-chain monomeric rather than noncovalent dimeric folded state.
To avoid undesirable side reactions, redox-active amino acids near the di-metal site
were removed. A single tyrosine was kept between the metal center and the pigment as an
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intermediate electron donor, similar to tyrosine Z of photosystem II. Two interfacial Trp
residues were changed to Leu, one Tyr was changed to Glu, and one of the two active site
second-shell Tyr residues was mutated to Leu (see Table 2.2). A Tyr to Phe mutation might have
been more conservative than Tyr to Leu, but studies involving the single-chain Due Ferro variant
DFsc showed that the Y51F mutation resulted in sample heterogeneity and was not amenable to
spectral analysis. Instead, the Y51L mutation was selected as an alternative because Leu has a
similar Stokes radius to Tyr; Y51L was useful for spectroscopy (23).

heptad
positions
DF section
of MZH3
“snaked”
sequence
DF3
“snaked”
sequence

(N)Forward:
(C)Reverse:
(N-term) →
(C) ←
(N) →
(C-term) ←

efgabcdefgabcdefgabcdefg
gfedcbagfedcbagfedcbagfe
... RELLKGELQGIKQLREASEK ARN
... TELLEIHKEEDELIKQLVSKKEP
... AKILEDEEKHIELLETIL GGSGG
... ERYQKIGQLEGKLLERLED

→
←
→
←

(C)
(N)
(C)
(N)
(C)
(N)

(N-term) →
DYLRELLKGELQGIKQYREALEY THN
→ (C)
(C-term) ←
GLITELWEIHKEEDELIKALVP
← (N)
(N) →
PVLAKILEDEEKHIEWLETILG
→ (C-term)
(C) ←
NHT YELAERYQKIGQLEGKLLERLYD
← (N-term)
(N-term) →
MDYLRELYKLEQQAMKLYREASEK ARN
→ (C)
DF2t
(C-term) ←
GNITELWEIHKEEDELIKQLVSKKEP
← (N)
“snaked”
(N)
→
PEKKSVLQKILEDEEKHIEWLETING
→
(C-term)
sequence
(C) ←
NRA KESAERYLKMAQQELKYLERLYDM
← (N-term)
Table 2.2: Comparison of the Due Ferro section of MZH3 to DF2t and DF3 sequences
Residues written in orange line the active site and are thought to be important for metal
binding affinity and catalysis (21). Residues of MZH3 in red are found in neither DF2t nor DF3,
and were selected in order to remove redox-active amino acids or to connect helices using a
flexible linker. Loops are separated from the helices by a space. Residues highlighted yellow
are in a-positions. The termini of each helix are denoted by the letter in parentheses at either
end of each helix.

2.2.2 Tetrapyrrole binding section of MZH3
While Due Ferro maquettes are compatible with the envisioned structure and function
of MZH3, no tetrapyrrole binding maquette precisely suits the needs for the tetrapyrrole section
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of MZH3. In addition, high-resolution structures of any maquette with tetrapyrroles bound do
not exist, so the predicted structures have not been confirmed. By designing a new tetrapyrrole
binding section, inter-cofactor distances can be more precisely controlled, the structure can be
tailored to help it join seamlessly to the Due Ferro section of the maquette, and important
lessons learned from years of research on four-helix bundle sequence and structure that appear
to have been neglected in some maquettes can be implemented in full force to build a uniquelystructured high-affinity multi-cofactor binding protein.
Charge separation in an MZH3 tetrad should be optimized if the rate of electron transfer
between the pigment and acceptor is slowed relative to the donor-to-pigment rate. This can be
accomplished by using a long pigment-acceptor distance and short donor-pigment distance. If
the pigment-acceptor distance is too long, however, the excited state of the zinc tetrapyrrole
will decay before electron transfer can take place. Cytochrome b from the bc1 complex, with its
~12 Å distance between hemes (24), is close to optimal for the purposes of MZH3. For this
reason, general structural attributes of cytochrome b were reproduced in the MZH3 design. The
sequence of cytochrome b, however, would not work in a soluble maquette, because
cytochrome b is a transmembrane four-helix bundle. Cytochrome b has many nonpolar residues
on its exterior, and helical propensities of amino acids are very different in nonpolar membrane
environments; while glycines, prolines, and buried polar groups like glutamines and threonines
are all tolerated quite well in a helical membrane protein, these residues would induce
misfolding and aggregation in a water soluble maquette.
Layers of core a- and d-position amino acids in MZH3 followed the general layering
pattern of cytochrome b. The design of MZH3 made use of the universally conserved hemeligating histidines and notch glycines of cytochrome b (24). The histidines were placed at d71

positions and the glycines at a-positions. At the zinc tetrapyrrole site, one histidine was
changed to isoleucine, since zinc tetrapyrroles have a pentacoordinate zinc ion and only one
ligand is needed. Isoleucine was the residue chosen for a similar role in a four-helix bundle
maquette that bound a synthetic zinc porphyrin (25). The d-position histidines were designed to
make second shell hydrogen bonds to g-position threonines, as in cytochrome b. A hydrogen
bond between a porphyrin-ligating histidine and a threonine has been incorporated into a
maquette previously, and electron paramagnetic resonance (EPR) measurements with and
without the second shell threonine indicated that the hydrogen bond tilted the imidazole rings
of the histidines (26). Two a-position arginines were placed near the N-termini of helices 1 and
3 in order to try to make salt bridging interactions with propionate groups as observed in
cytochrome b and to prevent hydrophobic collapse of the apo-state of the acceptor site, which
might inhibit cofactor binding.
The three layers between the hemes of cytochrome b are subject to considerable
variation across different species, but there are patterns in the total sizes of the layers (27). The
bulkiest amino acids are in the middle layer (yellow in Figure 2.5, left). In the corresponding
positions in MZH3, Phe and Ile were placed at the d-positions and Leu and Val were placed at
the a-positions. The intermediate layers between the middle and histidine layers (blue in Figure
2.5, left) were composed of small and flexible Ala and Leu residues to accommodate the
presence of part of the tetrapyrrole ring.
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Figure 2.5: Layers in natural proteins
Structure of cytochrome b subunit from
cytochrome bc1 complex is shown at left
with heme B cofactors represented as
sticks (PDB ID: 1EZV) (24).
Bacterioferritin monomer is shown at
right with Mn(II) ions represented as
mauve spheres in the center (PDB ID:
1BCF) (28). Core a- and d-position amino
acid side chains are represented as
spheres. These residues segregate into
layers which are distinguished by color.
The basic idea of the MZH3 design is to
merge a green layer from a cytochrome
b-like structure and a green layer from a
bacterioferritin-like structure to make a
reaction center maquette. Images
rendered using The PyMOL Molecular
Graphics System, Version 1.7
Schrödinger, LLC.

2.2.3 Helix-helix interfaces in MZH3
Designing MZH3 to have proper distances between adjacent helices (interface widths),
is a serious concern in the joining of these two very different protein modules. (Figure 2.6
shows a helical wheel diagram of an antiparallel four-helix bundle). Natural carboxylate-bridged
diiron proteins tend to have e-position alanines to stabilize narrow, tightly packed e-e interfaces
to make the canonical ferritin-like Alacoil (18, 29). In contrast, as described in the introduction,
cytochrome b and other heme-binding antiparallel four-helix bundle proteins tend to bind heme
so that the porphyrin ring lies parallel to the g-g interface and expands the e-e interface. As a
result, the exceptionally wide e-e interface in the tetrapyrrole section of MZH3 must transition
to become very narrow in the bacterioferritin-like section of the maquette. In addition, the g-g
interface of carboxylate-bridged diiron proteins tends to be wide in order to accommodate the
entry and departure of substrate and product molecules (18). Crystal structures of cytochrome
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b show a slightly narrower g-g
interface than is observed in diiron
proteins (24). Some tetrapyrrole
binding maquettes in the past
have used a Rop-like Alacoil fold
with alanines in g-positions to
narrow the g-g interface (26, 30,
31).
In this way, the
geometries of the cytochrome blike and bacterioferritin-like fourhelix bundles appear to be at odds
with each other; if too much strain
is exerted by one module onto the

Figure 2.6: Helical wheel diagram of one heptad of an
antiparallel four-helix bundle protein
The distance of an amino acid from the view is
represented by the size of the heptad letter designation.
Dotted lines represent hydrophobic interactions within a
layer. In helices, thick ribbons connect α-carbons, while
thinner lines represent Cα-Cβ bonds. Image rendered
using The PyMOL Molecular Graphics System, Version
1.7 Schrödinger, LLC.

other, cofactor binding in one module could affect the structure of the other. One advantage of
using a Due Ferro sequence for the metal binding section of MZH3 is that its narrow e-e
interface is unusually wide compared to most natural diiron and dimanganese proteins, and its
wide g-g interface is unusually narrow compared to the natural proteins (32). In order to
prevent a conflict between the tetrapyrrole and metal sections of the protein, the Rop-like
Alacoil fold of earlier porphyrin binding maquettes (26, 30, 31) was rejected in favor of a wider
g-g interface. To this end, the amino acid for most of the g-positions in the tetrapyrrole section
of MZH3 was leucine. (The exceptions were the second shell threonines that were meant to
make hydrogen bonds to histidines). Mutations of e-position interfacial alanines to leucines in
74

the Lac repressor tetramerization domain have been predicted to force helices to rotate and
move apart to accommodate the increased side chain volume (33). In addition, interfacial
leucines are significantly more stabilizing than alanines (29, 33). Using g-position leucines in
MZH3 allows for the expansion of the g-g interface to prevent strain in the transition between
the tetrapyrrole and metal binding sections of MZH3.
Another way to prevent strain between the modules might be to ensure flexibility in the
helices where the two modules meet. The pigment binding site already has two a-position
glycine residues in the same layer as the histidine because of the similar notch glycine positions
in cytochrome b, but it was given two more a-position glycines, G27 and G128, in the layer
adjacent to the histidine layer nearest the metal binding module. This further expands the zinc
tetrapyrrole binding pocket, which is at risk of hydrophobic collapse that could prevent binding
of the pigment. Gylcine residues G27 and G128 were also intended to increase the flexibility to
allow a seamless transition from one module to the next.

2.2.4 Inter-helical loops in MZH3
In MZH3, the joining of a Due Ferro protein to a tetrapyrrole-binding protein required
careful consideration of loop placement. On the electron acceptor end of MZH3, some solvent
access is required to solubilize the propionate groups of protoporphyrin IX derivatives like heme
B, and flexibility in the apo-state is believed to facilitate entry of the large, bulky tetrapyrrole
cofactor into the binding cleft (34-36). In contrast, the DF3-like di-metal site of MZH3 is
destabilized by four α-helical glycine residues and a water-filled active site containing four
charged glutamates. In fact, the stability of DF3 was poor enough that it required the design of
its own structured loop (21). For these reasons, the heme-binding end of MZH3 was chosen as
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the end with N- and C-termini, and the DF end was given two loops in order to increase its
stability (see Table 2.1). One of these loops came from DF2t (37), because the DF3 loop contains
a solvent-exposed histidine, which may be capable of ligating metallo-tetrapyrroles (38) and
thereby complicating characterization of MZH3. Similarly, the redesign of bacterioferritin for
zinc chlorin binding called for the removal of surface histidines to avoid unintentional cofactor
ligation (39). The metal site was chosen to be DF3-like because of the high metal binding affinity
of DF3, but some parts of the sequence beyond the loop and active site regions differed
between DF2t and DF3. Amino acids that were close to the loop were chosen to be DF2t-like,
because loop stability depends on the overall structure of the protein (40). The other loop on
the DF end is simply a flexible linker. This Gly-Gly-Ser-Gly-Gly linker unites the DF maquette into
a single chain, as was done similarly in Rop and BT6 (2, 14). An identical linker was used on the
heme-binding end of MZH3. A length of 5 residues was chosen for the glycine-rich linkers in
order to guarantee sufficient length to prevent misfolding but also ensure high stability.

2.2.5 Inter-helical charge pairing interactions
The helical topology in Due Ferro proteins appears to be dictated by the sum of many
interactions throughout the bundle including complementarity of core packing, inter-helical
hydrogen bonds, and short, structured loops (37, 41). In MZH3, most core layers of the
tetrapyrrole binding section are symmetrical, meaning that these hydrophobic contacts would
not select for the left-turning antiparallel topology over the right-turning antiparallel topology.
In addition, two of the loops in MZH3 are unstructured and cannot determine the topology.
Interfacial g-position leucine pairing would strongly favor the antiparallel fold over the four
other possible topologies that are all mixed parallel/antiparallel folds, but the right-turning
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antiparallel topology would have the same leucine-leucine interactions as the left (see Figure
2.7). In order to help constrain the topology, charge pairing interactions were included in cpositions, as has been done previously in maquettes to dictate the topology (26, 42). Each helix
in MZH3 included three charged c-position amino acids to pair with its adjacent helix across the
g-g interface. Helices 1 and 2 were given c-position glutamates and helices 3 and 4 were given
lysines, as depicted in Figure 2.7. As a result, each of the five alternative helix threading
topologies that are possible given the short loops have helix-helix interactions that destabilize
them relative to the intended helix topology. In order to prevent the c-position charged
residues from being steered away from their intended hydrogen bonding partners, b- and fposition surface-exposed residues were made uncharged polar amino acids. There is really only
one polar, uncharged amino acid with a reasonably high helical propensity, and that is glutamine
(43). The decision to include many glutamine residues on the exterior of MZH3 along with cposition charged residues gives it an exterior that is very similar to the porphyrin array
maquettes from the DeGrado group (25, 26, 44).
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Figure 2.7: Negative design of MZH3
Possible four-helix bundle conformations are viewed from the heme-binding end. The helix
number of each helix is given along with which end (N- or C-terminus) is facing the viewer.
Thick black arcs represent connecting inter-helical loops on side facing viewer, and thin black
dotted arcs represent inter-helical loops on far end of maquette. The circled + and – symbols
stand for charged c-position lysine and glutamate residues, respectively. Green dotted lines
represent charge pairing interactions, and large red X’s represent charge clashes. Small red
X’s symbolize that the leucine zipper-like interaction of g-position leucines is disrupted.

This careful approach to the design of a four-helix bundle leans heavily upon specific
examples of natural and de novo designed proteins in the literature. Can the many disparate
lessons learned from all of these studies be integrated into a single design of a new protein? Or
does each protein have such important nuances in its structure that takeaway messages from
studies of other proteins cannot be relied upon to produce general rules for four-helix bundle
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design? In order to evaluate the effectiveness this approach, the next section will describe the
expression and routine characterization of MZH3.

2.3 Routine characterization of MZH3
In order to determine whether the design of MZH3 succeeded in creating a stable,
folded protein maquette with the intended functions, MZH3 was subjected to a battery of
routine tests. These included size exclusion chromatography to check the oligomeric state,
ultraviolet/visible spectroscopy to measure cofactor binding, circular dichroism to test the
stability, and redox titration to measure midpoint potentials. Methods for each technique are
described in the appendix.

2.3.1 Size exclusion chromatography
Size exclusion chromatography (SEC) was used to determine the oligomerization state of
MZH3. A mixture of monomeric and oligomeric MZH3 was observed after overexpression in E.
coli, purification by Ni-NTA affinity chromatography, and cleavage of the His6 tag by TEV
protease (Figure 2.8, panel A). Addition of stoichiometric heme B or 4-fold excess ZnSO4 to
MZH3 injectant solution was not found to significantly affect the elution profile (data not
shown). Monomeric and oligomeric MZH3 were collected and stored at 4°C overnight. To
determine whether MZH3 monomers and oligomers rapidly interconvert, the samples were
injected onto the SEC column again the next day (Figure 2.8, panels C and D). The
chromatograms show that monomers remained monomeric and oligomers remained
oligomeric. Oligomers can be converted to monomers by denaturing with 6.5 M GdnHCl and
refolding by dilution.
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(A)

monomers

(B)

dimers
trimers
larger
oligomers

(C)

(D)

monomers

trimers
Larger
oligomers

dimers

Figure 2.8: Size exclusion chromatography elution profiles of MZH3
(A) Chromatogram for initial SEC injection, with fraction numbers given at bottom. Fractions
were collected separately and stored overnight at 4°C. (B) SDS-PAGE gel on SEC eluates from
panel (A). Molecular weights of ladder bands are given at left in kDa. Well numbers given at
the top of each well correspond to fraction numbers from SEC chromatogram in panel (A).
After 1 day, (C) monomeric fraction was injected again, followed by (D) oligomeric fraction.
Blue, red, and pink lines represent absorbance at indicated wavelengths vs. elution volume
(mL). Running buffer was 50 mM NaCl, 10 mM MOPS buffer, pH 7.

To verify that the putative oligomeric MZH3 eluates were composed of MZH3 and not a
higher molecular weight contaminant, samples from SEC fractions (labeled at the bottom of
Figure 2.8A) were run in an SDS-PAGE gel, which denatures proteins so that they run as
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monomers (Figure 2.8B). SDS-PAGE showed that a single band at ~22 kDa was present in all SEC
fractions that had light-absorbing eluates, demonstrating that MZH3 (which has a molecular
weight of 22.5 kDa) was present in each elution peak of the SEC column. No other significant
bands were observed in SDS-PAGE.
MZH3 was designed to have a rod-like cylindrical shape with a diameter of about 2 nm
and a length of about 7 nm, but roughly spherical globular proteins were used to standardize
the size exclusion column. Given that SEC columns separate proteins based on Stokes radius
rather than molecular weight (45), the rod-like shape of MZH3 is expected to decrease its
elution volume relative to spherical proteins of the same molecular weight. This effect is
observed for monomeric, dimeric, and trimeric states of MZH3, as shown in Figure 2.9.
Figure 2.9: Size exclusion
chromatography calibration
curves
Blue: calibration curve for
the XK 16/70 column (GE
Healthcare Life Sciences)
packed with 110 mL of
Superdex 75 prep grade gel
filtration medium (GE
Healthcare Life Sciences).
Red: MZH3 peak positions
on same column for
monomers, dimers, and
trimers. Running buffer was
50 mM NaCl, 10 mM MOPS
buffer, pH 7.5.

2.3.2 Ultraviolet/visible spectroscopy
Tetrapyrroles are strong absorbers of ultraviolet and visible light, and their absorption
spectra are sensitive to their environments. Ligation of the central metal ion of a
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metallotetrapyrrole by ligating amino acids such as histidine can trigger a pronounced band shift
that can be used to monitor binding by ultraviolet/visible spectroscopy (UV/vis).
Overexpression of MZH3 in E. coli
results in a red cell pellet, suggesting that
MZH3 overexpression increases heme B
biosynthesis. The red color of the sample
persists during purification of MZH3 by
Ni-NTA column chromatography, His-tag
cleavage by TEV protease, and SEC. After
purification, MZH3 is found to contain
approximately 0.1 equivalents of heme B

Figure 2.10: Heme binding by MZH3 in vivo
Spectrum of MZH3 after overexpression and
purification, but before addition of heme B. The
peak at 280 nm is due to absorbance of Trp and
Tyr residues, and the peak at 415 nm is the Soret
band of heme B. Conditions: 150mM NaCl, 6 mM
phosphate buffer, pH 7.4.

per mole of MZH3, as estimated from the UV/vis spectra (Figure 2.10). When necessary, heme
can be removed by high-performance liquid chromatography (HPLC) or by denaturation and
washing with 2-butanone (46).
In the spectroscopic titrations presented below, cofactor solutions were titrated into
protein solutions. Absorbance values at a selected wavelength were fitted to Equation 2.1, a
one-site binding equation that relates the cofactor concentration c (the independent variable),
absorbance A (the dependent variable), and four parameters: the total protein concentration P,
the extinction coefficient of the cofactor bound to the protein εb, the extinction coefficient of
the unbound cofactor εu, and the dissociation constant KD:

𝐴 = 𝑐 ∙ 𝜀𝑢 +

(𝜀𝑏 − 𝜀𝑢 ) ∙ [(𝐾𝐷 + 𝑃 + 𝑐) − √(𝐾𝐷 + 𝑃 + 𝑐)2 − 4 ∙ 𝑃 ∙ 𝑐]
2
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Equation 2.1

2.3.3 UV/vis spectroscopy: Acceptor site
High-affinity binding of ferric heme B by MZH3 was demonstrated by UV/vis titration.
The absorbance spectrum of MZH3 in complex with ferric heme has a Soret band at 415 nm with
an extinction coefficient of 115,000 M−1cm−1 and broad Q bands at about 534 nm and 566 nm.
This is similar to the yeast cytochrome b absorbance features which include a Soret band at 416
nm with an extinction coefficient of about 120,000 M−1cm−1 (47). Heme B is not soluble in
aqueous solutions, so the unbound heme B spectrum is easily distinguished from the bound
spectrum. Unbound heme B has broadened bands with significantly decreased extinction
coefficients at the peaks. Fitting the absorbance of the Soret band at 415 nm vs. heme B
concentration to Equation 2.1 gives a dissociation constant of less than 10 nM, which is near the
resolution limit for the procedure (see Figure 2.11). This ferric heme B dissociation constant is
very close to that of the natural soluble four-helix bundle hemoprotein cytochrome b562, which
is estimated at about 9 nM (48), although some other natural hemoproteins have much higher
affinities (35).
Figure 2.11: Heme B
binding titration
UV/vis binding titration
of ferric heme B into 1.2
µM MZH3. The
structure of heme is
shown at upper left and
the spectrum at 0.8
equivalents of heme B
per MZH3 is shown at
beneath the curve. The
schematic at right shows
where heme B is
expected to bind.
Conditions: 10 mM
Na2HPO4, 15 mM NaCl,
pH 7.
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A measurement of the reduced, ferrous heme B spectrum was made by adding
dithionite to a solution of MZH3 with ferric heme B (Figure 2.12). The dithionite absorbance
peak centered at 319 nm may interfere with the estimation of the Soret extinction coefficient in
the reduced state, but it is about 160,000 M−1cm−1 at 430 nm.
Figure 2.12: Heme B
spectra in MZH3
Ferric heme B (red) and
ferrous heme B (blue)
spectra in MZH3.
Ferrous spectrum was
prepared by reduction
with dithionite
compared. Peak at 319
nm is due to excess
dithionite. Conditions: 8
μM MZH3 with 1
equivalent of heme B,
15mM NaCl, 10mM
phosphate buffer, pH7.

Replacement of the iron ion of heme B with cobalt gives cobalt protoporphyrin IX
(CoPPIX), which is stable to oxygen in the Co(III) (cobaltic) state. CoPPIX is interesting as a
potential electron acceptor because reduced cobalt tetrapyrroles are capable of proton
reduction (49, 50). Co(III)PPIX does not have the pronounced spectral difference between the
bound and unbound states that heme B has in aqueous solutions, partly because CoPPIX is more
soluble. As a result, fitting the absorbance of the Soret band vs. CoPPIX concentration is
difficult, because the curve is almost a straight line. However, the absorbance difference
between 426 and 419 nm vs. CoPPIX concentration has a much sharper change in slope around
1.0 equivalent of cofactor per protein, allowing curve fitting with Equation 2.1 (see Figure 2.13).
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The result of this fit was a dissociation constant of approximately 250 nM and an extinction
coefficient of 220,000 M−1cm−1 for the Soret band at 426 nm in the MZH3-bound state. The
estimated extinction coefficient of the Soret maximum for unbound Co(III)PPIX was 190,000
M−1cm−1, in agreement with previous work that found a value of 170,000 M−1cm−1 under similar
conditions (49). The dissociation constant of 250 nM of MZH3 for Co(III)PPIX is about 25 times
weaker than it is for heme B, but 35-fold stronger than the Co(III)PPIX affinity of cytochrome b562
of 8.9 µM (49).
Figure 2.13: CoPPIX
binding titration to MZH3
UV/vis binding titration of
Co(III)PPIX into 0.9 µM
MZH3. The structure of
Co(III)PPIX is shown above
the curve and the
spectrum at 0.8
equivalents of Co(III)PPIX
per MZH3 is shown
beneath the curve.
Schematic of where
CoPPIX is expected to bind
is shown at right.
Conditions: 10 mM MOPS,
50 mM NaCl, pH 7.

Another iron tetrapyrrole with a structure similar to heme B is Fe(III) 2,4-diacetyl
deuteroporphyrin IX (Fe-DADPIX), and it binds to MZH3 with a KD of less than 10 nM, similar to
heme B (Figure 2.14). Fe-DADPIX is similar in structure to heme B, but it has a higher
electrochemical midpoint potential and red-shifted absorption bands relative to heme B. Its
Soret maximum in MZH3 is about 90,000 M−1cm−1 at 431 nm.
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Figure 2.14: Ferric DADPIX
binding titration with
MZH3
UV/vis binding titration of
Fe(III)-DADPIX into 4.4 µM
MZH3. The structure of
Fe(III)-DADPIX is shown at
upper left and the
spectrum at 0.8
equivalents of Fe(III)DADPIX per MZH3 is
shown above the curve.
Schematic of where FeDADPIX is expected to
bind is shown at right.
Conditions: 50 mM NaCl,
20 mM phosphate buffer,
pH 7.

A fourth possible electron acceptor, Fe(III) 5,10,15-tri-(p-carboxyphenyl) corrole
(provided by Nicholas Roach from the laboratory of David Officer and referred to as PM56)
showed no evidence of binding to MZH3 (see Table 2.3).
These UV/vis titrations are consistent with high-affinity bis-histidine ligation of iron and
cobalt tetrapyrroles, and the 1:1 binding stoichiometry indicates that only one site in MZH3 is
involved in ligation of these electron accepting cofactors. Of four cofactors tested, three bind
tightly. The MZH3 electron acceptor site shows some discrimination between cofactors, but its
ability to ligate different cofactors suggests a degree of plasticity in the binding site. This is
similar to natural heme B proteins which can frequently bind cofactors slightly different from
heme B (49). It is likely that many other iron and cobalt tetrapyrroles will bind to the acceptor
site, and, as shown in the next section, some zinc tetrapyrroles will bind to this site as well,
although they are intended for the mono-histidine pigment site.
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Cofactor
Heme B
Fe-DADPIX
CoPPIX
PM56
KD
< 10 nM
< 10 nM
~250 nM
None detected
Soret λ
415 nm
431 nm
426 nm
N/A
−1
−1
−1
−1
−1
−1
Soret εb 115,000M cm
90,000 M cm
220,000 M cm
N/A
Table 2.3: Summary of properties of tetrapyrroles tested for binding to MZH3 acceptor site
Structures, dissociation constants (KD), Soret band wavelengths in the bound state (Soret λ),
and Soret extinction coefficients in the bound state (Soret εb) are given.

2.3.4 UV/vis spectroscopy: Pigment site
Zinc tetrapyrroles are useful as pigments for light-driven electron transfer, because they
can absorb light to enter a high-energy, reducing, photo-excited state similar to chlorophyll in
natural reaction centers (2, 38, 39). The iron ion of iron tetrapyrroles prefers a hexacoordinate
geometry, but zinc tetrapyrroles are stable with the zinc ion in a pentacoordinate geometry.
This means that zinc tetrapyrroles can bind with high affinity to a binding pocket that has only
one histidine (such as the pigment site of MZH3), but they could also bind to a pocket with two
histidines (such as the electron acceptor site of MZH3). For this reason, it was necessary to first
add an electron accepting cofactor such as heme B prior to zinc tetrapyrrole titrations of MZH3
in order to prevent the electron acceptor site from binding the zinc tetrapyrrole.
To demonstrate the necessity of an electron acceptor to block binding of the pigment to
the acceptor site, a zinc Newkome porphyrin (ZnNP, provided by Tatiana Esipova in the
laboratory of Sergei Vinogradov) was titrated into an MZH3 solution (Figure 2.15: ZnNP titration
into MZH3). A band shift indicated binding of the ZnNP to MZH3. Using Equation 2.1, the
binding stoichiometry appeared to be roughly 3.75 ZnNP molecules per protein. Cofactors at
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different sites in the protein could have slightly different spectra, but this method can still give a
rough estimate of binding affinities, assuming the spectra are similar. The dissociation constant
was estimated at about 20 nM.
Figure 2.15: ZnNP titration
into MZH3
UV/vis binding titration of
ZnNP into 0.51 µM MZH3 in
the absence of an electron
acceptor cofactor. The
structure of ZnNP and the
spectrum at 0.8 equivalents
of ZnNP per MZH3 are
shown beneath the curve.
Schematic of where ZnNP is
expected to bind is shown at
right. Conditions: 15 mM
NaCl, 10 mM phosphate
buffer, pH 7.

This titration was repeated in the presence of 1.0 equivalent of heme B per MZH3
protein (Figure 2.16). The dissociation constant for ZnNP was estimated at about 70 nM, and
the binding stoichiometry appeared to be 1:1, suggesting that ZnNP binds to the pigment site
and nowhere else in the protein when heme B is present.
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Figure 2.16: Binding titration of
ZnNP into MZH3/Heme
UV/vis binding titration of ZnNP
into 1.0 µM MZH3 in the
presence of 1.0 equivalent of
heme B per protein. The
structure of ZnNP and the
spectrum at 0.8 equivalents of
ZnNP per MZH3 are shown
beneath the curve. The dotted
line is the initial spectrum with
heme B, before addition of ZnNP.
Schematic of where ZnNP is
expected to bind is shown at
right. Conditions: 15 mM NaCl,
10 mM phosphate buffer, pH 7.

Other titrations were performed with heme B and other zinc tetrapyrroles. Of special
interest was Zn 5-phenyl-15-(p-carboxyphenyl) porphyrin (ZnPCP), which bound with a 1:1
stoichiometry and dissociation constant of <10 nM at pH 6.5 in the presence of 1.0 equivalent of
heme B and 1.5 mM ZnCl2 (Figure 2.17). ZnPCP was subsequently used for crystallography and
transient absorption spectroscopy experiments.
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Figure 2.17: ZnPCP titration
into MZH3/Heme/Zn(II)
UV/vis binding titration of
ZnPCP into 1.2 µM MZH3 in
the presence of 1.0
equivalent of heme B per
protein. The structure of
ZnPCP is shown above the
curve, and the spectrum at
0.8 equivalents of ZnPCP per
MZH3 is shown beneath the
curve. The dotted line is the
initial spectrum with heme B,
before addition of ZnPCP.
Schematic of where ZnPCP is
expected to bind is shown at
right. Conditions: 15 mM
NaCl, 1.5 mM ZnCl2, 10 mM
PIPES buffer, pH 6.5.

Synthetic zinc tetrapyrroles were prepared by collaborators following methods
described previously (5, 51). The zinc porphyrins ZnNP, ZnPCP, TE312, and TE394, TE400, and
TE400b were synthesized by Tatiana Esipova in the laboratory of Sergei Vinogradov following
methods described previously. NR117 was provided by Nicholas Roach and the laboratory of
David Officer. The zinc chlorins SE370 and SE375 were synthesized in the laboratory of Jonathan
Lindsey. Other tetrapyrroles were purchased from Frontier Scientific. A list of zinc tetrapyrroles
that bind MZH3 with high affinity when an acceptor cofactor is present is shown in Table 2.4,
and those with low affinity are shown in Table 2.5.
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Pigment
name
ZnNP

Pigment structure

Acceptor
cofactor
none

Metal

ZnPCP

Heme B
CoPPIX
Heme B
Heme B

−
−
Co(II)
Zn(II)

1
1
1
1

~20 nM
average
~70 nM
~50 nM
~50 nM
< 10 nM

SE370

Heme B

−

1

~30 nM

SE375

Heme B

−

1

~70 nM

NR117

Heme B

−

inconclusive

~30 nM

ZnC

Heme B

−

~100 nM

Heme B

Co(II)

inconclusive
1

TE312

Heme B

Zn(II)

n.d.

band shift
observed,
KD was not
measured

TE394

Heme B

−

n.d.

band shift
observed,
KD was not
measured

−

Table 2.4: Zinc tetrapyrroles that bind to MZH3/Heme with high affinity
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Stochiometry
~3.75

Binding

~200-500
nM

Pigment
name
ZnPPIX

Pigment structure

Acceptor
cofactor
Heme B

Metal
Zn(II)

Stochiometry
1

Binding
~2 µM

ZnMPIX

Heme B

−

0

not
detected

ZnCe6

Heme B

−

0

not
detected

TE400

Heme B

−

0

not
detected

TE400b

Heme B

−

0

not
detected

ZnTCP

Heme B

−

inconclusive

~5 µM

ZnTPP

Heme B

−

0

not
detected

ZnDPDP

Heme B

−

0

not
detected

Table 2.5: Zinc tetrapyrroles that do not bind to MZH3/Heme with high affinity
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The tests of zinc tetrapyrrole affinity for the MZH3 pigment site summarized in Table 2.4
and Table 2.5 reveal a pattern of selectivity for zinc tetrapyrroles with particular structural
attributes. Consideration of the potential for steric clashes and burial of polar groups can help
predict what zinc tetrapyrrole structures will bind to the pigment site of MZH3. The pigment
binding cavity in the center of the maquette is a deep, narrow slit that stretches across the
width of the four-helix bundle and is lined with tightly packed hydrophobic residues in layers
above and below the ligating histidine. It cannot expand enough to accommodate the bulk of
meso-tetraphenyl porphyrins (ZnTCP, ZnTPP, and ZnDPDP), and tetrapyrroles with carboxylate
groups too close to the tetrapyrrole ring may be prevented from binding because the histidine
cannot ligate the zinc ion without burying those negative charges (ZnPPIX, ZnMPIX, ZnCe6,
TE400, and TE400b). This issue of charge burial is believed to have prevented binding of heme B
and ZnPPIX to porphyrin-binding four-helix bundle maquettes that had similarly hydrophobic
binding sites (25, 26, 31). The most successful zinc tetrapyrrole designs have two phenyl groups
on opposite sides of the tetrapyrrole ring and lack bulky, inflexible substituents at the 10 and 20
meso positions that are present in the low-affinity tetraphenyl ZnTCP, ZnTPP, and ZnDPDP
porphyrins. This narrower shape of the 5,15-diphenyl porphyrin better complements the shape
of the binding cleft. The successful zinc tetrapyrroles also typically have polar groups in para
positions on the phenyl rings. These polar groups might not increase the stability of the MZH3zinc tetrapyrrole interaction, but they are likely to destabilize aggregates of zinc tetrapyrroles
that might otherwise sequester the cofactor and prevent binding to MZH3, as is likely the case
for the somewhat lower affinity ZnC, which has low solubility in aqueous solutions.
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2.3.5 UV/vis spectroscopy: Donor site
Unlike tetrapyrroles, transition metal dications in proteins are weak absorbers of visible
light and are not usually suitable for UV/vis spectroscopic titrations. A Co(II) ion bound to a
protein has a maximum extinction coefficient of about one thousandth that of a typical
tetrapyrrole, but this is still significantly greater than the absorbance of most other transition
metals. Co(II) also has the advantage of having an absorbance spectrum that is highly sensitive
to its coordination number, allowing UV/vis titrations to yield information on both binding
affinity and ligation state. Extinction coefficients for Co(II) typically range from approximately
10-20 M−1cm−1 for 4-coordinate, 100-150 M−1cm−1 for 5-coordinate, and 400-600 M−1cm−1 for 6coordinate complexes (52).
Co(II) binding to MZH3 was tested by a UV/vis titration of Co(NO3)2 into a solution of 34
µM MZH3 in a 10 cm (Figure 2.18). The result was a stoichiometry of two Co(II) ions per protein
with an extinction coefficient of 90 M−1cm−1 per Co(II) ion at 545 nm and an average dissociation
constant of about 3.3 μM at pH 7.3. For comparison, DF3 has a Co(II) extinction coefficient of 98
M−1cm−1 at 548 nm and an average dissociation constant of about 240 nM at pH 7 (22). Another
Due Ferro maquette, DFsc, has an extinction coefficient of 136 M−1cm−1 at 550 nm and an
average dissociation constant of about 160 μM at pH 6 (53). The natural diiron protein
bacterioferritin has an extinction coefficient of 155 M−1cm−1 at 548 nm and an average
dissociation constant of about 10 μM in the absence of heme B at pH 7.1 (54). The Co(II)
affinities are similar to Mn(II) affinities in most Due Ferro maquettes (22, 40, 55). The Co(II)
titration shows that MZH3 has a penta-coordinate binding site similar to the Co(II) binding
properties of other di-metal proteins.
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Figure 2.18: Co(II)
binding titration with
MZH3.
UV/vis binding titration
of Co(NO3)2 into 33.7
µM MZH3 in 10 cm path
length cuvette. The
spectrum at 1.8
equivalents of Co(II) per
MZH3 is shown beneath
the curve. Schematic of
where Co(II) is expected
to bind is shown at
right. Conditions: 150
mM KCl, 100 mM MOPS
buffer, pH 7.3.

2.3.6 Ferroxidase activity
Natural diiron proteins and the Due Ferro series of de novo proteins catalyze ferroxidase
activity, wherein a diferrous center reacts with oxygen to produce an oxo-bridged diferric site
with a characteristic ligand-to-metal charge transfer (LMCT) band around 300 nm. As expected,
MZH3 catalyzes this reaction as well. Figure 2.19 shows the absorbance at 300 nm of an
anaerobic sample of 30 μM MZH3 in complex with stoichiometric iron chloride. At time t=0, the
anaerobic sample was exposed to ambient oxygen, triggering a rapid conversion to the differic
species with a lifetime of roughly 3.6 minutes for the transition. The inset spectra show the rise
of the LMCT band with time. The extinction coefficient for the diferric state at 300 nm is 3400
M−1cm−1, which agrees with the values for DF2 and bacterioferritin of 3240 M−1cm−1 and 3380
M−1cm−1, respectively (55, 56). Iron oxidation in MZH3 is reversible, as it is in DF3 (21).
Reduction of MZH3-Fe(III)2 by dithionite eliminated the LMCT band and subsequent air oxidation
regenerated it.
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Figure 2.19: Ferroxidase
activity of MZH3.
Exposure to ambient
oxygen at time t=0 lead
to rapid increase in LMCT
band with lifetime of ~3.6
minutes. Conditions: 30
μM MZH3, 60 μM FeCl2,
1500 mM KCl, 50 mM
MOPS buffer, pH 7.3.

In DF3, ferroxidase activity appears to give rise to a tyrosinate-Fe(III) ligation, as
evidenced by a putative tyrosinate-to-Fe(III) LMCT transition with an extinction coefficient of
1,200 M−1cm−1 at 500 nm (22). In contrast, MZH3 lacks a distinct absorbance feature in this
region and has only a 200 M−1cm−1 extinction coefficient at 500 nm, probably due to the broad
absorbance of the oxo-to-Fe(III) charge transfer band or a small amount of Rayleigh scattering.
The absence of a tyrosinate-Fe(III) in MZH3 may be because one of the tyrosine residues is
replaced with leucine and because the increased stability of MZH3 prevents the structural
rearrangement that would allow the other tyrosine to ligate the iron.

2.3.7 Circular dichroism to assay secondary structure
At 25°C under low salt conditions at pH 7, the mean molar ellipticity per residue at 222
nm, [θMMR]222, of apo-MZH3 was −29,000 deg cm2 dmol−1 res−1 (see Figure 2.20 and Table 2.6).
The shape of the curve and the intensity of [θMMR]222 are consistent with high α-helical content
(57). In addition, the ratio of [θMMR]222/[θMMR]208 of 1.09 is high, which is consistent with a coiled
coil structure (4, 58-60). The addition of 33 µM MnCl2 to 15.2 µM MZH3 (~2 molar equivalents
of MnCl2 per MZH3 protein) increased the magnitude of [θMMR]222 and the ratio of
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[θMMR]222/[θMMR]208, while the
addition of 1 molar equivalent of
heme B to 20.3 µM MZH3
lowered the magnitude of
[θMMR]222 and the ratio of
[θMMR]222/[θMMR]208 (see Table 2.6).
Heme binding has a similar effect
on [θMMR]222 in DDH2, a truncated

Cofactor
added to
MZH3
Apo

[θMMR]222 (deg cm2
dmol−1 res−1)

[θMMR]222/
[θMMR]208

TM (°C)

−29,000

1.09

82

1 eq. heme B

−19,400

1.04
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2 eq. Mn(II)
−31,900
1.12
>100
3 eq. Ca(II)
n.d.
1.11
90
Table 2.6: MZH3 circular dichroism measurements
All samples contained 15 mM NaCl and 10 mM NaH2PO4
at pH 7. MZH3 concentration for each sample were 16.8
μM (apo), 15.2 μM (MnCl2), 20.3 μM (Heme), and ~16 μM
(CaCl2).

version of MZH3 that binds two hemes B and lacks a metal binding site, as discussed in detail in
section 2.4. This suggests that the decrease of [θMMR]222 is caused by the effect of heme on
nearby helices rather than a long-range effect on the metal-binding section of the protein.
The effect of heme B binding in MZH3 appears to be a decrease in helicity and an
increase in thermal stability. While it is common for the melting temperature to increase upon
heme binding, the decrease in [θMMR]222 sets MZH3 apart from the behavior of other helical
porphyrin-binding proteins. As described in the introduction, natural hemoproteins are usually
unstable in the apo-state, and finish folding once heme is bound (34, 35). Designed porphyrinbinding proteins follow this pattern as well, showing increased ellipticity at 222 nm (26, 31, 6163). For example, myoglobin has an apo-state [θMMR]222 that is only 70% of the magnitude in the
holo-state (64, 65). In one exception, an iron porphyrin-binding maquette with a highly stable
apo-state (similar to MZH3) showed a small decrease in [θMMR]222 upon porphyrin binding, but
the authors attributed this to transitions of the synthetic porphyrin itself, rather than helical
content (44). The decrease in [θMMR]222 upon heme binding by MZH3 cannot be attributed to
dichroic absorption of the heme B cofactor itself, as its contribution to the CD signal at 222 nm is
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negligible (57, 66, 67). The

have a helical conformation
accounts for much of the
observed value of [θMMR]222,
but [θMMR]222 is also influenced
by subtle variations of α-

Mean molar ellipticity per residue
(deg•cm2/dmol/res)

total fraction of residues that

B

residues (68). It is not
inconceivable, then, that heme
binding influences the
structure of MZH3 in such a
way that [θMMR]222 decreases
significantly, but the total helix
content remains similar to the
apo-state. However, the loss

Fraction Folded

conformation of helical

Apo
2eq MnCl2
1eq Heme B

40000
20000
0
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protein, and the precise
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-40000
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lengths of the helices,
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Figure 2.20: Circular dichroism measurements of MZH3
A: Far UV CD spectra at 25°C. B: Melting curves estimated
from [θMMR]222 signal. Black curves at apo-MZH3, blue curves
are have two equivalents of MnCl2 per protein, red curves
have one equivalent of heme B per protein, and orange
curve is 3 equivalents of CaCl2 per protein. All samples
contained 15 mM NaCl and 10 mM NaH2PO4 at pH 7.

of ellipticity upon heme binding is consistent with a disruption of core packing by heme binding,
which might mean that heme affinity could be further improved by reengineering the heme site
to make it less stable in the apo-state so that MZH3 is more like natural apo-hemoproteins.
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The decrease in [θMMR]222 could be explained if estimates of extinction coefficients were
inaccurate, since the apo-MZH3 and heme-MZH3 concentrations were estimated by measuring
different absorption features. However, the extinction coefficient for the heme B Soret band at
415 nm was determined from UV/vis titrations in which MZH3 concentration was determined
from Trp and Tyr absorbance at 280 nm. These titrations showed a heme B stoichiometry of
precisely 1.0, demonstrating consistency between concentration estimates based on the two
absorption features. In addition, an error in extinction coefficients would not explain the
significant decrease in [θMMR]222/[θMMR]208 ratio that results from heme binding.
Melting curves demonstrate that Mn(II) binds to MZH3 more tightly than Ca(II), which is
expected from typical stabilities of Mn(II) and Ca(II) complexes (69). It is surprising that Mn(II)
binding has a significantly greater stabilizing effect on MZH3 than the binding of heme B.
Cytochrome b562, which has a ferric heme B affinity similar to MZH3, increases in stability by ~15
kJ mol−1 upon binding of ferric heme B (35, 70). In DF3, Zn(II) binding stabilizes the protein by
43.5 kJ mol−1, but Mn(II) only increases the stability by 12.1 kJ mol−1 (22). This is consistent with
the Irving-Williams series, which predicts metal complex stabilities to follow the trend Mn(II) <
Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II), where Zn(II) affinities are generally high and close to Cu(II)
(69). Given the similarities between MZH3 and these proteins, it should follow that heme B is
more stabilizing than Mn(II), but the thermal melts show that the reverse is true. The
pronounced difference between the stabilities of MZH3-Mn(II)2 and MZH3-heme B could be due
to an unexpected high Mn(II) affinity, but it is more likely that in the apo-state of MZH3, the Due
Ferro section of the protein is less stable than the heme binding section. This would mean that
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the stabilizing effect of heme B is applied primarily to a region of the maquette that is already
stable, while Mn(II) increases the helicity of a more dynamic part of MZH3.

2.3.8 Circular dichroism in Soret region to assay exciton coupling
If a chromophore is either chiral, covalently bonded to a chiral center, or located in an
asymmetric environment, then it is optically active and capable of producing a CD signal at
wavelengths where normal absorption occurs. CD signals come from the interaction between
transition dipoles of a chromophore and other transition dipoles in the molecule. If two
chromophore transitions are close to degenerate, excitation of one chromophore can be
delocalized across both chromophores through exciton coupling, creating a sigmoidal CD signal
centered at the absorption maximum of the transition (71). Exciton coupling has been observed
between the hemes of cytochrome b (47, 72) and cytochrome bd (73) and between
bacteriochlorophylls of the bacterial light-harvesting antenna complex LH2 (74, 75). The
phenomenon has been used in de novo proteins that bind two synthetic metalloporphyrins in
order to determine whether the porphyrins bind in a cooperative manner (31).
CD spectra in the Soret region of MZH3 in complexes with heme B and ZnNP
demonstrate that both ZnNP and Heme B are bound to MZH3 at the same time. Figure 2.21A
shows weak CD signals when only one heme B or only one ZnNP is bound to the protein. Based
on comparison to spectra of myoglobin and hemoglobin, these signals may be due to coupled
oscillator interactions between the porphyrin and aromatic amino acids, the polypeptide
backbone, or alkyl side chains (76). In contrast, Figure 2.21B shows that the addition of both
heme and ZnNP or two ZnNP molecules results in CD signals more than an order of magnitude
larger than the signal due to heme by itself, and about double the magnitude of the ZnNP by
100

itself. Such an amplification of the CD signal is expected for exciton coupling between two
porphyrins with similar excitation energies bound close together in the same protein (72, 73).
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Figure 2.21: Exciton coupling effects of MZH3 with heme B and ZnNP by circular dichroism
(A) MZH3 spectra with only one porphyrin. Red trace: 5.2 μM MZH3 with 1 equivalent of
ferric heme B per bundle, 1 cm path length. Blue trace: 5.2 μM MZH3 with 1 eq. ferrous
heme (reduced with sodium dithionite), 1 cm path length. Green trace: 23 μM MZH3 with 19
μM ZnNP (0.83 eq.), 0.1 cm path length. Orange trace: 31 μM ZnNP, no protein, 0.1 cm path
length. (B) MZH3 spectra with two porphyrins. Red trace: 33 μM MZH3 with 1.0 eq. ferric
heme and 1.0 eq ZnNP, 0.1 cm path length. Blue trace: 33 μM MZH3 with 1.0 eq. ferrous
heme (reduced by sodium dithionite) and 1.0 eq ZnNP, 0.1 cm path length. Green trace: 23
μM MZH3 with 42 μM ZnNP (1.83 eq.), 0.1 cm path length. All data sets were collected in 15
mM NaCl, 10 mM phosphate buffer, pH 7.
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Since the heme Soret bands at 415 nm in the oxidized state and 430 nm in the reduced
state are very close to the ZnNP Soret band at about 423 nm, there is significant exciton
coupling, giving rise to the observed intense CD bands. Indeed, the expected ~25-45° dihedral
angle between the bound porphyrin planes at the two sites will tend to enhance CD excitonic
coupling signals (72).

2.3.9 Heme B Redox titration
A rate of electron transfer depends partly on the driving force of the reaction, which is
determined from the difference between the midpoint potentials of the cofactors involved in
the reaction. The midpoint potential of a cofactor is the potential at which half of it is oxidized
and half is reduced. The Nernst equation can be used to relate the midpoint potential of a redox
center Em, the potential of the solution measured with the standard hydrogen electrode Eh, the
number of electrons transferred in the reaction n, the ratio of the concentrations of oxidized to
reduced cofactor [ox]/[red], the universal gas constant R, temperature T, and Faraday’s constant
F (77):
𝐸ℎ = 𝐸𝑚 +

𝑅𝑇
[𝑜𝑥]
∙ 𝑙𝑛 (
)
𝑛𝐹
[𝑟𝑒𝑑]

Equation 2.2

At room temperature, this equation reduces to following, where Eh and Em are in volts:
𝐸ℎ = 𝐸𝑚 +

0.059
[𝑜𝑥]
∙ 𝑙𝑜𝑔 (
)
𝑛
[𝑟𝑒𝑑]

Equation 2.3

A redox titration was used to determine the midpoint potential of heme B in MZH3 at
pH 7 following procedures described previously (77, 78). Details are given in the Appendix. The
relative concentrations of oxidized and reduced heme were monitored by UV/vis spectroscopy
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of the Q-band region of the heme absorption spectrum. Increases in the absorbance difference
between 560 nm and 545 nm compared to the initial oxidized spectrum were proportional to
the total concentration of reduced heme, allowing absorbance changes to be fitted to the
Nernst equation (Figure 2.22). The reducing and oxidizing curves were fitted with Em values of
−184 mV and −168 mV, respectively, which are the same within error, so no significant
hysteresis is apparent. The fitted n values were both within 7% of 1.0, consistent with the
expected one-electron transition from ferric to ferrous heme B.
Figure 2.22: Redox titration
of heme B bound to MZH3
Titration was done at pH
7.0 in reducing (black) and
oxidizing (red) directions.
Inset: absorbance spectra
of Q band region of MZH3heme B in reduced (blue)
and oxidized (red) states.

This midpoint potential of -180 mV for heme B in MZH3 is not unusual for a four-helix
bundle maquette. Midpoints of bis-histidine-ligated heme B in maquettes have ranged from
−260 mV to −150 mV (79). Generally, potentials are higher when the heme is more buried.

2.4 DDH2: A truncated version of MZH3 that binds two hemes
MZH3 is essentially the joining of a well-described di-metal binding de novo maquette,
Due Ferro, to a newly-designed and uncharacterized cytochrome b-like maquette that binds two
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metallotetrapyrroles. Because the cytochrome b-like section of MZH3 has not been studied as
an independent protein previously, it is difficult to compare it to other successful di-heme fourhelix bundle maquettes such as BT6 (2), a di-heme binding homotetramer (62), a cytochrome blike template-assembled synthetic protein (TASP) (61), a series of porphyrin array (PA) proteins
developed by the DeGrado group (25, 26, 31), and combinatorially designed heme proteins from
the Hecht group (80).
To ascertain whether the cytochrome b-like section of MZH3 remains functional in the
absence of the di-metal Due Ferro section, a shortened di-heme maquette based on the
sequence of MZH3, DDH2 (“Diagonal Di-Heme”), was expressed in E. coli with an N-terminal His6
tag and TEV cleavage site. DDH2 is as similar in sequence to MZH3 as possible, except at the
ends of the helices where DDH2 has helix caps and loops in place of helices that continue
through the Due Ferro section of the protein. In addition, the pigment site of MZH3 becomes a
second heme binding site in DDH2. Two a-position glycines in MZH3 were change to alanines,
because the helices are expected to be relatively flexible in that region of DDH2. DDH2 is 135
amino acids long with a molecular weight of 14.99 kDa in the apo-state, an extinction coefficient
of 11,000 M−1cm−1 at 280 nm due to two tryptophan residues, and a theoretical isoelectric point
of 6.1, as estimated using the ExPASy ProtParam server (81). The sequence of DDH2 is given in
below:

GGSPELRQEHQQLAQEFQQLLQEHQQLARELGGSGGDPAEELQQTGQEAQQLLQELQQTGQELWQLGGS
GGPELRQKHQQLAQKIQQLLQKHQQLARKLGGSGGDPAEKLQQTGQKAQQLVQKLQQTGQKLWQLG
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A more informative layout of the sequence of DDH2 for comparison to the original
MZH3 sequence is given in Table 2.7:
heptad
positions
MZH3
“snaked”
sequence
DDH2
“snaked”
sequence

(N)Forward: efgabcdefgabcdefgabcdefgabcdefgabcdefgabcdef
(C)Reverse: gfedcbagfedcbagfedcbagfedcbagfedcbagfedcbagf
(N-term) →GSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEK ARN
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLTELLEIHKEEDELIKQLVSKKEP
(N) →
PELRQKHQQLAQKIQQLLQKHQQLGAKILEDEEKHIELLETIL GGSGG
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGLQQLERYQKIGQLEGKLLERLED
(N-term)→GGSPELRQEHQQLAQEFQQLLQEHQQLAREL GGSGG
(C) ← GGSGG LQWLEQGTQQLEQLLQQAEQGTQQLEEAPD
(N) →
PELRQKHQQLAQKIQQLLQKHQQLARKL GGSGG
(C-term) ← GLQWLKQGTQQLKQVLQQAKQGTQQLKEAPD

→
←
→
←
→
←
→
←

(C)
(N)
(C)
(N)
(C)
(N)
(C)
(N)
(C)
(N)

Table 2.7: Amino acid sequence of DDH2 compared to MZH3
The differences between DDH2 and MZH3 are shown in bold in the DDH2 sequence, and the
added capping sequences of DDH2 are underlined. Coiled coil heptad positions a through g
are denoted in the top row for both forward (N- to C-terminus) and reverse (C- to N-terminus)
sequences. Residues highlighted yellow are a-position residues. Red boxes enclose layers of
the hydrophobic core, each of which includes two a- and two d-position residues. The amino
acid sequences have each helix written on a new line with loops separated from the helices by
a space. In the “snaked” sequences, helices 2 and 4 are written in reverse so that amino acids
that are spatially close together in the folded protein are close together in the snaked
sequence diagram. The N- and C-terminal ends of each helix are denoted by the letter in
parentheses at either end of each helix, and “N-term” and “C-term” denote termini of the
protein. Green amino acids belong to the cytochrome b-like tetrapyrrole binding section of
MZH3, and blue amino acids belong to the Due Ferro-like di-metal binding section of the
protein.

2.4.1 Size exclusion chromatography
Size exclusion chromatography was used to assay the oligomerization state of DDH2.
Unlike MZH3, only a single peak was detected for DDH2, consistent with a monomeric 15 kDa
protein (Figure 2.23). The elution peak for DDH2 puts it between the lines for the globular
protein standards and the rod-shaped MZH3 protein (Figure 2.23, inset). This is consistent with
the shortened rod-like shape of DDH2 compared to MZH3.
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Figure 2.23: Size exclusion chromatography elution profile of DDH2
The blue line is the absorbance of the sample at 280 nm vs. elution volume. Inset: Plot of log
molecular weight against elution volume for DDH2 (black), globular protein standards (blue),
and MZH3 (red).

2.4.2 Ultraviolet/visible spectroscopy of DDH2 with heme B
Overexpression of DDH2 in E. coli produced red cell pellets, as with MZH3, and after
purification, DDH2 appeared to have roughly ~0.25 equivalents of ferric heme B per DDH2
protein (or ~0.13 equivalents of heme B per binding site). DDH2 was purified by HPLC to remove
heme B that was bound during expression. After purification by size exclusion chromatography,
a ferric heme B binding titration was performed at pH 7.5 with 0.5 μM DDH2, as shown in Figure
2.24. The stoichiometry was two hemes B per DDH2 protein, as expected. The dissociation
constant was similar to MZH3; both maquettes bind heme B with a dissociation constant of
about 10 nM or less. The extinction coefficient for the Soret peak in DDH2 was 120,000
M−1cm−1, which is similar to the value for MZH3 of 115,000 M−1cm−1.
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Figure 2.24: Heme
titration into DDH2
UV/vis binding titration
of ferric heme B into 0.5
µM DDH2. Inset:
Spectrum at 0.8
equivalents of heme B
per MZH3. Conditions:
50 mM NaCl, 10 mM
MOPS buffer, pH 7.5.

2.4.3 Circular dichroism of DDH2 with heme B
DDH2 is highly α-helical, as demonstrated by circular dichroism (CD) spectra in Figure
2.25, top. The mean molar ellipticity per residue at 222 nm, [θMMR]222, in the apo-state is
−27,900 deg cm2 dmol−1 res−1. This ellipticity decreases progressively with the addition of heme
B to −21,100 deg cm2 dmol−1 res−1 when two hemes are bound. In addition, heme binding
decreases the ratio of [θMMR] at 222 nm to 208 nm from 1.11 in the apo-state to 0.97 in the holostate. This is similar to the behavior of MZH3 when it binds heme. DDH2 also exhibits relatively
high thermal stability, as shown in Figure 2.25, bottom. The midpoint of unfolding in the apostate occurs at about 71°C, which is about 11°C lower than the melting temperature of MZH3.
This decreased stability is not surprising given the shortened length of DDH2 and smaller
hydrophobic core. Like MZH3, heme binding has a stabilizing effect on the thermal unfolding
curve, despite the decrease in [θMMR]222.
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Figure 2.25: Far UV circular
dichroism spectroscopy of DDH2
Used 0.1 cm path length cuvette.
Black curves: 32 μM apo-DDH2.
Blue curves: 18.2 μM DDH2 with
0.47 equivalents of heme B per
protein. Green curves: 20.9 μM
DDH2 with 0.91 equivalents of
heme. Red curves: 18.3 μM DDH2
with 2.0 equivalents of heme. Top:
Far UV CD spectra of DDH2.
Bottom: Thermal denaturation of
DDH2. Fraction folded is estimated
by the decreased in measured by
mean molar ellipticity at 222 nm
relative to the ellipticity at 2°C.

Exciton coupling between hemes B in DDH2 is observed by CD, as shown in Figure 2.26.
The addition of less than one equivalent of heme B per DDH2 protein results in a weak exciton
coupling signal near the heme Soret (blue and green traces in Figure 2.26, top). However, when
more than one heme B per protein is added, a pronounced exciton coupling signal is observed.
In Figure 2.26, top, the trace with 0.47 hemes per protein (blue) overlaps with the trace with
0.91 hemes per protein (green), but the trace with 1.37 hemes per protein (black) has a distinct
spectrum, which is increased with 2.0 hemes per protein (red). (The mean molar ellipticity is
given per heme, not per protein). If we assume that the heme CD signal in the 2.0 hemes per
protein spectrum (red) represents the CD spectrum for any heme in a protein with a second
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heme, and the 0.91 hemes per protein spectrum (green) represents the CD spectrum for heme
by itself in DDH2, we can predict the spectrum for 1.37 hemes per protein; at 1.37 hemes, 54%
of the heme is in a protein where there is a second heme, and 46% is in a protein by itself. The
grey dotted line represents this calculated spectrum, and it overlaps with the measured 1.37
hemes spectrum in black. It follows that heme binds to DDH2 anti-cooperatively; a second
heme B does not bind to DDH2 until all of the protein has one heme B bound already. In Figure
2.26, bottom, the 0.47 equivalents (blue) and 2.0 equivalents (red) spectra were reduced with
dithionite (dotted lines) and compared to the oxidized spectra. The red-shift and increased
magnitude of exciton coupling are consistent with heme B reduction.
Figure 2.26: Exciton coupling
between hemes B in DDH2
Measured in 1 cm path length
cuvette. Blue curves: 18.2 μM
DDH2 with 0.47 equivalents of
heme B per protein. Green
curves: 9.4 μM DDH2 with 0.91
equivalents of heme. Black
curves: 6.6 μM DDH2 with 1.37
equivalents of heme. Red curves:
18.3 μM DDH2 with 2.0
equivalents of heme. Top: Grey
dotted line: calculated spectrum
of 1.37 equivalents of heme B,
based on spectra from 2.0 and
0.91 heme per protein spectra.
Bottom: Red and blue dotted
lines: heme B reduced with
dithionite.
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2.4.4 Significance of DDH2
DDH2 has properties that are very similar to the porphyrin binding section of MZH3.
DDH2 has high affinity for heme B, binds heme B in vivo, is stable, and shows the same decrease
in ellipticity at 222 nm upon binding heme. Therefore, the removal of the Due Ferro section of
MZH3 does not significantly perturb the structure or heme-binding function of the tetrapyrrolebinding section of MZH3; both the tetrapyrrole-binding and Due Ferro sections of MZH3 can
function as a standalone maquettes. In effect, MZH3 can be regarded as the joining of two
separate functional proteins into a single fold. DDH2 is a viable candidate for the testing of
other functions performed by BT6 including electron transfer, energy transfer, and oxygen
binding (2).
However, it should be noted that these experiments cannot prove that DDH2 folds as
the intended left-turning antiparallel four-helix bundle and not the right-turning antiparallel
structure; it remains possible that the Due Ferro section of MZH3 might help select for the
correct helical topology or that charge pairing interactions in DDH2 do not sufficiently widen the
energy gap between the right- and left-turning folds. Future studies of DDH2 should involve
high resolution structure determination by NMR or crystallography to test the hypothesis that
DDH2 folds as designed.
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Chapter 3: Structure of a reaction center maquette
No high-resolution structure of a de novo-designed protein has been reported in
complex with heme B or any other tetrapyrrole. High-resolution structures do exist for small
peptides that are covalently linked to a tetrapyrrole cofactor (1, 2), modified natural proteins
with bound tetrapyrroles (3), and apo-states of de novo proteins that are capable of binding
tetrapyrroles (4-7). This conspicuous absence is not for lack of effort, as structural
characterization of designed proteins is generally pursued with purpose; experimentally-derived
structures of de novo-designed proteins have the power to validate design methods, guide
future designs, reveal structure-function relationships, and help explain the significance of
structural elements of natural proteins.

3.1 Crystallographic structure determination of MZH3
Given the past difficulties in structural characterization of tetrapyrrole maquettes,
crystallography of MZH3 in complex with heme B and zinc 5-phenyl,15-(p-carboxyphenyl)
porphyrin (ZnPCP) was pursued with caution, initially. However, it was soon found that MZH3
crystallizes readily, with some limitations, in different space groups and unit cells with different
cofactors and under various conditions. The very first crystal tray of MZH3 that was set to
optimize results from an initial screen yielded heme-containing red crystals shown in Figure 3.1
that diffracted to 1.45 Å at the National Synchrotron Light Source (NSLS) at Brookhaven National
Laboratory.
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MZH3 samples that were subjected to
HPLC and lyophilization prior to SEC showed no
attenuation in crystal quality. MZH3 samples of
only ~90% purity as estimated from SDS-PAGE
gels were often easy to crystallize with heme
and metal ions, but samples of MZH3 with a
zinc tetrapyrrole were much more difficult to
grow, and sometimes required seeding with

Figure 3.1: Crystals of MZH3 with heme B

crystals that did not contain a zinc tetrapyrrole.

These crystals were grown with heme B and
Zn(II) in the first optimization tray and
diffracted to 1.45 Å resolution for crystal
structure CS-D (Table 3.2).

UV/vis spectroscopy and the quality of crystal
growth and diffraction suggested that careful

addition of 1.0 equivalent of low-solubility electron acceptor and pigment tetrapyrroles per
maquette was necessary to prevent tetrapyrrole aggregates from sequestering cofactors and
lowering occupancy of the acceptor and pigment binding sites. See the appendix for details
concerning crystallography methods.
Three different crystallization conditions were used to solve high-resolution structures
of MZH3, and a fourth condition was identified that provided only small, thin crystals that were
not suitable for diffraction. These conditions and the ranges across which crystal growth was
observed are shown in Table 3.1. Most crystal structures came from crystallization conditions
CC-1 and CC-2, which have pH less than or equal 5.0, but crystals were also observed at pH as
high 6.1 in CC-3. Lest it be surmised that MZH3 is only singularly structured at low pH, CC-4 was
included in Table 3.1 to show that MZH3 crystals at higher pH have been observed, suggesting
that MZH3 remains uniquely structured across a wide pH range.
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Name
Salt
CC-1
2.2 – 4.0 M
NaCl

buffer
100 mM
Na
acetate

pH
precipitant
Notes
3.2 – 5.0
–
One metal ion is located in
unintended position, ligated
by His138 Nε atom instead of
Nδ. Can grow with or without
ZnPCP. Requires heme and
metal dications.
CC-2
40 – 120 mM
100 mM
4.0 – 4.9 18 – 30%
Crystals did not grow with
CdCl2
Na
PEG 400 – ZnPCP. Can grow with or
acetate
20,000
without heme B. Cd(II) is
unavoidable in metal site.
CC-3
1 – 1.5 M Li2SO4 100 mM
5.6 – 6.1
–
Crystals grew with heme B
0.5M (NH4)2SO4 Na3citrate
and Zn(II) or Mn(II).
CC-4
10 – 200 mM
various
6.8 – 9.5 24 – 40% Crystals grew in presence of
Na/K tartrate or buffers
PEG 200 – heme B, ZnPCP, and Zn(II). No
Na3citrate
PEG 400
diffraction-quality crystals
grown
Table 3.1: Crystallization conditions used to grow MZH3 crystals
Details of the crystallization conditions for each crystal are given in the appendix. PEG is
polyethylene glycol; the number beside it is the average molecular weight of PEG used.

Eight crystal structures of MZH3 are reported in this chapter, and they are listed in Table
3.2. Each of these structures contributes unique information about the assembly of cofactors.
The first MZH3 structure was CS-A, which was solved by multi-wavelength anomalous dispersion
(MAD) using the X-ray absorption of the three zinc ions (two from the metal site and one from
the zinc tetrapyrrole) to create the phase shift and anomalous dispersion. All of the subsequent
structures were solved by using molecular replacement starting from previously solved
structures. Diffraction data for crystal structures CS-A and CS-D were collected using
synchrotron radiation at the National Synchrotron Light Source. All others were collected using
an in-house rotating copper anode X-ray generator at the University of Pennsylvania. Details of
the methods and statistics for each crystal are given in the appendix.
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Name Condition Resolution Acceptor
CS-A
CC-1
2.0 Å
Heme B

Pigment
ZnPCP

Metal
2 Zn(II)




CS-B

CC-1

2.02 Å

Heme B

ZnPCP


3 Mn(II) 


CS-C

CC-1

2.10 Å

Heme B

ZnPCP


2 Mn(II) 



CS-D

CC-1

1.45 Å

Heme B

–

CS-E

CC-3

1.90 Å

Heme B

–

CS-F
CS-G

CC-2
CC-2

2.01 Å
1.78 Å

Heme B
–

–
–


2 Mn(II) 

2 Cd(II) 
2 Cd(II) 

CS-H

CC-2

2.02 Å

Heme B

–

2 Cd(II)

2 Zn(II)








Notes
used for MAD phasing
Zn(II) on wrong side of
H138
pH 4.5
Tyr in two rotamers
Mn(II) on both sides of
H138
pH 4.9
Tyr in unintended rotamer
extra ZnPCP
Mn(II) on wrong side of
H138
pH 4.8
Zn(II) on wrong side of
H138
pH 4.5
one low-occupancy Mn(II)
pH 5.9
pH 4.2
Cd(II) bound to acceptor
site
pH 4.4
L71H mutant with His-Tyr
hydrogen bond
pH 4.6

Table 3.2: List of MZH3 crystal structures
Details of the crystallization conditions for each crystal are given in the appendix.

3.2 Overall structure of MZH3
As designed, MZH3 folds as a four-helix coiled coil (Figure 3.2). All eight structures are
similar overall and largely consistent with the design. Helices begin and end at the intended
positions, a- and d-position amino acids are directed into the core, each helix is oriented
antiparallel to its two adjacent neighboring helices to form e-e and g-g interfaces, the bundle
has the intended left turning topology, and, with some exceptions that will be described in
subsequent sections, cofactors bind to intended sites in accordance with the design.
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Figure 3.2: Crystal structure of MZH3 in holo-state.
Structure CS-B with backbone amino acids is traced
by cartoon helices and loops. Mn(II) ions are
portrayed as mauve spheres and tetrapyrroles as
sticks. (A) Axial view of MZH3 from the electron
donating end shows canonical left-handed
superhelix. Structured loop is at upper right and a
dynamic glycine-rich loop is at lower left. (B) Lateral
view of MZH3 shows correct placement of heme B in
electron acceptor site (top), ZnPCP in pigment site
(middle), and tyrosine with two Mn(II) ions in
electron donor site (bottom). Images rendered using
The PyMOL Molecular Graphics System, Version 1.7
Schrödinger, LLC.

3.2.1 MZH3 is a coiled coil
Coiled coil structural parameters of MZH3 were evaluated by the programs SOCKET (8),
TWISTER (9), and CCCP (10). These programs assess the structure of a coiled coil by taking
atomic coordinates from a PDB file as input and searching for knob-into-hole interactions and/or
determining the Crick parameters, a set of parameters that can be used to define the amino acid
backbone coordinates in an idealized coiled coil (11, 12). Using the coordinates of CS-B as a
prototypical MZH3 structure, all three programs find that MZH3 is a canonical coiled coil with a
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left-handed superhelix. In addition, the heptad abcdefg positions of helical amino acids in MZH3
designated by the programs agree with the abcdefg assignments intended by design. For a set
of coordinates that included only the residues between and including the core a-d-a-d layers at
either end of the MZH3 bundle, CCCP calculated an average of 3.51 residues per turn (canonical
coiled coils have 3.5 residues per turn) and a 0.968 Å RMSD deviation from an idealized coiled
coil structure. SOCKET identified extensive knob-into-hole interactions involving a, d, e, and g
positions across each helix. SOCKET also calculated the average pairwise helix crossing angle
between adjacent helices to be 19.9°; idealized coiled coils with left-handed supercoils tend to
have crossing angles near 20° (13). This analysis shows that the secondary and tertiary structure
of MZH3 is consistent with the design.

3.2.2 Layers in the hydrophobic core
MZH3 forms layers in the hydrophobic core that are consistent with the design. Each
helix contributes two heptad a- and two d-positions to each layer to make groups of four amino
acids each that are roughly aligned in the same plane. This validates the original design
approach of connecting the set of layers from a di-heme protein such as cytochrome b to the set
of layers from a diiron protein such as bacterioferritin to form a long string of layers in an
extended four-helix bundle. The left panel in Figure 3.3, shows how the a-d-a-d layers of
cytochrome b and bacterioferritin were essentially strung together to make the core of MZH3.
While the exact identities of each core a- and d-position are not copied from nature, the total
size of the amino acid side chains and cofactors in each layer is kept consistent throughout the
length of the holo-state bundle, with small exceptions to aid cofactor binding and function. The
right panel of Figure 3.3 shows the simplified cartoon backbones and cofactors of cytochrome b
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and bacterioferritin to show how MZH3 retains structural properties of both a transmembrane
hemoprotein and a water soluble diiron protein. When connected, they create a metaltyrosine-pigment-electron acceptor tetrad that should be competent for light-activated electron
transfer and the trapping of a charge-separated state.

Figure 3.3: Seamless connection of MZH3 cofactor binding modules facilitated by layers
Left: layering of the hydrophobic core in MZH3 (CS-B) is similar to that of a cytochrome b-like
protein joined to a bacterioferritin-like protein. The four-helix bundle on the top left is a
crystal structure of cytochrome b (14). The bottom left bundle is a crystal structure of
bacterioferritin (15). Layers of a-d-a-d positions are shown as spheres. Colors of layers in
MZH3 match up with layers in cytochrome b and bacterioferritin, as indicated by arrows.
Right: Cartoon of MZH3 with cofactors (green, structure CS-B) is shown alongside cytochrome
b in cyan (16), and bacterioferritin in magenta (17). Cofactors are labeled A for electron
acceptor, P for pigment, Y for tyrosine, and M for di-metal center. Images rendered using The
PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.
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3.2.3 Inter-helical charge patterning interactions
Charge patterning interactions between c-position glutamates and lysines in the
tetrapyrrole-binding section of MZH3 did not result in stable salt-bridging hydrogen bonds. In
some crystal structures, some of the distances between lysine nitrogens and glutamate oxygens
are close enough for hydrogen bonding, but these flexible, solvent-exposed side chains tend to
have relatively high temperature factors, indicating that hydrogen bonding interactions are
transient. It may be that the g-g interfaces in MZH3 are too wide for persistent hydrogen
bonding between c-position residues. In addition, the high ionic strengths of the three
crystallization conditions may shield the charges to some extent and destabilize surface-exposed
polar contacts. Despite the lack of stable salt bridges, the cumulative effect of all of the interhelical electrostatic interactions may be involved in determining the topology.

3.2.4 Inter-helical loops
The structures of the inter-helical loops in MZH3 follow the design (Figure 3.4). The
structured turn between helices 1 and 2 in MZH3 forms the same set of hydrogen bonds as the
Due Ferro protein DF2t, which has the same loop sequence (18). This structured loop has
backbone temperature factors that are similar to backbone temperature factors within the
helices, indicating that the loop is stable and that the hydrogen bonding pattern in the turn
persists. In contrast, the N- and C-termini and glycine-rich loops in MZH3 are dynamic.
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Figure 3.4: Structured loop in MZH3 and DF2t
The structured turn in MZH3 that connects helices 1 and 2 (above left,
from structure CS-D) closely matches the conformation of the turn in
DF2t (above right, PDB ID: 1MFT) (18). Yellow dotted lines represent
hydrogen bonds between side chains and backbone atoms. Right:
backbone atoms in CS-D represented by temperature factor from low
(blue, narrow tube), to medium (white), to high (red, wide tube). As
expected, the most dynamic parts are the N- and C- termini and glycinerich loops. The structured loop (bottom, rear) has temperature factors
similar to the center of the bundle. Images rendered using The PyMOL
Molecular Graphics System, Version 1.7 Schrödinger, LLC.

The overall structure of MZH3 is consistent with the design. The following sections will
examine specific interactions at cofactor binding sites to validate or challenge design methods
and consider possible effects on function.

3.3 Electron acceptor site
3.3.1 Heme B binding site agrees with design
Heme B was selected as the electron acceptor in all crystallography experiments, except
in crystal structure CS-G, which lacks an electron acceptor. All heme-containing structures show
that the acceptor site histidine residues ligate the ferric ion of heme B with Nε atoms, the
propionate groups of the heme are directed away from the hydrophobic core and are partially
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exposed to solvent, and the porphyrin ring is secured into a well-defined conformation with low
temperature factors (Figure 3.5). This fixed heme conformation is surprising, because no facet
of the design was consciously included to prevent free rotation of the porphyrin ring about the
histidine-iron ligands while keeping propionate groups solvent exposed.

Figure 3.5: Heme B has well-defined conformation in MZH3
Crystal structure CS-D at 1.45 Å resolution shows heme B with welldefined conformation. (A) An (Fobs, φcalc) electron density map
contoured at 1.8 σ of electron acceptor site with bis-histidine ligated
heme B. Helix 2 is cut away for better view of heme. (B) Full length
lateral view of CS-D shows heme B in acceptor site at top and two
Zn(II) ions in metal site. Images rendered using The PyMOL Molecular
Graphics System, Version 1.7 Schrödinger, LLC.

All of the crystal structures with heme in the electron acceptor site exhibit the intended
second-shell inter-helical hydrogen bonds between the Nδ atoms of the heme-ligating histidines
and the threonine hydroxyl groups (Figure 3.6). The lengths of the hydrogen bonds range from
about 2.6 to 3.1 Å. Helices 1 and 3, which bear heme-ligating histidines are pushed outward to
make room for the histidine-iron ligation, while helices 2 and 4, which contain notch glycines,
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make close contact with heme. The Cα atoms of the notch glycines (shown as green spheres in
Figure 3.6) are within van der Waals contact of the heme.
Figure 3.6: Heme B
binding site and 2nd
shell threonines
Axial view of crystal
structure CS-D from
electron acceptor end.
Blue dotted lines
represent hydrogen
bonds between
threonine residues and
ligating histidines.
Glycine residues (with
Cα as green spheres)
make close van der
Waals contact with
heme (translucent
spheres).
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

3.3.2 Multiple heme conformations in the acceptor site
Despite the low temperature factors of heme B in MZH3, different conformations are
observed in the crystal structures. A close-up view of the isolated electron density map of the
heme B from crystal structure CS-D at 1.45 Å shows that the diffraction data is consistent with
heme B in either of two orientations related by a 180° rotation that switches the positions of the
vinyl groups (Figure 3.7). A similar lack of conformational specificity with regard to the vinyl
groups is observed in cytochrome b5, neuroglobin, and others (19, 20), but some proteins
display selectivity for one orientation. Protein contacts at the heme edge are generally not well
conserved, suggesting that this 180° flipping of the heme has little effect on function (21).
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Figure 3.7: Heme flipping in MZH3
Left: Two possible orientations of heme B
superimposed in structure CS-D (Fobs, φcalc)
map contoured at 1.8 σ. One orientation
has heme vinyl methylene groups colored
yellow, the other magenta. Top right:
Heme B has asymmetric arrangement of
vinyl and methyl groups in pyrrole βpositions.
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

While the positions of the vinyl groups of heme B are sometimes in a mixture of states,
heme B is otherwise fixed in natural proteins. In MZH3, mutation of leucine 71 to histidine in
crystal structure CS-H led to a 90° rotation of the heme porphyrin ring relative to the wild type
structure, putting the propionate groups between helices 3 and 4 instead of between 1 and 2
(Figure 3.8). The MZH3-L71H mutant will be discussed in more detail in section 3.6.
Figure 3.8: Heme B rotation by
90° in MZH3-L71H mutant
Heme B is rotated in crystal
structure CS-F (left) relative to
CS-H (right). Both crystals were
grown in condition CC-2 with
heme B and Cd(II), but CS-H has
L71H mutation. Space groups
were C2 for CS-F and P21 for
CS-H. Helices 1, 2, 3, and 4 are
colored blue, green, yellow,
and red, respectively.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.
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3.3.3 Influence of arginine and tryptophan residues on heme binding in MZH3
Arginine residues in cytochrome b
make stable salt bridging hydrogen bonds
with the propionate groups of heme B. In
MZH3, two d-position arginines were placed
one turn N-terminal to the heme-ligating
histidines in an effort to reproduce this
interaction. Crystal structures indicate that
these arginines do not make stable hydrogen
bonds with heme propionate groups. The low
pH of most of the crystal structures might
inhibit salt bridging interactions by
protonating the propionate groups. In
structure CS-E at pH 5.9, the arginine nitrogen
to propionate oxygen distance is 2.8 Å, close

Figure 3.9: Heme-arginine interaction in
MZH3
MZH3 crystal structure CS-E at pH 5.9 shows
heme propionate-arginine interaction. Heme
B and arginine side chains are represented as
sticks. Atoms are colored by temperature
factors from low (blue) to medium (white) to
high (red). Temperature factors suggest
propionate-arginine hydrogen bond is
unstable. Image rendered using The PyMOL
Molecular Graphics System, Version 1.7
Schrödinger, LLC.

enough for hydrogen bonding, but elevated temperature factors suggest that these interactions
are transient (Figure 3.9). Nevertheless, d-position arginines may serve to prevent hydrophobic
collapse of the electron acceptor site in the apo-state to make the site accessible for cofactor
binding, attract the heme B cofactor (which has an overall charge of −1 in the ferric state at
neutral pH), stabilize the propionate groups by electrostatic interactions, and raise the midpoint
potential of the electron acceptor. Calculations performed by Dirk Auman using multiconformer continuum electrostatics (MCCE) (22, 23) indicate that despite the conformational
freedom of the two arginine residues, they each raise the heme B midpoint potential by ~16 mV
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to a predicted midpoint of -192 mV (personal communication). This is consistent with the −180
mV measurement at pH 7 by redox titration (Figure 2.22).
MZH3 has two tryptophan residues in interfacial e-positions next to the electron
acceptor site that were included mainly as spectroscopic probes for concentration
measurements. They are located very close to the dynamic C-termini of helices 2 and 4, and
their conformations vary widely in different crystal structures. However, most of the MZH3
crystal structures have one tryptophan residue within about 4 Å of the heme cofactor, possibly
forming stabilizing T-stacking interactions. The second tryptophan side chain appears to be very
close to the propionate groups of heme, which is a potentially destabilizing interaction. Despite
their proximity to the heme, the effect of the tryptophan residues on heme binding is
ambiguous.

3.3.4 Structural similarity between heme sites of MZH3 and cytochrome b
The MZH3 crystal structures that contain heme B reveal remarkable structural
similarities with cytochrome b despite negligible sequence similarity (Figure 3.10). As intended
by design, MZH3 shows similar interface widths, hydrophobic core packing, rotameric states of
heme-ligating histidines, and second shell histidine-threonine hydrogen bonds. Furthermore,
the orientation of the maquette heme relative to the superhelical bundle axis is conspicuously
similar to that observed in cytochrome b, suggesting that the particular conformation of heme
in cytochrome b is not precisely controlled for any functional purpose, but rather is an accident
of the structural constraints demanded by this protein fold.
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Figure 3.10: Structural similarity between MZH3 and cytochrome b
Despite low sequence similarity, MZH3 and cytochrome b bind heme B with very similar
conformations. Left: MZH3 crystal structure CS-D. Right: cytochrome b crystal structure, PDB
ID: 2A06 (16). Images rendered using The PyMOL Molecular Graphics System, Version 1.7
Schrödinger, LLC.

3.3.5 Apo-state of the acceptor site
Binding of heme B appeared to improve crystal growth in most cases, but crystallization
condition CC-2 containing ~35 mM CdCl2 was able to facilitate MZH3 crystal growth from a
sample that lacked an electron acceptor cofactor. Because MZH3 expresses with some heme
already bound, extra purification steps were required including HPLC purification to remove
heme, lyophilization to remove acetonitrile, resuspension in GdnHCl to solubilize the lyophilized
powder, and dilution to refold the protein. After SEC, the crystallization trays were set, and the
resulting structure, CS-G, diffracted to 1.78 Å using a rotating copper anode X-ray tube.
In CS-G and other crystal structures that came from crystallization condition CC-2,
several Cd(II) ions are bound to the surface of MZH3, and some of them mediate crystal
contacts. In CS-G, one of the resolved Cd(II) ions is ligated by the two histidines in the electron
acceptor site. The Cd(II) takes on a tetrahedral geometry with two coordinated water molecules
and the two histidines ligating with Nε atoms (Figure 3.11). Because of the tetrahedral geometry
of the Cd(II) ion, the histidines cannot have the same rotameric state as they do when ligating
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heme. Instead, His110 has its imidazole ring flipped, disrupting the second-shell hydrogen-bond
to Thr91.
Figure 3.11: MZH3 structure
without electron acceptor
MZH3 conformation is similar
with heme B or Cd(II) in acceptor
site. Left: crystal structure CS-D
has bis-histidine ligated heme B
and second shell His-Thr
hydrogen bonds. Right: structure
CS-G lacks an electron acceptor,
but a Cd(II) ion is coordinated by
the two histidine residues. One
His-Thr hydrogen bond remains
intact, but the other is broken.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

In comparing the structures of MZH3 with and without heme, it is important to
remember that the Cd(II) ion in the acceptor site may serve to stabilize the site. As described in
the introduction, natural hemoproteins typically have significant conformational variability in
heme binding sites in the apo-state, and the binding of heme stabilizes secondary and tertiary
structure. In contrast, the structures of MZH3 with heme and with Cd(II) in the acceptor site
have relatively subtle differences. They have essentially identical helix content, and the only
significant difference between their tertiary structures is a modest expansion of e-e interface
through which the porphyrin ring lies. As shown in Figure 3.12, the most notable changes seem
to be in side chain rotamers. The two tryptophan residues next to the acceptor site, W96 and
W193, are fully or partially buried in the absence of heme, but heme binding displaces them into
more solvent-exposed conformations. Gln residues in e-positions and two d-position Leu
residues also change conformation to accommodate the steric bulk of the heme cofactor.
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Figure 3.12: Conformational changes associated with heme binding in MZH3
Heme binding in MZH3 triggers a slight expansion of the e-e interface as well as rotameric
changes in the side chains of Trp96, Trp193, Arg6, Arg107, Gln10, Gln111, Leu88, and Leu185.
Some of these changes, particularly the removal of the tryptophans from the core, might
weaken heme affinity. Left: MZH3 crystal structure CS-D. Right: MZH3 crystal structure CS-G.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

The electron acceptor site probably does not bind metal ions at lower concentrations,
and it is possible that the bis-histidine-ligated Cd(II) ion affects the structure. Even with Cd(II)
contributing to stability, it is still surprising that the acceptor site is so structured without heme;
the hydrophobic core in this part of the protein includes two d-position arginines, two a-position
glycines, and two d-position histidines, all of which should be strongly destabilizing. It may be
that interfacial interactions between g-position leucines and electrostatic interactions between
c-position glutamates and lysines are the most stabilizing forces in the vicinity of the apo-state
acceptor site.

3.4 Pigment site
3.4.1 Apo-state of the pigment site
Given the importance of apo-state flexibility for heme binding sites, it was deemed
important to create ample space for the binding of a zinc tetrapyrrole at the pigment site of
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MZH3. The pigment site lies in the center of the four-helix bundle, where the protein should be
the most stable, and if the pigment site succumbs to hydrophobic collapse in the apo-state, the
inherent inflexibility of the helices in this section of the bundle would prevent entry of the zinc
tetrapyrrole. For this reason, MZH3 design included a-d-a-d layers of bulky hydrophobic amino
acids adjacent to the pigment site and four helical a-position glycines in the pigment site in
order to create a cavity into which a zinc tetrapyrrole could penetrate.
Figure 3.13 shows that in
the absence of a pigment
cofactor, the helices are indeed
held apart to create a pore in the
center of the bundle. The
highest resolution crystal
Figure 3.13: MZH3 structure without pigment
structures that lack a zinc
tetrapyrrole, CS-D and CS-G,
have four well-resolved water
molecules in the pigment site.
These four waters are found in

The MZH3 pigment site contains four structured water
molecules when zinc tetrapyrrole is absent. Crystal
structure CS-G is shown here with the four buried waters
shown as red spheres and the zinc tetrapyrrole-ligating
histidine and intended second-shell threonine shown in
red. Part of helix 2 is cut away for better view of pigment
site. Image rendered using The PyMOL Molecular
Graphics System, Version 1.7 Schrödinger, LLC.

the same positions regardless of differences in the crystallization condition or whether heme B
is present. The fact that water is able to penetrate into the pigment site means that a proper
binding cavity has been created for the zinc tetrapyrrole.
The presence of water in the hydrophobic core is usually strongly destabilizing.
However, circular dichroism showed that in the absence of cofactors, MZH3 is highly α-helical
and has a high melting temperature of 82°C. Given that apo-MZH3 has poor hydrophobic core
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packing in the acceptor site, water in core at the pigment site, water and four negatively
charged glutamate residues in the core at the metal site, and a total of ten helical glycine
residues at mostly a- and d-positions, its high stability cannot be attributed to packing of a-d-a-d
layers alone. Interfacial hydrophobic contacts and possibly inter-helical charge pairing
interactions may provide much of the driving force for folding of MZH3.
Figure 3.13 also shows that the pigment site histidine residue H124 and an interfacial
threonine T77 (both shown in red) are not in rotameric states that would allow a hydrogen bond
to form. These residues were designed to make a hydrogen bond when the zinc tetrapyrrole is
bound, and with their Cα atoms 5.9 Å apart in CS-G, they appear to be close enough to make a
hydrogen bond if their rotamers changed.

3.4.2 Holo-state of the pigment site
All three crystal structures that contain a pigment molecule, CS-A, CS-B, and CS-C, used
Zn 5-(p-carboxyphenyl)-15-phenyl porphyrin (ZnPCP), which was kindly provided by Tatiana
Esipova in the laboratory of Sergei Vinogradov. As shown in Figure 2.17, ZnPCP binds with a
dissociation constant of <10 nM. These three structures also had heme B and either Zn(II) or
Mn(II) as the metal ion. Zn(II) has the advantage of being able to form strong ligands, as
predicted by the Irving-Williams series (24), and zinc was useful for MAD phasing in concert with
the zinc ion of ZnPCP to solve the crystal structure CS-A.
The pigment binding site of CS-A is shown in Figure 3.14. The ZnPCP molecule in CS-A is
resolved in the pigment site with a conformation that is largely consistent with the design. The
phenyl groups protrude through the e-e interfaces on either side of the protein, as expected.
Similar to heme B, the ZnPCP molecule is tilted in the binding site so that two of the pyrrole
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nitrogens are closer to the central superhelical axis of MZH3 than the other two. ZnPCP has
higher temperature factors and less well-defined electron density than the heme B, which
suggests sub-stoichiometric occupancy of the pigment site or increased conformational
variability compared to heme B.
Like the ZnPCP cofactor itself, the ZnPCP-ligating His124 has poorly-defined electron
density, and its rotameric state is ambiguous. It is not clear whether His124 ligates ZnPCP with
the Nδ or Nε imidazole nitrogen, possibly because partial occupancy of the ZnPCP may result in
the histidine having multiple conformations that complicate its electron density. The pigment
site was designed for ligation of the zinc ion of ZnPCP by the histidine Nε, and this conformation
is consistent with the (Fobs, φcalc) electron density map of CS-A (Figure 3.14), but not conclusive.
In the conformation that has the Nε atom as the ZnPCP ligand, the His124 Nδ is 2.7 Å from the
second shell Thr77 oxygen, forming a putative hydrogen bond, as designed.
The ZnPCP molecule has one carboxylate group in the para-position on one of the
phenyl groups. The temperature factors of this carboxylate group are high, but the electron
density map is more consistent with the carboxylate being in the e-e interface between helices 3
and 4 than between helices 1 and 2 (Figure 3.14). This could be because the charge-pairing cposition amino acids in the porphyrin-binding section of MZH3 are distributed so that helices 3
and 4 are positively charged and helices 1 and 2 are negatively charged, creating a dipole
moment that may cause the preference in ZnPCP orientation.

135

Figure 3.14: CS-A pigment site with ZnPCP
The cofactor Zn 5-(p-carboxyphenyl)-15phenyl porphyrin (ZnPCP) (lower right) binds
to the pigment site of MZH3 in crystal
structure CS-A (upper right). An (Fobs, φcalc)
electron density map of CS-A contoured at 1.0
σ (upper left) shows the electron density of
the ZnPCP in the pigment site. Blue dotted
line shows second shell histidine-threonine
hydrogen bond.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

In contrast to the heme in MZH3, the structure of the pigment site with its ZnPCP
deviates slightly from the structure of cytochrome b. ZnPCP does not bind with its porphyrin
ring in the same orientation relative to the helical bundle axis as the hemes of cytochrome b,
possibly because the bulky phenyl groups would clash with the hydrophobic core of the
maquette. Also, the metal-to-metal distance in MZH3 is about ~1 Å longer than in cytochrome
b, probably because the four glycine residues in the core near the pigment binding cavity in
MZH3 create a pocket that causes the ZnPCP to shift away from the electron acceptor. Whereas
heme is ligated by two histidines, ZnPCP is ligated by only one histidine, giving it more
conformational freedom to adapt to the shape of the binding cleft.
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3.4.3 ZnPCP can bind to an unexpected site in MZH3
The (Fobs, φcalc) electron density map of crystal structure CS-A has an unusually large
peak of 3.0 σ located at the opening of the metal-binding cavity. (For comparison, the peak for
the zinc ion of ZnPCP in the pigment site is 9.5 σ). The peak of 3.0 σ is located between the
carbonyl oxygen atoms of helical glycines G33 and G160, which line the opening to the metal
binding cavity. The center of the peak is 2.9 Å from the carbonyl oxygen of G160 and 3.6 Å from
the oxygen of G33. A chloride ion at this position would clash with the nearby partial negative
charge of the glycine carbonyl oxygens. The peak was deemed unlikely to represent a free
metal ion because carbonyl oxygens are not strong ligands, and the crystallization drop only had
a stoichiometric concentration of ZnCl2. The 3.0 σ peak is surrounded by a coplanar arc of
diffuse electron density on one side, not unlike a metal ion surrounded by a partially-resolved
tetrapyrrole ring. If this electron density does come from a tetrapyrrole, the occupancy of that
tetrapyrrole would be very low, so the peaks in this region were assigned to water molecules
instead.
Crystal structure CS-A (Figure 3.14) was solved with zinc ions in the metal site for MAD
phasing with the zinc of the ZnPCP cofactor, but Zn(II) is redox-inactive and not useful as an
electron donor in a reaction center maquette. The most promising metal ion for use in an
oxygen evolution catalyst is manganese, because of its relevance to photosystem II, rich redox
chemistry, known capacity for oxygen evolution, and abundance (25). For this reason,
additional crystal structures of MZH3 with heme B and ZnPCP were grown with Mn(II) to
produce structures CS-B and CS-C. Unlike the crystals from CS-A which grew spontaneously,
growth of crystals for CS-B and CS-C structures required seeding with crystals that contained
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heme B and Mn(II) but not ZnPCP. All pigment-containing structures came from crystallization
condition CC-1. Efforts to grow crystals with ZnPCP in conditions CC-2 and CC-3 resulted in
crystal structures that lacked the pigment; evidently, the ZnPCP cofactor dissociated from MZH3
before crystallization.
In crystal structure CS-C, the temperature factors and the shape of the electron density
for the ZnPCP cofactor in the pigment site were improved compared to structure CS-A (Figure
3.15). In CS-C, the overall conformation of ZnPCP in the pigment site is in good agreement with
the structures of CS-A and CS-B. The carboxylate group of ZnPCP is between helices 3 and 4 for
all three structures, which supports the hypothesis that the ZnPCP orientation is influenced by a
dipole moment created by charged c-position residues. The conformation of the ZnPCP-ligating
histidine H124 appears to be more consistent with ligation of the zinc by the Nδ atom than the
Nε atom. This is unusual
because natural hemebinding proteins
overwhelmingly favor
heme ligation by histidine
Nε atoms over Nδ atoms.
Despite the flipping of the
imidazole ring, there
remains a 2.8 Å hydrogen
bond between the H124

Figure 3.15: CS-C pigment site with ZnPCP
ZnPCP in MZH3 pigment binding site in crystal structure CS-C has
lower B-factors than CS-A, suggesting increased occupancy of
ZnPCP. An (Fobs, φcalc) electron density map contoured at 1.0 σ
corroborates ZnPCP conformation in CS-A, but His124 in CS-C
appears to fit electron density better when ligating ZnPCP with
Nδ. Image rendered using The PyMOL Molecular Graphics
System, Version 1.7 Schrödinger, LLC.

Nε atom and the hydroxyl
oxygen of T77.
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Crystal structure CS-C has a clearly-resolved second ZnPCP molecule at the opening of
the metal site cavity in the same position as the tetrapyrrole-like features observed in CS-A
(Figure 3.16). In the (Fobs, φcalc) map of CS-C, the electron density peak heights for the zinc ion in
the pigment site and the metal cavity are 12.8 σ and 6.7 σ respectively, compared to 9.5 σ and
3.0 σ in CS-A. In CS-C, the G160 carbonyl oxygen appears to interact with the zinc ion which is
2.9 Å away, and the distance between the zinc and G33 carbonyl oxygen is 3.7 Å. The porphyrin
ring of ZnPCP makes van der Waals contact with all four of the glycine residues that line the
opening of the metal binding cavity, G33, G37, G160, and G164. The pyrrole group of the
porphyrin ring furthest from the porphyrin-binding section of the protein packs against the side
chains of residues L41 and L157. The p-carboxyphenyl group of ZnPCP projects out of the
protein into the solvent and is not resolved at all. The other phenyl group projects into the core
of MZH3 and displaces the tyrosine 168 side chain so that Y168 rotates outward into a partially
solvent-exposed interfacial position, pushing Gln172 into a strained conformation. The phenyl
group makes hydrophobic contacts with side chains of L30, L71, I131, and Y168.
The binding of ZnPCP to the metal site is reminiscent of work done on Due Ferro
proteins that has shown quinone molecules binding to the metal cavity for redox reactions with
iron ions (26). While interesting in its own rite, the ZnPCP binding at the metal cavity presents a
problem for light-driven electron transfer studies, because it changes the rotameric state of
tyrosine 168, which changes the distances between cofactors and therefore electron transfer
rates, impedes binding of metal ions and potential substrates to the metal site, and may
participate in light-activated redox chemistry that would interfere with charge separation. All
three ZnPCP-containing structures, CS-A, CS-B, and CS-C, have some evidence of this metal
cavity ZnPCP, but it is clearest in CS-C and nearly undetectable in CS-A.
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Figure 3.16: Extra ZnPCP at opening of metal binding site cavity
ZnPCP is well-resolved in an unintended site at the opening of the metal binding cavity in
crystal structure CS-C, but not CS-A. (A) (Fobs, φcalc) map of CS-C contoured at 1.0 σ shows
electron density of ZnPCP at opening of metal-binding cavity. Dotted blue line shows
proximity of G160 carbonyl oxygen to zinc ion of ZnPCP. Solvent-exposed p-carboxyphenyl of
ZnPCP is not resolved. Part of helix 4 is cut away for better view. (B) (Fobs, φcalc) map of CS-C
at 1.0 σ contour level showing the two ZnPCP cofactors in yellow and the change in Tyr168
rotamer with ZnPCP binding to metal cavity. Tyr168 of structure CS-A, shown in cyan, would
clash with ZnPCP phenyl group if it did not adopt interfacial conformation observed in CS-C.
Part of helix 1 is removed. (C) CS-C interfacial Tyr168 side chain rotamer avoids steric clash
with ZnPCP phenyl group. Gln172 (top right) in strained conformation avoids steric clash with
Tyr168. (D) CS-A Tyr168 side chain is located in the core in the absence of ZnPCP at metal
cavity, and Gln172 adopts relaxed conformation. Images rendered using The PyMOL
Molecular Graphics System, Version 1.7 Schrödinger, LLC.

The crystal structures indicate that ZnPCP binds with higher affinity to the intended
pigment site than the metal cavity. In all three structures, the electron density of the zinc ion of
ZnPCP at the pigment site is significantly higher than the zinc ion of ZnPCP at the metal cavity.
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All three crystal structures grew from crystallization condition CC-1 well solutions with pH
between 4.5 and 4.9, and this may disfavor binding to the pigment site, which involves
coordination by histidine 124. His124 is likely to be protonated in this pH range the absence of
ZnPCP, because the solution pKa of histidine is about 6.4, and His124 is surrounded by water in
the apo-state (see Figure 3.13). Acidic conditions have been observed to weaken histidinemetalloporphyrin interactions in maquettes previously (27). In contrast, the ZnPCP at the metal
cavity is not contingent upon ligation by any protonatable groups, suggesting that acidic
conditions would favor ZnPCP binding to the metal cavity over the pigment site. Despite the low
pH, however, the electron density maps clearly show more density for ZnPCP at the pigment
site, and this disparity may be higher at neutral pH.
The unexpected binding of ZnPCP to the metal cavity likely cannot be reproduced in
other zinc tetrapyrroles that bind to MZH3 with high affinity. Table 2.4 shows that SE375,
NR117, TE312, and TE394 have different substituents on the porphyrin ring, and they would not
be able to make the same interactions that ZnPCP makes at the metal cavity. NR117, for
example, has two p-carboxyphenyl groups which would not easily be buried in the core to pack
against L30, L71, and I131 as ZnPCP does. TE312 and TE394 have benzyl substituents fused to
two of the pyrrole units, and these are likely to clash with glutamate residues in the metal
binding site and core leucine residues L30 or L157 on either side of the opening to the metal
binding cavity. In SE375, an alkyne group connects the porphyrin ring to a phenyl group, and
this long, inflexible substituent would create severe steric clashes if the porphyrin ring were
lodged at the opening of the metal cluster as it is in CS-C. Despite these potential clashes at the
metal binding cavity, SE375, NR117, TE312, and TE394 all bind to MZH3 with high affinity,
suggesting that the intended pigment binding site is the preferred site for zinc tetrapyrroles.
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3.5 Metal-binding site
3.5.1 Di-metal site structure consistent with design
All MZH3 crystals grown in crystallization conditions CC-2 and CC-3 had metal binding
sites that closely match the design. Histidines H67 and H138 ligate the metal ions with Nδ atoms
and make second-shell hydrogen bonds with Nε atoms to aspartates D134 and D63, respectively.
Glutamates E34 and E161 make bidentate axial ligands with the metal ions, while E64 and E135
make bridging ligands to connect the two metal ions. In one exception, the Mn(II)2 site of CS-E
has a low-occupancy Mn(II) in the site closest to the tyrosine, and E34 appears to be out of
place. This crystal was grown with a slightly sub-stoichiometric amount of MnCl2, which may not
have been enough to fill the metal sites, given the relatively weak affinity of Mn(II) compared to
other metals (28). In the highest resolution structure that came from CC-2 or CC-3, CS-G, a
bridging μ-aqua or μ-hydroxo ligand is resolved between the two cadmium ions. Crystal
structures CS-F and CS-H, which both have Cd(II) and heme B, look very similar to the CS-G
structure, which has only Cd(II). In all three structures containing CdCl2, the Cd(II) ions are 3.6 Å
apart. In the Mn(II) structure CS-E, the distance between the ions is 5.5 Å. This change is likely
due to the lengthening of the ligands between the Mn(II) ions and the amino acid ligands
compared to Cd(II). Figure 3.17 shows an election density map of the metal site in CS-G and the
overall structure.
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Figure 3.17: Cd(II)
bound to MZH3
Crystal structure CS-G
shows high-affinity
metal binding. Left:
(Fobs, φcalc) map
contoured at 1.0 σ
with part of helix 3 cut
away. Cd(II) ions are
shown as grey
spheres. Right:
overall fold of MZH3
in CS-G.
Images rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.

The metal binding site of MZH3 in crystals from crystallization conditions CC-2 and CC-3
are very similar to the metal site of bacterioferritin. As an example, structure CS-G is shown in a
side-by-side comparison with bacterioferritin in Figure 3.18.

Figure 3.18: Comparison of MZH3 to bacterioferritin
Metal binding site of crystal structure CS-G with Cd(II) (left) closely matches the structure of
the natural diiron protein bacterioferritin with Mn(II) (right). Side chain rotamers of first shell
histidines and glutamates and second-shell asparates and tyrosine are nearly identical in the
two structures. Bacterioferritin structure comes from PDB ID: 1BFR (17). Images rendered
using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.
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3.5.2 Di-metal site structure with metal in unintended position
In contrast to structures
from crystallization conditions CC-2
and CC-3, all structures from
condition CC-1, including CS-A, CSB, CS-C, and CS-D, had a misplaced
metal ion on the outside of the
metal binding site and
corresponding lowered or absent
occupancy of a metal in the
intended site on the interior of the
protein (Figure 3.19). The
unexpected external metal ion was
coordinated in a tetrahedral

Figure 3.19: Unintended metal binding site
Crystal structure CS-D exemplifies the external metal
binding site from crystallization condition CC-1
structures. While the Zn(II) ion nearest the porphyrinbinding section of the protein is ligated correctly, the
far site is empty and an external Zn(II) coordinates the
active site His138 and second shell residues D63 and
D134. Image rendered using The PyMOL Molecular
Graphics System, Version 1.7 Schrödinger, LLC.

geometry by active site residue H138, a water molecule, and the two aspartates, D63 and D134,
which were intended to be second shell contacts to the histidines. H138 is designed to ligate a
metal ion in the interior of the protein using the Nδ atom, and in structures from condition CC-1,
H138 retains the conformation it was intended to have, but ligates the external metal ion using
its Nε atom. The (Fobs, φcalc) electron density maps from condition CC-1 structures show that the
external metal has very strong scattering intensity that is higher than that of the internal metal
at the site nearest the porphyrin binding section of MZH3.
Structures CS-A and CS-D contained Zn(II), a metal that commonly adopts a tetrahedral
geometry, but Mn(II) is rarely stable in this geometry (29). Crystals of MZH3 with Mn(II), heme
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B, and ZnPCP were

Figure 3.20: Metal binding
with extra Mn(II) and ZnPCP

grown in condition CC-1

Crystal structure of CS-B
with three Mn(II) ions.
His138 is shown ligating
internal Mn(II) with Nδ and
external Mn(II) with Nε.
Tyr168 adopts two
rotamers, presumably
because of partial
occupancy of ZnPCP at
metal binding cavity.
Tyr168 in core would clash
with ZnPCP, so it moves to
the interfacial rotamer
when ZnPCP is present.
Image rendered using The
PyMOL Molecular Graphics
System, Version 1.7
Schrödinger, LLC.

with the expectation that
Mn(II) would not be able
to bind to the external
site because it would
have to be tetrahedral.
Instead, structures CS-B
and CS-C showed that
Mn(II) did, in fact, bind
with a tetrahedral
geometry to the unusual

external metal site (Figure 3.20). In structure CS-C, which had 2 mM MnCl2 in the protein stock
solution (about 3 equivalents of MnCl2 per protein), only two metal ions were observed with
one in the internal site close to the porphyrin section of the protein and one in the external site,
similar to the Zn(II) structures CS-A and CS-D. In crystal structure CS-B, however, ~35 mM MnCl2
was added in an attempt to fill the intended metal binding site. The result was electron density
consistent with a Mn(II) ion on both sides of His138, suggesting that either His 138 was ligating
two Mn(II) ions at once or that there was a mixture of states of Mn(II) binding. The (Fobs, φcalc)
map showed the internal and external Mn(II) ions ligated by His138 had peaks of 3.7 σ and 4.8 σ,
respectively.
The metal binding site of structures from condition CC-1 may not be an accurate
representation of the metal binding site of MZH3 in solution. The CC-1 metal site structure is
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not consistent with structures from the other two crystallization conditions, which suggests that
the external metal ion may be an artifact of crystal packing. This external metal ion is not
observed in any structure reported for Due Ferro proteins, and UV/vis titration of Co(NO3)2 into
an MZH3 solution produced a spectrum and extinction coefficients for MZH3-Co(II) that are
consistent with pentacoordinate ligation and not tetrahedral ligation, similar to Due Ferro
proteins (Figure 2.18) (28, 30, 31). As a result, structures from crystallization conditions CC-2
and CC-3 are presumed to be more reliable representations of the mode of metal binding by
MZH3 in solution at neutral pH.

3.6 Leu71His mutation and His-Tyr hydrogen bond
The redox active tyrosine Z of Photosystem II has a hydrogen bonding interaction with a
histidine side chain (32). The histidine is necessary for rapid proton transfer to and from
tyrosine Z to enable efficient oxidation and reduction of the tyrosine side chain. In order to
reproduce this effect in MZH3, Leu71 was mutated to histidine to make MZH3-L71H. The MZH3L71H mutant was crystallized in the cadmium-containing condition CC-2 with heme B in the
electron acceptor site. Figure 3.21 (bottom) shows that a hydrogen bond forms in MZH3-L71H
with a length of 2.6 Å between the His71 Nε atom and the Tyr168 oxygen. This relatively short
distance is consistent with a stable hydrogen bond. The L71H mutation does not seem to affect
binding of the Cd(II) ions.
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Figure 3.21: Histidine-tyrosine
hydrogen bond in MZH3-L71H
mutant
Electron density (Fobs, φcalc) maps
of crystal structures CS-D (top) and
CS-H (bottom) contoured at
1.0 σ. Blue dotted line in L71H
mutant, structure CS-H, shows that
a hydrogen bond forms between
H71 and Y168, as designed. Image
rendered using The PyMOL
Molecular Graphics System,
Version 1.7 Schrödinger, LLC.

The length of the hydrogen bond in MZH3-L71H shown in Figure 3.21 appears to be
typical of a strong hydrogen bond, but not unusually strong. In contrast, the hydrogen bond in
photosystem II between tyrosine Z and a histidine has special characteristics. It has a 2.5 Å
donor-acceptor distance, and analysis of the 1.9 Å crystal structure suggests that the proton is
shared equally between the tyrosine and the histidine, facilitating rapid proton coupled electron
transfer reactions of the tyrosine (32, 33). The MZH3-L71H hydrogen bond, with a length of 2.6
Å, probably does not have these special features, but can still act as a probe to explore the role
of hydrogen bonding in tyrosine electron transfer kinetics.
As noted above in Figure 3.8, the heme B of L71H is rotated by 90° relative to the wild
type MZH3 structures so that the propionate groups project out of the core in a different
direction. It is not obvious why L71H would cause such a conformational change on the other
end of the protein. The change could be due to differences in crystal contacts; one of the heme
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propionate groups in the L71H structure appears to be involved in a 3.3 Å inter-protein
hydrogen bond with Gln7 from a neighboring protein. However, all six heme-containing wild
type MZH3 structures from all three crystallization conditions in different states of cofactor
assembly have the same heme conformation. In addition, dogged attempts to crystallize MZH3L71H in crystallization condition CC-1 produced only long needle-like crystals that were not
useful for diffraction. Wild type MZH3 crystal structures from CC-1 have a heme propionate
inter-protein hydrogen bond with Lys32 with a length of 2.8 Å (as measured in CS-D), and
crystals did not grow in CC-1 without heme B. While wild type MZH3 crystallized readily in CC-1,
the needle-like crystals of L71H were difficult to grow. It is likely, therefore, that a subtle shift in
core packing created by the L71H mutation is translated up the helices to the electron acceptor
site, causing a different heme B conformation. The fact that such a subtle shift could tip the
balance to favor a different heme conformation is not surprising given the symmetry of the
heme binding site and the fact that no design element was consciously included to favor one
orientation over the other. What is surprising is that all of the wild type structures have a
consistent heme orientation with the propionate groups in the same position.

3.7 Summary
X-ray crystal structures of MZH3 from 1.45 to 2.10 Å resolution show that the overall
structure of MZH3 closely matches the design; the maquette folds as a left-turning antiparallel
four-helix coiled coil, with heptad a- and d-positions forming layers in the hydrophobic core.
The protein retains its fold in the absence of a pigment or electron acceptor, despite the
penetration of solvent into the hydrophobic core. The apo-state stability may be the result of
stabilizing interactions between interfacial g-position leucines. Stable inter-helical salt bridging
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interactions were not observed in these crystal structures, but charge pairing interactions might
still play an important role in determining helix topology.
Heme B and metal ions bind to the correct sites with structures very similar to natural
proteins cytochrome b and bacterioferritin, respectively, despite the absence of sequence
identity between these proteins. Heme and metal ions are coordinated exactly as intended by
design, complete with second-shell hydrogen bonding interactions. In crystallization condition
CC-1, ZnPCP is shown to bind to the pigment site, and is ligated by the intended histidine 124.
The rotameric state of His124 when it ligates ZnPCP is not resolved conclusively, but it appears
to make the intended second-shell hydrogen bond to Thr77. Unexpected details emerged from
crystals grown in CC-1, including the improper binding of a tetrahedral metal ion to the exterior
of MZH3 and the unintended binding of ZnPCP to the opening of the metal binding cavity. The
exterior metal was not present in other crystallization conditions, and only a single ZnPCP is
observed to bind to MZH3 by UV/vis spectroscopy. These results suggest that crystal packing
may have distorted the metal site of MZH3 in condition CC-1 and given rise to these unexpected
results.
There is room for improvement of the sequence of MZH3. Some glutamine residues in
the vicinity of tetrapyrrole binding sites appear to be pushed into strained rotameric states by
the binding of the cofactor. In addition, two tryptophan residues are buried in the apo-state
and must be solvated to allow heme binding. Mutation of some of these amino acids to smaller
residues may increase the binding affinity of the tetrapyrroles. It may also be wise to change
the metal binding site so that metals and ZnPCP cannot bind to unintended sites in the manner
of crystals grown in condition CC-1, even though these anomalies appear to be artifacts of
crystal packing. Redesign should be approached with caution, however, as increasing the
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stability of the holo-state might also increase the stability of the apo-state, which could have the
effect of slowing the binding rate or weakening cofactor affinity. Even without enhancements,
however, these crystal structures show that MZH3 has an architecture consistent with the
design, with cofactors positioned appropriately for long-lived light-activated charge separation.
The next chapter will use transient absorption spectroscopy to investigate whether MZH3 can in
fact function as a reaction center maquette.
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Chapter 4: Light-driven electron transfer in a reaction center
maquette
The long-term goal of this project is to convert solar energy to fuel, and this means the
energy of a light-activated charge separated state must be converted into chemical energy by
oxidizing one substrate (such as water to make oxygen) and reducing another (such as protons
to make hydrogen fuel). Such chemical reactions are usually much slower than the charge
separating electron transfer reactions, because they need time for the comparatively slow
making and breaking of chemical bonds. Previous work has demonstrated the use of de novodesigned protein maquettes to create light-activatable electron transfer dyads, in which a
pigment molecule photo-reduces an electron acceptor (1-3). Dyads can be useful in
investigating the parameters that affect electron transfer, but they are not equipped to trap a
long-lived charge separated state, because the electron on the reduced electron acceptor
quickly recombines with the hole on the oxidized pigment. In order to stabilize the charge
separated state, a third cofactor, an electron donor, must be introduced to increase the distance
between the electron and the hole in order to allow a charge separated state to persist for long
enough for chemical reactions to make fuel. The electron donor should be placed close to the
pigment so that oxidation of the donor can outcompete the electron-hole recombination that
would quench the electrical potential energy of the charge separated state. In photosystem II, a
long string of electron donors and acceptors gives the reaction center a quantum yield for
producing product O2 and reduced plastoquinone of up to 95% in favorable light conditions (4,
5). Here, MZH3 makes use of a redox-active triad to trap a long-lived charge separated state.
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4.1 Electron transfer background
4.1.1 A kinetic model of electron transfer in MZH3
MZH3 was designed for tetrad activity involving an iron or cobalt porphyrin, a zinc
tetrapyrrole, a tyrosine side chain, and two metal ions. Here, the discussion will focus on
development of a triad, and a charge separating tetrad will be a future aim. A comparison of the
electron transfer pathways of a light-activatable dyad and triad in MZH3 is shown in Figure 4.1.
A dyad can be prepared by making an MZH3 mutant that lacks a tyrosine or by inhibiting
tyrosine oxidation in the wild type MZH3. A model such as this can be used to predict how a
system will progress after the pigment absorbs light to enter the excited state.

Figure 4.1: Model of electron transfer pathway in dyad and triad versions of MZH3
Cofactor A is the electron acceptor, P is the pigment, and D is an electron donor, such as a
tyrosine side chain. CS is a charge separation, and CR is a charge recombination.

Figure 4.1 makes use of a few assumptions. For example, the singlet excited state of the
zinc porphyrin is not relevant, because it goes through intersystem crossing to the triplet state
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before electron transfer. In addition, the triplet excited state does not relax to the ground state,
the A-P+ state does not return to the excited triplet state of the zinc porphyrin, and the A-D+
state in the triad case does not return directly to the ground state. These assumptions are valid
because competing reactions are significantly faster than these reactions, so they do not play a
significant role in the electron transfer pathway of the system.
Using Figure 4.1, a set of equations can be written to describe how the concentration of
each state of the system changes with time after light absorption. For example, in the triad
case, the rate of change of the concentration of the excited state, d[E]/dt, depends only on the
concentration of the excited state, [E], and the rate constant for its conversion to the A-P+ state,
kCS1, as shown below:
𝑑[𝐸]
𝑑𝑡

= −𝑘CS1 [𝐸]

Table 4.1 gives the rate of change of each state of the triad system. From this
information, a system of equations can be compiled to describe how the triad system evolves
after absorption of a photon.

𝑑[𝐸]
𝑑𝑡
𝑑[A−P+ ]
𝑑𝑡
𝑑[A−D+ ]
𝑑𝑡
𝑑[𝐺]
𝑑𝑡

[E]
−𝑘CS1

[A-P+]
0

[A-D+]
0

[G]
0

+𝑘CS1

−𝑘CR1 − 𝑘CS2

+𝑘CS2

0

0

+𝑘CS2

−𝑘CR2

0

0

+𝑘CR1

0

0

Table 4.1: Rates of change of each state of the MZH3 triad system
The rate of change of the concentration of each state given on the left of each row is equal to
each rate constant in that row times its corresponding concentration at the top of the
column. The names of each state and rate constant are taken from Figure 4.1. E is the
excited state and G is the ground state. CS is charge separation and CR is charge
recombination. The rate constants kCS1, kCS2, kCR1 and kCR2 represent the transitions labeled 1st
CS, 2nd CS, 1st CR, and 2nd CR, respectively, in Figure 4.1.
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When the triad system is photo-activated at time t = 0, the entire system is in the
excited state, E, so the occupancy of [E] is 1.0. With this starting condition and the equations
from Table 4.1, the relative occupancies of each state can be determined at any time t after light
absorption in terms of the electron transfer rate constants given in Table 4.1. If we can make
accurate estimates of these rate constants, then we can accurately predict how the system will
change with time after light absorption.

4.1.2 Parameters that govern electron transfer rates
MZH3 was designed to arrange its cofactors in a way that could manipulate lightactivated electron transfer rates to maximize the yield and lifetime of charge separation.
Prediction of electron transfer rates was guided by an empirical approximation of Marcus theory
sometimes referred to as the Moser-Dutton ruler, shown below in Equation 4.1 (6-8). In this
equation, kET is the rate constant for electron transfer from one redox center to another in s-1, R
is the distance between them measured in Å, ΔG is the driving force of the reaction in eV, and λ
is the reorganization energy in eV.
log(𝑘𝐸𝑇 ) = 15 − 0.6𝑅 − 3.1 ∙

(∆𝐺 + 𝜆)2
𝜆

Equation 4.1

The most important variable that influences electron transfer rates is the distance
between the redox centers, R; for every 1.6 Å change in distance, the rate of electron transfer
changes by an order of magnitude. Crystal structures of MZH3 with heme B, ZnPCP, and Mn(II)
give the distances between cofactors. The R values relevant to electron transfer rates in
Equation 4.1 are measured by the distance of closest approach between the two redox centers
(6, 7). The edge-to-edge distance between the porphyrin rings of pigment ZnPCP and acceptor
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heme B, RPA, is 13.0 to 13.1 Å in the crystal structures that contained both cofactors. Vinyl and
methyl groups of the heme B cofactors are assumed not to be part of the redox-active center
and are therefore ignored in this distance measurement. The edge-to-edge distance between
tyrosine 168 and the pigment ZnPCP, RYP, is 5.0 to 5.1 Å in crystal structures CS-A and CS-B when
tyrosine is in the intended conformation. The RYP distance is reduced to 3.4 to 3.5 Å in crystal
structures CS-B and CS-C when the tyrosine has moved to an interfacial conformation to
accommodate the binding of ZnPCP to the metal binding cavity, but this conformation may not
be relevant to these electron transfer studies. The distance between tyrosine 168 and the
nearest metal, RMY, appears to vary by metal ion. Structures containing Cd(II) have a 4.7 Å RCdY
distance, Zn(II) structures have a 3.7 to 4.0 Å RZnY distance, and Mn(II) structures have a 3.2 to
3.5 Å RMnY distance. If the tyrosine is not an active participant in photo-oxidation of bound metal
ions, then the distance between the metal and the pigment, RMP, becomes important. This
distance ranges from 9.6 to 10.1 Å in crystal structures that contain ZnPCP and Mn(II) or Zn(II).
The second most important variable in calculating electron transfer rates is the driving
force for electron transfer, ΔG, which is calculated from the difference in midpoint potentials of
the redox centers involved in electron transfer. Redox titration provided a midpoint potential
for heme B in MZH3 in the absence of ZnPCP of -180 mV vs. SHE (Figure 2.22). Zinc porphyrins
in the excited state tend to be powerful reducing agents. The excited singlet state of the ZnPCP
used for these experiments has a lifetime on the order of nanoseconds, which is too short for
electron transfer to heme in MZH3. However, ZnPCP bound to MZH3 undergoes relatively
efficient intersystem crossing to a triplet excited state that persists for milliseconds before
phosphorescing (9). For this reason, it is assumed that the heme B in MZH3 transient absorption
experiments is reduced only by the triplet excited state of the zinc porphyrin, and the singlet
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state is not relevant to these electron transfer studies. Spectroelectrochemical titration and
phosphorescence measurements of ZnPCP in MZH3 by Zhenyu Zhao gave potentials of 0.91 V
for the [ZnPCP•+/ZnPCP0] redox couple and −0.69 V for [ZnPCP•+/3ZnPCP*] (9).
The midpoint potential of tyrosine in MZH3 has not been measured. Tyrosine
potentials depend upon the protonation states and the mechanism of the electron transfer or
proton-coupled electron transfer (PCET) of the redox reaction. Tyrosine has a pKa of about 10.2
in solution, and at high pH, it can exist partly in the neutral protonated form and partly as the
deprotonated tyrosinate species (10). Oxidation of tyrosine in MZH3 should be treated as the
oxidation of a mixture of these two components, as opposed to the oxidation of a single
tyrosine species with a pH-dependent driving force for electron transfer (11). Oxidation of
protonated tyrosine leads to an unstable radical cation that has a pKa of −2 (12). If tyrosine
oxidation proceeds by electron transfer followed by proton transfer (an ET-PT mechanism), then
protonated tyrosine will have a high midpoint potential of ~1.34 V, because the radical cation
product of the reaction is so unstable (13). In contrast, oxidation of the negatively charged
tyrosinate anion forms the neutral tyrosyl radical that is much more stable than the radical
cation, giving the Tyr-O−/Tyr-O• redox couple a lower midpoint potential of about 0.72 V, based
on work by the laboratory of Cecilia Tommos (14). However, other mechanisms such as
concerted proton-electron transfer (CPET) are observed in photosystem II redox active tyrosines
and various phenols from model systems (15-19). The potentials of these CPET reactions
depend on the nature of the proton acceptor, among other environmental details.
Unfortunately, reorganization energy, λ, is very difficult to measure. The reorganization
energy for electron tunneling within the hydrophobic core of proteins is typically around 0.7 eV,
but inter-protein electron transfer, which usually involves tunneling through solvent, has a
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reorganization energy closer to about 1.3
eV (6). An intermediate reorganization
energy of 1.2 eV may be most appropriate
for electron transfer rate calculations in
MZH3, because some cofactors are
solvent-exposed while others are buried.
A summary of the measured and predicted
electron transfer parameters is given in

RPA
13.1 Å
RYP
5.0 Å
RMY
3.7 Å
RMP
9.6 Å
Em, [Fe(II)-Heme B/Fe(III)-Heme B] -0.18 V
Em, [3ZnPCP*/ZnPCP•+]
−0.69 V
0
•+
Em, [ZnPCP /ZnPCP ]
0.91 V
Em, [Tyr-OH/Tyr-OH•+]
~1.34 V
−
•
Em, [Tyr-O /Tyr-O ]
~0.72 V
λ
~1.2 eV
Table 4.2: Summary of parameters that
determine electron transfer rates in MZH3
Parameters listed with a tilde (~) are estimates,
and the other values have been measured
experimentally. Midpoint potentials are vs. SHE.

Table 4.2. Figure 4.2 illustrates these
parameters and applies them to the kinetic model described in section 4.1.1.

Figure 4.2: Electron transfer predictions in MZH3
Left: MZH3 crystal structure CS-B shows inter-cofactor distances, and energy diagrams show
midpoint potentials and corresponding driving forces for electron transfer. Right: Once a
photon is absorbed, the progression of the dyad and triad systems can be predicted using the
Moser-Dutton ruler (Equation 4.1) and the parameters listed on the left and in Table 4.2. Red
traces: Occupancy of the excited state. Orange trace: Occupancy of A-P+. Green trace:
Occupancy of A-D+. Blue traces: Occupancy of the ground state. The triad case assumes a
deprotonated tyrosinate in the starting condition.
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4.2 Transient absorption
Tetrapyrroles like heme B and ZnPCP are strong absorbers of visible light, and their
UV/vis absorbance spectra are highly sensitive to changes in their electronic state. This makes
them amenable to characterization by transient absorption spectroscopy, in which a sample is
photo-excited by a short pulse of bright light, and a measurement of the absorbance is made
after a series of set time delays to track changes in electronic states. Here, transient absorption
is used to examine light-driven electron transfer rates and yields of charge separated states in
MZH3.

4.2.1 Transient absorption experimental approach
Here, a transient absorption setup was used that included a 2 ns excitation pulse of 532
nm light from an Nd:YAG laser directed toward one end of a 1 mL, 1 cm path length quartz
cuvette containing a sample of interest; the other end of the sample was not exposed to the
laser light. After a time delay, the excitation pulse was followed by emission of white light from
a Xe flash lamp as a probe beam to determine absorbance spectra of the sample that was kept
in the dark and the sample that was exposed to the excitation pulse. A monochromator
separated the light by wavelength, and a PiMax CCD detector recorded the spectra. The dark
reference spectrum was subtracted from the photoexcited sample spectrum for data analysis.
After each measurement, a magnetic stir bar stirred the sample. Sets of 50 spectra per time
point were recorded from about 350 nm to 650 nm at time points from 1 μs to up to 10 s after
the laser pulse. The gate width of the Xe flash lamp for the experiments described here ranged
from 600 ns to 1 μs to maximize the signal-to-noise ratio, but the limit of the time resolution for
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this setup is about 30 ns. Transient absorption samples were held at 20°C using a Peltier
temperature controller. Figure 4.3 illustrates the transient absorption setup.

Figure 4.3: Schematic of setup for transient absorption experiments
An excitation flash of 532 nm laser light is absorbed by pigment cofactor in one part of the
cuvette, while the other part remains dark. After a variable time delay t, the Xe flash lamp
emits a probe beam to measure the absorbance spectra of the photo-excited sample and dark
sample at time t. A monochromator separates light by wavelength and a PiMax CCD detector
collects the absorbance spectra. The light minus dark difference spectrum shows the redox
states of light-absorbing cofactors.

To avoid redox reactions with oxygen, all transient absorption experiments reported
here were done with samples that were sealed in a quartz cuvette and thoroughly purged with
argon purified through an oxygen-scrubbing gas train as described previously (20). Argon
purging was continued during the experiment. Exposure to ambient oxygen resulted in gradual
attenuation of transient absorption signals and an increased rate of photo-degradation of the
sample, consistent with production of reactive oxygen species from the zinc porphyrin excited
triplet state. Under anaerobic conditions, absorbance spectra at time t = 1 μs after the laser
flash were measured at the beginning and end of each experiment, and the magnitude of the
ZnPCP Soret bleach in the final measurement at 1 μs was usually within 5-10% of the first.

161

Transient absorption experiments with MZH3 sought to track two signals with time: one
from the conversion of the ground state of ZnPCP to the excited triplet state 3ZnPCP* and one
from ferric Fe(III)-heme B reduction to ferrous Fe(II)-heme. The difference absorption spectra
corresponding to these transitions are shown in Figure 4.4. The ZnPCP•+ radical cation species
was not observed, presumably because it had a short lifetime and its spectrum is similar to
3

ZnPCP* in the measured wavelength range. Oxidized tyrosyl radicals have a weak absorbance,

measured at 2,750 M−1cm−1 at 408 nm in a three-helix bundle maquette (14), but this signal was
not resolved in experiments described here, probably because the tyrosyl radical absorbance is
too low and it overlaps with larger absorbance signals from the other cofactors.

Figure 4.4: Redox difference spectra relevant to transient absorption experiments
Green: 3ZnPCP* minus ground state of ZnPCP in MZH3-Y168L mutant at pH 7.5, 1 μs after
flashing with 532 nm light. Extinction coefficients are rough estimates based on the ground
state spectrum. Black: Fe(II)-heme minus Fe(III)-heme difference spectrum in MZH3 wild
type at pH 7. Fe(II)-heme spectrum was prepared by reducing the Fe(III)-heme sample with
excess dithionite, which may cause slight overestimate of Fe(II)-heme extinction coefficients.
Inset: Spectra of ZnPCP ground state (green), Fe(III)-heme (red), and Fe(II)-heme (blue) bound
to MZH3. The ZnPCP spectrum was measured in MZH3 that also contained heme; the heme
spectrum was subtracted out.
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4.2.2 Monad and Dyad in MZH3
The first step was to reproduce light-activated electron transfer dyad results involving
zinc tetrapyrroles and heme B that were demonstrated previously in de novo four-helix bundle
maquettes (1). To confirm electron transfer between the two cofactors of a dyad, the behavior
of the dyad must be compared to a monad (a pigment by itself), in order to determine the effect
of the electron acceptor. This is because the P+A− state (Figure 4.1) is transient in the dyad and
is difficult to observe directly.
A monad maquette was prepared by adding zinc Newkome porphyrin (ZnNP) to MZH3
at pH 7.3 in the absence of any other cofactor, and the lifetime of the triplet excited state was
measured by transient absorption. The lifetime of 3ZnNP* is similar to 3ZnPCP*. All other
transient absorption experiments presented in this chapter use ZnPCP as the pigment. The
addition of ZnNP to an MZH3 protein that lacks an electron acceptor might allow the ZnNP to
bind preferentially to the acceptor site or to a mixture of both the pigment and acceptor sites.
This is not a concern, because the decay rate of the triplet excited state is not expected to be
sensitive to the relatively modest differences between the environments of the pigment and
acceptor sites. The recovery of the ground state spectrum was estimated by the absorbance of
the Soret band at 423 nm. Fitting to a single exponential fit gave an estimated lifetime of 3.3 ms
(Figure 4.5, upper left, black curve).
A dyad maquette was prepared using an MZH3 mutant in which the tyrosine was
removed and replaced with leucine. Leucine was chosen over phenylalanine to avoid a
structural disruption of the Due Ferro section of the protein, as was observed in a previous Due
Ferro mutant (21). As a result MZH3-Y168L/Heme B/ZnPCP has only two redox centers available
to participate in electron transfer. Transient absorption measurements were performed at pH
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7.5, and fitting the Soret absorbance to a single exponential curve showed that the ground state
recovery was 70 μs, 50 fold faster than in the monad (Figure 4.5). The Y168L mutant behaved
similarly at pH 9.5. This demonstrates that heme B quenched the energy of the excited triplet
state and is consistent with quenching by an electron transfer mechanism. However, no Fe(II)heme Soret band at 432 nm is evident, even in a close-up view of the heme Soret region (Figure
4.5, bottom).

3

Fraction of initial ZnP* remaining

Figure 4.5: Monad and dyad transient
absorption experiments
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The lifetime of the zinc porphyrin P* state
in MZH3 is greatly reduced when heme B is
also bound to MZH3. Upper left: Scaled
absorbance at 423 nm of the ZnNP monad
(black square points) and the ZnPCP-Heme
B dyad in MZH3-Y168L (red circular points)
are fitted to single exponential curves
(lines). The P* lifetimes of the monad and
dyad are 3.3 ms and 70 μs, respectively.
Bottom: Dyad spectra show progression of
the recovery of the ground state spectrum
0.1 from 1 μs to 10 ms. Inset: Close-up view of
the area in the dotted box, where no
reduced heme Soret is observed.
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As expected, MZH3-Y168L containing heme B in the acceptor site and ZnPCP in the
pigment site does not stabilize a long-lived charge-separated state; no peaks suggesting heme
reduction were observed. The results are consistent with the behavior of a redox active dyad;
electrons are transferred from one cofactor to the other, but cannot trap the charge separated
state for long enough for chemical reactions to occur.

4.2.3 Triad with tyrosine in MZH3
Some precautions were necessary to ensure that MZH3 triad transient absorption
results were reproducible and did not contain artifacts from improper cofactor incorporation.
First, given the impact of the second ZnPCP on the conformation of the tyrosine residue as was
shown in Figure 3.16, only ~0.8 equivalents of ZnPCP per protein were added to ~3.5 μM MZH3
samples for triad experiments. This is to avoid the possibility of an extra ZnPCP binding to the
metal cavity and interfering with electron transfer. Second, MZH3 chelates metals, and after
purification, MZH3 often contains bound metal ions, presumably Ni(II) from a Ni-NTA column.
For this reason, it was necessary to treat MZH3 samples with a metal chelating agent such as
100-500 μM ethylenediaminetetraacetic acid (EDTA), and then remove the chelator by desalting
column or dialysis.
In transient absorption experiments where the signal-to-noise ratio is large and signals
from different species do not overlap, the change in concentration of a species with time can be
approximated by its absorbance at a single wavelength. In MZH3 triad experiments, however,
absorbance features from different species overlap extensively, as shown in Figure 4.4, and if
the yield is low, the heme redox spectrum may be noisy. For this reason, it was necessary to use
singular value decomposition (SVD) to separate spectral components and determine the rates of
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electron transfer reactions (22), following methods described in the appendix. Quantum yields
were calculated using an approximate ratio of −2.8 between the extinction coefficient at 423 nm
at 1 μs (due to the ZnPCP excited triplet minus ground state) and the extinction coefficient at
431 nm of the peak of the heme redox spectrum from SVD analysis. In this way, rough
estimates of the yields of the charge separated state for different triad experiments were
calculated in a self-consistent manner in order to make comparisons between experiments with
different MZH3 mutants and at varying pH. For consistency, all of the following triad
experiments used the following conditions: ~3.5 μM MZH3, 1.0 equivalent of heme B per
protein, ≤ 0.8 equivalents of ZnPCP per protein, and 50 mM NaCl. Experiments at pH 7.5 used
10 mM 3-(N-morpholino)propanesulfonic acid (MOPS) as a buffer, and at pH 9.5, 10 mM Ncyclohexyl-2-aminoethanesulfonic acid (CHES) buffer was used.
Transient absorption with wild type MZH3 at pH 7.5 produced results that had
similarities to the MZH3-Y168L dyad, but a distinct peak at 432 nm was observed, consistent
with the reduced heme difference spectrum in Figure 4.4. SVD analysis showed that the
recovery of the ground state of ZnPCP had a lifetime of 40 μs, similar to the 70 μs lifetime in
Y168L, but the absorbance peak at 432 nm persisted for 4 ms. The Q-band absorbance at 560
nm could not be resolved. The relatively weak putative heme Soret band at 432 nm
corresponds to a quantum yield of the charge separated state of 2%. The wild type MZH3
transient absorption spectra are shown in Figure 4.6.
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Figure 4.6: Transient absorption spectra of wild type MZH3 with heme B and ZnPCP at pH 7.5
Inset: Close-up view of the region in the dotted box shows an absorbance feature at 432 nm,
where the ferrous heme Soret band absorbs.

Given that tyrosine oxidation depends on protonation state, pH was expected to have a
pronounced effect on electron transfer kinetics. For this reason, the wild type MZH3 transient
absorption experiment was repeated at pH 9.5. The results were similar to the wild type results
at pH 7.5 in some regards, with a weak feature at 432 nm corresponding to a quantum yield of
2.5% and a triplet excited state lifetime of 50 μs. However, the lifetime of the putative charge
separated state increased to 150 ms at pH 9.5. This is 38-fold longer than the 4 ms lifetime of
the charge separated state at pH 7.5. In addition, SVD analysis found that weaker absorbance
features at 560 nm and ~533 nm were correlated with a stronger absorbance feature at 532 nm;
this SVD component strongly resembled the heme redox spectrum from Figure 4.4. The
transient absorption spectra and SVD analysis are shown in Figure 4.7.
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Figure 4.7: Transient absorption
and SVD of wild type MZH3 with
heme and ZnPCP at pH 9.5
A: Transient absorption spectra.
Inset: close-up of dotted box. B:
Time evolution of SVD component
1 corresponding to ZnPCP ground
state recovery (red points), and
model fitting (large orange
points). C: Time evolution of SVD
component 2 corresponding to
the heme redox signal (green
points), and model fitting (large
blue points). D: Spectrum of SVD
component 2 (cyan points) and
overlay of heme redox spectrum
(black line).

The MZH3-L71H mutant was made to facilitate proton-coupled electron transfer
reactions involving the tyrosine, similar to the interaction between tyrosine Z and a histidine
side chain in photosystem II. The crystal structure of MZH3-L71H was solved with heme B and
Cd(II) bound, and the mutant succeeded in forming the intended histidine-tyrosine hydrogen
bond, as was shown in Figure 3.21. Transient absorption results show that the MZH3-L71H
mutant also succeeded in increasing the yield of the charge separated state compared to the
168

wild type. At pH 7.5, the calculated yield was 6%, and at pH 9.5 the yield was 4%. The increased
yield was accompanied by a decreased lifetime of the charge separated state. The lifetimes of
the MZH3-L71H charge separated state at pH 7.5 and 9.5 were 1.2 ms and 32 ms, respectively.
Once again, the lifetime was shorter at pH 7.5 than at 9.5. (Transient absorption results with
tyrosine are summarized in Table 4.3).
Other MZH3 mutants were made to further examine the dependence of tyrosine
oxidation kinetics on the presence of protonatable groups. In photosystem II, the histidine that
hydrogen bonds the redox active tyrosine Z shares a second hydrogen bond with the side chain
of asparagine 298 on the D1 protein (23). An exhaustive mutagenesis study of the 19 possible
mutants at position 298 found that 12 mutants were incapable of oxygen evolving activity and
the other 7 had significantly decreased activity and increased photosensitivity (24). Evidently,
this distal hydrogen bond plays a significant role in tyrosine oxidation kinetics. To try to
reproduce this effect, an aspartate residue was placed at position 31 in the mutant MZH3-L71HL31D. Asp31 was meant to make a hydrogen bond to His71 to keep the His71 Nδ atom
protonated so that the His71 Nε atom would accept a hydrogen bond from tyrosine. In addition,
the aspartate was intended to stabilize the protonated histidine imidazolium cation and increase
the yield of the charge separated state in MZH3. The intended structure is shown in Figure 4.8.
Figure 4.8: Predicted structure of MZH3-L71HL31D double mutant
The crystal structure of MZH3-L71H with
Cd(II) and heme B is shown with carbon atoms
in green. The predicted preferred rotamer of
D31 is overlaid onto the position of L31 in the
crystal structure and colored with white
carbon atoms. The histidine and aspartate
are within hydrogen bonding distance.
Image rendered using The PyMOL Molecular Graphics System, Version 1.7 Schrödinger, LLC.
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Transient absorption experiments showed that the MZH3-L71H-L31D mutant succeeded
in increasing the yield of the charge separated state over the yield of the MZH3-L71H mutant
and the wild type protein. The addition of Asp31 increased the yield to 8% at pH 7.5 and 12% at
pH 9.5. In addition, the lifetimes of the charge separated state decreased to 140 μs and 2.5 ms
at pH 7.5 and 9.5, respectively; as with other MZH3 variants, the charge separated state lasted
longer at higher pH. The lifetime of the ground state recovery of ZnPCP was similar to other
variants, about 30 μs at pH 7.5 and 50 μs at pH 9.5. The MZH3-L71H-L31D transient absorption
results at pH 9.5 are presented in Figure 4.9.

Figure 4.9: Transient absorption and
SVD analysis of MZH3-L71H-L31D with
heme and ZnPCP at pH 9.5
A: Transient absorption spectra. Inset:
close-up of dotted box. B: Time
evolution of SVD component 1
corresponding to ZnPCP ground state
recovery (red points), and model fitting
(large orange points). C: Time
evolution of SVD component 2
corresponding to the heme redox
signal (green points), and model fitting
(large blue points). D: Spectrum of SVD
component 2 (cyan points) and overlay
of heme redox spectrum (black line).
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The tyrosine 168 side chain of MZH3 and MZH3-L71H makes a hydrogen bond to the
metal-ligating residue glutamate 34 (see Figure 3.21). This reproduces an interaction that is
observed in Due Ferro proteins and natural diiron proteins such as bacterioferritin (25, 26). In
order to probe the involvement of Glu34 in tyrosine redox activity, the MZH3-L71H-E34A mutant
was prepared. Transient absorption results showed a significant drop in the yield of the charge
separated state and a modest increase in lifetime. At pH 7.5, MZH3-L71H-E34A had a yield of
only 1% and a lifetime of roughly 3 ms. At pH 9.5, the yield was about 3%, and the lifetime was
about 40 ms. The significant drop in yield upon removal of Glu34 suggests that Glu34 is involved
in modulating the midpoint potential of the tyrosine, its pKa, or the efficiency of the proton
transfer step in tyrosine oxidation.
Bacterioferritin binds heme B by bis-methionine ligation, and the Wydrzynski group has
shown that a modified bacterioferritin can bind zinc chlorin e6 (ZnCe6) in place of heme B, and
this pigment is able to photo-oxidize tyrosine amino acids in bacterioferritin (27, 28). To our
knowledge, methionine ligation of zinc tetrapyrroles has not been tested in protein maquettes.
Substitution of a hydrophobic methionine ligand for a polar histidine could serve to raise the
midpoint potential of a zinc tetrapyrrole to increase the yield of tyrosine and metal ion
oxidation. To test whether a methionine ligation of the zinc tetrapyrrole affects oxidation of
tyrosine, the histidine in the pigment site was mutated to a methionine residue in the MZH3L71H-H124M mutant. An ultraviolet/visible spectroscopic titration showed that MZH3-L71HH124M binds heme B with high affinity, albeit slightly more weakly than wild type MZH3. The
dissociation constant for ZnPCP binding was weakened from 10 nM with His124 to about 100
nM with Met124. The titration of ZnPCP into a solution of MZH3-L71H-H124M that contained
heme B showed that the ZnPCP Soret band absorbance was centered at 420 nm, representing a
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blue-shift of about 2 nm relative to the wild type. Despite these differences between the
histidine- and methionine-ligated ZnPCP, transient absorption experiments of MZH3-L71HH124M were not radically different from MZH3-L71H. At pH 7.5, the yield was 8% and the
charge separated state lifetime was 3.4 ms (compared to 6% and 1.2 ms for MZH3-L71H). At pH
9.5, the yield for MZH3-L71H-H124M was 5% and the lifetime was 60 ms (compared to 4% and
32 ms for MZH3-L71H).
A summary of these transient absorption results is shown in Table 4.3. In each protein
tested, the lifetime of the charge separated state was extended by an increase in the pH. In
general, measurements of the lifetimes of the charge separated states were found to be highly
reproducible, but yield estimates were subject to a larger error. These transient absorption
experiments do not provide direct experimental evidence of tyrosine oxidation, but the
observed changes in electron transfer kinetics would be difficult to explain without invoking
tyrosine redox activity. The
replacement of tyrosine with
leucine completely eliminates
detection of a long-lived charge
separated state, and the
introduction of polar groups
near the tyrosine residue
effects pronounced changes in
yield and lifetime that are
consistent with the known

MZH3 mutant
pH CS lifetime
CS yield
wt
7.5 ~4 ms
2%
Y168L
7.5 N/A
N/A
L71H
7.5 1.2 ms
6%
L31D/L71H
7.5 140 µs
8%
E34A/L71H
7.5 ~3 ms
1%
L71H/H124M
7.5 3.4 ms
8%
wt
9.5 150 ms
2.5%
Y168L
9.5 N/A
N/A
L71H
9.5 32 ms
4%
L31D/L71H
9.5 2.5 ms
12%
E34A/L71H
9.5 40 ms
3%
L71H/H124M
9.5 60 ms
5%
Table 4.3: Transient absorption results in MZH3 with heme
B and ZnPCP
Summary of quantum yields and lifetimes of charge
separated (CS) states in MZH3 and MZH3 variants with
Heme B and ZnPCP and in the absence of metal ions.
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proton dependence of tyrosine oxidation.

4.2.4 Triad with iron in MZH3
MZH3 was originally intended to function as a redox-active tetrad involving an iron or
cobalt tetrapyrrole, a zinc tetrapyrrole, a tyrosine side chain, and a metal ion. However, the
ZnPCP-to-metal distance is close enough for direct electron transfer to occur, and tyrosine
oxidation could be bypassed if the driving force and reorganization energy are favorable. The
metal-to-ZnPCP distance for Zn(II) is 10.1 Å, and it is 9.6 Å for Mn(II). The metal dication that
would be easiest to photo-oxidize in MZH3 transient absorption experiments would probably be
Fe(II), because it should bind to the di-metal site with high affinity, and it has a lower midpoint
potential than Mn(II) or Co(II). Due Ferro maquettes and natural diiron proteins like
bacterioferritin can alternately oxidize and reduce iron using oxygen and a reductant (26, 2931), so it is a natural starting point for tests of metal photo-oxidation in MZH3. All transient
absorption experiments with metal ions were carried out at pH 7.5 and not pH 9.5 because of
the risk of precipitation of metal hydroxide complexes, which could complicate results.
Addition of large concentrations of FeCl2 (in excess of 500 μM) in transient absorption
experiments with 3.5 μM MZH3 appears to have led to the use of Fe(II) as an unbound sacrificial
electron donor. Treatment of MZH3-L71H, MZH3-Y168L, and MZH3-L71H-E34A with high Fe(II)
concentrations always resulted in the trapping of a reduced state of heme B for at least 10 s;
recombination was not observed.
The MZH3-L71H-E34A mutant is likely to have impaired metal binding activity at the site
closest to the ZnPCP, because Glu34 is a bidentate ligand of the metal at that site. Removal of
either of the corresponding bidentate axial glutamate residues from bacterioferritin results in a
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protein that can only bind one Co(II) ion per bundle (32). Therefore, it is likely that E34A
prevents binding of metal ions to the site nearest the tyrosine. Transient absorption
experiments of 3.0 μM MZH3-L71H-E34A with heme B, ZnPCP, and 1 mM FeCl2 led to heme B
remaining reduced for longer than 10 s, but when the experiment was repeated with only 10
μM FeCl2, the lifetime of the charge separated state was roughly 5 ms, which is similar to the ~3
ms lifetime that was observed in the absence of FeCl2. In addition, the yields of MZH3-L71HE34A experiments with and without 10 μM FeCl2 were both about 1%, but at 1 mM FeCl2, the
yield was 6%. At 50 μM FeCl2, the yield and lifetime of the charge separated state were 1.5%
and ~10 ms, which are only slightly different from the metal-free MZH3-L71H-E34A.
In contrast, MZH3-L71H, which binds metal ions with high affinity, had a dramatic
increase in the lifetime of the charge separated state when only 10 μM FeCl2 was added. In the
absence of Fe(II) the lifetime was 1.3 ms, but the presence of 10 μM FeCl2 increased the lifetime
to 300 ms. The 10 μM FeCl2 experiment also had a modest increase in yield to 8% from 6%
without FeCl2. These results are presented in Figure 4.10. The lifetime of the recovery of the
ground state bleach of the ZnPCP was close to the lifetime without iron, 60 μs.
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Figure 4.10: Transient absorption
and SVD analysis of MZH3-L71H
with heme, ZnPCP, and 10 μM
FeCl2 at pH 7.5
A: Transient absorption spectra.
Inset: close-up of dotted box. B:
Time evolution of SVD component
1 corresponding to ZnPCP ground
state recovery (red points), and
model fitting (large orange
points). C: Time evolution of SVD
component 2 corresponding to
the heme redox signal (green
points), and model fitting (large
blue points). D: Spectrum of SVD
component 2 (cyan points) and
overlay of heme redox spectrum
(black line).

The MZH3-Y168L mutant should be competent to bind metal ions, but its metal affinity
might be weakened slightly, because the Tyr168 makes a hydrogen bond to Glu34, which
stabilizes Glu34 in the metal-binding conformation. The metal ligand Glu161 is intended to
make a bidentate ligation of a metal ion in the same way that Glu34 ligates the other metal ion,
and Glu161 has consistently higher temperature factors in its side chain than Glu34 in almost all
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MZH3 crystal structures. Glu161 lacks a second shell hydrogen bond to a tyrosine, which
suggests a stabilizing role for the second shell tyrosine contact. For this reason, removal of
Tyr168 in MZH3-Y168L could weaken metal ion affinity. When 10 μM FeCl2 was added to 3.5
μM MZH3-Y168L for a transient absorption experiment, the results showed a clear heme redox
signal with a low yield of approximately ~2% and a lifetime of roughly ~500 ms. This charge
separated lifetime is similar to the lifetime in MZH3-L71H with 10 μM FeCl2, which suggests that
the tyrosine is not involved in formation of the charge separated state. The decreased quantum
yield in MZH3-Y168L compared to MZH3-L71H can be attributed to the presumed decreased
affinity for metal ions.
These results show that a bound iron ion can act as the electron donor in a redox-active
triad in MZH3. In MZH3-L71H, addition of 10 μM FeCl2 increases the lifetime of the charge
separated state by a factor of 220. The same concentration of FeCl2 does not significantly affect
the lifetime of MZH3-L71H-E34A, a mutant that probably does not bind Fe(II) with high affinity
at the metal site that is proximal to the pigment site. The disparity in the effect of 10 μM FeCl2
shows that at this low concentration, Fe(II) is not an effective sacrificial electron donor in
transient absorption experiments. Because 10 μM FeCl2 gives MZH3-L71H a longer lifetime and
higher yield but eventually recombines after 300 ms, MZH3-L71H must be photo-oxidizing
bound Fe(II) and not free Fe(II).
Since heme reduction in MZH3-Y168L is not observed in transient absorption
spectroscopy unless 10 μM FeCl2 is present, tyrosine 168 is not essential to photo-oxidation of
bound Fe(II) in MZH3. Therefore, MZH3 containing heme B, ZnPCP, tyrosine, and Fe(II) functions
as a triad and not as a tetrad that involves the activity of tyrosine. This could be the result of the
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relatively low potential of iron compared to manganese or cobalt; Fe(II) may have a sufficiently
high driving force for oxidation by ZnPCP that it can outcompete tyrosine oxidation.
A summary of the transient absorption results presented so far is given in graphical form
in Figure 4.11.
Figure 4.11: Summary
of transient
absorption results in
graphical form
Circular and square
data points represent
experiments at pH
7.5 and pH 9.5,
respectively. Unless
otherwise noted,
data points represent
experiments in the
absence of metal
ions.

4.2.5 MZH3 reverts to dyad behavior in the presence of Zn, Cd, or Mn
The addition of MnCl2 or ZnSO4 eliminated the long-lived charge separated state in
transient absorption experiments. Zn(II) is not redox active, but the potential of the
Mn(II)/Mn(III) redox couple should make Mn(II) susceptible to oxidation in this system. In one
experiment with 2.4 μM MZH3-L71H with heme B and ZnPCP and no metal ions at pH 7.5, a
charge separated state had a lifetime of 1.2 ms and a yield of 6%. A ZnSO4 stock solution was
added to a final concentration of 10 μM, and the experiment was repeated. The ZnPCP Soret
bleach was red-shifted with the addition of ZnSO4 by about 2-3 nm from 422 nm to 425 nm. The
heme redox signal was not observed in the presence of ZnSO4. The lifetime of the recovery of
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ZnPCP ground state was 70 μs with Zn(II), similar to the 60 μs lifetime in the absence of metal
ions. Evidently, Zn(II) binding to MZH3-L71H inhibits oxidation of the tyrosine.
This experiment was repeated with 3.4 μM MZH3-L71H-L31D with heme B and ZnPCP.
Despite the addition of Asp31 to increase the polarity of the tyrosine environment, the same
result was observed; a charge separated state was trapped in the absence of metal ions, but 10
μM ZnSO4 eliminated the heme redox signal.
Preliminary results have shown that the same inhibitory effect and red-shifted ZnPCP
Soret absorbance was observed in the presence of MnCl2. No long-lived charge separated state
was observed by transient absorption in MZH3-L71H-H124M with 10 μM MnCl2, MZH3-L71H
with 4 mM MnCl2, or wild type MZH3 with 1 mM MnCl2 at pH 7.5. All of these MZH3 variants
trap a long-lived charge separated state in the absence of Mn(II), but lose the ability to do so in
high yield when Mn(II) binds.
It is unclear why the binding of metal ions would inhibit formation of the charge
separated state in MZH3. One possibility is that metal binding alters the midpoint potential of
the tyrosine. The presence of the metal could alter the tyrosine potential by an electrostatic
effect, but crystal structures show that Glu34 appears to shield the positive charge of the metal
ion from the tyrosine. In addition, at pH 7.5, the initial and final states of the tyrosine are both
expected to be neutral, because the electron transfer is coupled to proton transfer. This would
make the electrostatic influence of the metal irrelevant if tyrosine oxidation follows a concerted
PCET mechanism.
It is unlikely that tyrosine 168 of MZH3 ligates a metal ion, which could change its
midpoint potential from the expected value. A tyrosinate-Fe(III) ligand has been detected in
Due Ferro proteins, but not a tyrosinate-Fe(II) ligand (21, 33, 34). A tyrosinate-Fe(III) spectral
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signature was not observed in MZH3 (Figure 2.19), and crystal structures show that the distance
between the tyrosine phenolic oxygen and metal ion is at least 3.2 Å. This is much longer than
the tyrosinate-Fe(III) ligand in Due Ferro variant DFsc, which has an Fe(III)-O bond length of 1.89
Å (21). In addition, the carboxylate group of Glu34 stands between Y168 and the metal to make
a hydrogen bond with the tyrosine and a bidentate ligation of the metal. The Tyr-to-Zn(II)
distance is even longer than the Tyr-to-Mn(II) distance; crystal structure CS-A, which has one
ZnPCP in the pigment site and Zn(II), has 3.7 Å between the tyrosine phenolic oxygen and the
Zn(II). Both Mn(II) and Zn(II) were shown to inhibit formation of the charge separated state, so a
tyrosinate-metal ligand in MZH3 is not supported by experimental evidence.
Metal binding may inhibit efficient deprotonation of the tyrosine. It could be that when
a metal ion binds, Tyr168 donates a hydrogen bond to Glu34 which cannot accept a proton
because it is ligating a metal ion. This would stabilize the proton on Tyr168 and inhibit
oxidation. However, a study of bacterioferritin shows that a tyrosine in an analogous hydrogen
bonding interaction with an iron-ligating glutamate residue, Tyr25, is oxidized during normal
function of the protein (29). Another study in a modified bacterioferritin showed photooxidation of this same tyrosine in the presence of manganese and further showed that tyrosine
could not be photo-oxidized in the absence of metal ions (27, 28, 35). The metal dependence of
Tyr25 oxidation in bacterioferritin is the opposite of what is observed for Tyr168 in MZH3.
Despite the difference in tyrosine oxidation activity, MZH3 and bacterioferritin have highly
similar overall folds (see Figure 3.18); specific interactions may be significant in achieving
tyrosine oxidation in the presence of bound metal ions. Unlike the Tyr168 residue of wild type
MZH3, which contacts only hydrophobic residues apart from the metal-ligating Glu34, Tyr 25 of
bacterioferritin is surrounded by a total of four carboxylate amino acids: the metal-ligating
179

Glu94 as well as Glu44, Glu47, and Asp90 (36). The difference in the polarity of the environment
of the tyrosines in MZH3 and bacterioferritin might be the source of the difference in redox
activity. The highly polar environment around Tyr25 in bacterioferritin could facilitate proton
transfer from Tyr25 even if Glu94 is unable to accept a proton.
The flexibility of MZH3 could play a role in tyrosine oxidation. DF3 is known to have
relatively low stability in the apo-state (33), and MZH3 does not crystallize in the absence of
metal ions and its helicity and stability increase significantly in the presence of MnCl2 and CaCl2
(Table 2.6 and Figure 2.20). This metal-dependent stability suggests that apo-MZH3 may have
structural fluctuations in the vicinity of the metal binding site that could increase solvent
exposure of tyrosine 168. Metal binding may restrict these motions and thereby lower the
solvent exposure of Tyr168. This would decrease the rate of deprotonation of the tyrosine so
that its oxidation is no longer able to compete with the rate of reduction of ZnPCP•+ by Fe(II)heme B. The 2-3 nm redshift in the ZnPCP Soret band when metal ions bind might also be
caused by a decrease in the degree of penetration of solvent into the core of MZH3.
Photo-oxidation of manganese ions has been achieved before in modified natural
proteins (27, 37, 38), and there is no reason why it can’t be done in a maquette. Future work
should seek to determine why metal binding inhibits tyrosine oxidation in MZH3 and how to
oxidize Mn(II). It may be possible to achieve efficient manganese oxidation by altering the
driving forces by raising the pH, using a higher potential zinc tetrapyrrole, or altering the
environment of the Mn(II) ion or Tyr168 through mutagenesis.
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4.2.6 Photo-reduction of cobalt protoporphyrin IX
Cobalt protoporphyrin IX (CoPPIX) has been used for photo-catalytic hydrogen
generation in modified natural proteins (39, 40). Co(III)PPIX binds to wild type MZH3 with a
dissociation constant of 250 nM, 35 times stronger than the Co(III)PPIX affinity of cytochrome
b562 (39), as described in section 2.3.3. For this reason, CoPPIX may be a viable candidate for
catalytic hydrogen production in MZH3. One of the natural proteins that promoted hydrogen
evolution using CoPPIX was cytochrome b562, which uses a histidine and a methionine to ligate
the cofactor (39). In order to reproduce this His-Met ligation scheme, the MZH3-His110Met
mutation was made.
Before testing for photo-reduction of CoPPIX, reference spectra of Co(III)PPIX and
Co(II)PPIX bound to MZH3-His110Met were determined in order to confirm binding and to aid
data analysis. The Co(III)PPIX state is more stable under aerobic conditions; the midpoint
potential of the [Co(III)PPIX/Co(II)PPIX] redox couple was measured at 100 mV vs. SHE in
myoglobin and 16 mV vs. SHE in cytochrome b562 (39, 41). These potentials should make it
possible for the excited state 3ZnPCP* cofactor to reduce Co(III)PPIX, since the
[ZnPCP•+/3ZnPCP*] midpoint potential is −0.69 V. The Co(III)PPIX Soret absorbance peak had a
wavelength of 429 nm in MZH3-His110Met and 426 nm in wild type MZH3, similar to the 424430 nm range found for cobalt cytochrome b562 variants, cobalt myoglobin, and a four-helix
bundle maquette (39, 41, 42). Co(III)PPIX was reduced in MZH3-His110Met and wild type MZH3
using dithionite, but the reduction was slow. This is consistent with observations that the
Co(III)PPIX/Co(II)PPIX transition in myoglobin and in maquettes is orders of magnitude slower
than heme reduction, and these slow kinetics have been attributed to a structural
rearrangement (41, 42). During reduction of Co(III)PPIX in MZH3 variants, the decrease in the
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Co(III)PPIX Soret band absorbance was accompanied by a concomitant increase in a weaker,
broader Co(II)PPIX Soret band increase at 399 nm in MZH3-His110Met or 397 nm in wild type
MZH3. Similar Co(II)PPIX Soret absorbance wavelengths have been reported between 394 nm
and 406 nm in myoglobin and at 401 nm in a four-helix bundle maquette (40-42). The CoPPIX
spectra in MZH3-His110Met and in myoglobin are shown in Figure 4.12.

Figure 4.12: Co(II/III)protoporphyrin IX spectra in MZH3 and myoglobin
Left: Spectra of 3 μM MZH3-His110Met bound to CoPPIX in 20 mM sodium phosphate, 50 mM
NaCl at pH 7.5. Red trace is Co(III)PPIX and black trace is Co(II)PPIX reduced with excess
dithionite. (Dithionite accounts for the steep increase in absorbance of the Co(II)PPIX trace
near 319 nm). The green and blue traces are mixtures of Co(III) and Co(II)PPIX collected
before the slow reduction was complete. Right: Literature Co(III)-myoglobin and Co(II)myoglobin spectra collected at pH 6.8 in a spectroelectrochemical cell. Potentials at which
spectra were measured are given vs Ag|AgCl (saturated KCl). Figure reproduced from Li et al.,
2000 (41).

CoPPIX photo-reduction was tested by transient absorption spectroscopy in MZH3
variants that also had ZnPCP bound. The experiment was run at pH 7.5 and pH 9.5 using wild
type MZH3 and MZH3-His110Met. There was no sign of a Co(II)PPIX peak in any of the transient
absorption experiments. However, in all cases, the excited 3ZnPCP* triplet state lifetime was
decreased from 3.3 ms in the ZnPCP-MZH3 monad to roughly 100 μs when Co(III)PPIX was
present. This could mean that Co(III)PPIX is transiently reduced to the Co(II)PPIX state, but that
182

reduction of ZnPCP•+ by Co(II)PPIX outcompetes tyrosine oxidation. Energy transfer is another
possible explanation for the reduced lifetime of the 3ZnPCP* excited state.
The fact that Co(III)PPIX reduction kinetics are slow might explain the absence of
Co(II)PPIX in transient absorption. To test whether CoPPIX reduction is possible in MZH3 over
longer timescales, continuous illumination experiments were used to look for Co(II)PPIX
production on a minutes to hours timescale. A CUDA model I-150 halogen lamp with a 150 W
bulb illuminated the sample using a fiber optic cable, and the anaerobic sample was held at 20°C
using a Peltier temperature controller. Anaerobic samples of ~3 μM wild type MZH3 and MZH3His110Met were prepared with CoPPIX and ZnPCP at pH 9.5 with 1 mM EDTA, 0.5-1 mM
ascorbate, 50 mM NaCl, and 10 mM CHES buffer. Under these conditions, a distinct Co(II)PPIX
Soret peak was observed at 397-399 nm within a few minutes of the start of illumination, and it
was accompanied by a concomitant decrease of the Co(III)PPIX Soret at 427-429 nm. Reduction
continued over the course of about 1 hour. However, no CoPPIX reduction was observed when
the pH was lowered to 7.5 or if either ascorbate or EDTA were not included in the sample.
In previous maquettes, CoPPIX has been reported to dissociate from the maquette after
reduction to the Co(II)PPIX state (42). For this reason, the wild type MZH3 sample was tested
for Co(II)PPIX dissociation. After 2 hours of illumination, when reduction to the Co(II)PPIX state
had been completed, the light source was turned off. About 0.2 μM Co(III)PPIX was added to
the anaerobic sample to test for binding; if Co(II)PPIX remains bound, then no Co(III)PPIX should
bind to MZH3. Unexpectedly, the added Co(III)PPIX was reduced within the time it took to
record a spectrum (less than one minute). This suggests that the solution potential had been
lowered over the course of the experiment. After removal of free CoPPIX by a PD-10 desalting
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column (GE Healthcare Life Sciences), a Co(II)PPIX Soret peak at ~398 nm remained, suggesting
that Co(II)PPIX remained bound to wild type MZH3 after reduction.
These results clearly establish that light-driven reduction of Co(III)PPIX to Co(II)PPIX
occurs slowly in MZH3. The requirements of high pH and the presence of both ascorbate and
EDTA are not easily explained, but the pH dependence suggests involvement of the tyrosine in
electron transfer. It could be that either EDTA or ascorbate serves as the sacrificial electron
donor, while the other performs an unexpected function such as storing reducing equivalents or
directly interacting with the protein in a way that influences electron transfer rates. This line of
research is ongoing, but current results show that CoPPIX photo-reduction occurs in MZH3.

4.3 Summary of electron transfer in MZH3
4.3.1 ZnPCP binding to metal cavity is not consistent with transient absorption results
If ZnPCP binds to the opening of the metal cavity in transient absorption experiments, it
would push the tyrosine side chain out of the core, as observed in crystal structures CS-B and
CS-C and shown in Figure 3.16. This would break the hydrogen bond with the histidine in the
MZH3-L71H mutant, and a more solvent-exposed tyrosine side might be easier to oxidize than a
buried tyrosine, because it might be more stable in the charged tyrosinate form. There are
several reasons why it is unlikely that a second ZnPCP binds to the metal cavity.
All transient absorption experiments were done with sub-stoichiometric ZnPCP to avoid
the possibility of a second ZnPCP binding to the opening of the metal binding site cavity.
Ultraviolet/visible spectroscopic titrations showed high-affinity binding of ZnPCP at neutral pH
with a stoichiometry of 1:1, and changing the pigment site His124 to Met124 results in changes
in binding affinity and creates a blue-shift in the ZnPCP spectrum. Crystal structures CS-B and
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CS-C showed a clear preference of the ZnPCP for the pigment site rather than the metal cavity.
This suggests that ZnPCP is not present in the metal binding site under the conditions of the
transient absorption experiments.
If a ZnPCP molecule were to bind to the metal cavity in these experiments, it would be
30 Å from the heme, meaning that this ZnPCP could not reduce the heme because the maximum
rate of heme reduction by 3ZnPCP* to the heme would have a lifetime of about 1000 s. The fact
that heme is reduced on a μs timescale shows that a ZnPCP must be bound to the pigment site.
Despite this reasoning, it may be worthwhile to confirm that ZnPCP does not bind to the
opening of the metal cavity in transient absorption experiments. One way to do this would be
to repeat these experiments with zinc tetrapyrroles that are unlikely to bind to MZH3 at the
metal site, such as NR117 or SE375 (see Table 2.4). Another alternative is to make mutations to
MZH3 that would destabilize the ZnPCP at the opening of the metal cavity and the interfacial
conformation of the tyrosine.

4.3.2 Analysis of transient absorption results
The rate of the electron transfer from the excited triplet state 3ZnPCP* to Fe(III)-heme B,
kCS1, was consistently measured at about 104.5 s−1 (30 to 70 μs lifetime) for all transient
absorption experiments. This lifetime is more than an order of magnitude slower than the
estimated 1 μs lifetime (106 s−1 rate of kCS1) calculated using the Moser-Dutton ruler (Equation
4.1) from parameters in Table 4.2. This discrepancy is surprising, but could be explained by an
unusually large reorganization energy (~1.6 eV) or an uneven distribution of the 3ZnPCP*
wavefunction that creates a longer effective distance RPA.
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Regardless of reorganization energy or distance, the rate of charge recombination
between the Fe(II)-heme and ZnPCP•+, kCR1, should be about 20 times faster than the forward
electron transfer rate, kCS1. Based on the measured rate of kCS1, this would put kCR1 close to 105.8
s−1. Therefore, less than 5% of the A-P+ intermediate should be observable in the dyad. This is
consistent with transient absorption results that did not detect the intermediate A-P+ state.
At pH 9.5, around 30% of Tyr168 will be deprotonated before the flash, assuming a
tyrosine pKa of 10. Using the parameters in Table 4.2, tyrosinate oxidation by ZnPCP•+ should
proceed with a rate kCS2 of 109.5 s−1, and the recombination rate, kCR2, should be 106.3 s−1, so the
rate of charge separation is favored by a factor of 103.2. Since the rate of the first recombination
kCR1 is 105.8 s−1, the return to the ground state should proceed at a rate of 105.8−3.2 s−1, or 102.6 s−1
corresponding to a lifetime of 2.5 ms. Transient absorption experiments with MZH3-L71H-L31D
are in agreement with this model; the measured lifetime of the MZH3-L71H-L31D charged
separated state at pH 9.5 is 2.5 ms and the yield is 12%. Other mutants that have lower yields
and longer lifetimes of the charge separated state are consistent with higher tyrosine pKa values
and corresponding lower midpoint potentials of the [Tyr-O−/Tyr-O•] redox couple.
At pH 7.5, the fraction of tyrosine in the tyrosinate state is small, assuming a pKa of 10,
and tyrosine oxidation might proceed through the tyrosyl radical cation, which would have a
midpoint potential of ~1.34 V. The 0.43 eV uphill driving force for tyrosine oxidation by ZnPCP•+
would have a lifetime of around 400 μs, and give <1% yield. However, if the tyrosine potential
were slightly lower, at 1.28 V, then 40 μs electron transfer could take place, and this could
account for a 4% yield, assuming proton transfer can also take place in 40 μs. This mechanism is
consistent with the wild type MZH3 yield of 2% at pH 7.5.
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Upon binding of Fe(II), the lifetime of the charge separated state becomes 300 ms. This
recombination rate is about 105.3 times slow than the dyad short circuit kCS1, and corresponds to
a [Fe(II)/Fe(III)] midpoint potential of about 0.59 V. This potential would be high for iron but is
not unreasonable, as iron midpoint potentials in diiron proteins can vary across a wide range.

4.3.3 Conclusion and future directions
The transient absorption results presented in this chapter demonstrate that MZH3 can
assemble a charge separating triad that involves heme B as the acceptor, ZnPCP as the pigment,
and either tyrosine or Fe(II) as the donor. A stable charge separated state is formed when
tyrosine is present in the protein, and the quantum yield and lifetime of charge separation can
be manipulated by hydrogen bonding interactions with the tyrosine. Hydrogen bonding
partners of the tyrosine seem to have the effect of increasing the yield of charge separation, but
decreasing the lifetime. It should be noted, however, that in photosystem II, the YZ• radical is a
transient species that is not itself used for bond making and breaking; YZ• has a short lifetime so
it can pass oxidizing equivalents to the OEC. In MZH3, bound Fe(II) enables lifetimes of charge
separation of 300 ms, long enough for chemical reactions to take place.
The transient absorption results strongly support electron transfer from the donors, but
the oxidized states of the donors could not be detected directly. Future studies of this system
by electron paramagnetic resonance may be able to detect a tyrosyl radical signal to confirm its
oxidation.
Cobalt tetrapyrroles are known to be capable of hydrogen production (39, 43).
Preliminary results have shown that when CoPPIX is used as the electron acceptor in place of
heme in MZH3, a charge separated state is not detected by transient absorption. However,
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continuous illumination experiments of MZH3 with CoPPIX and ZnPCP in the presence of
ascorbate and EDTA suggest Co(III)PPIX photo-reduction to Co(II)PPIX, as evidenced by a large
blue-shift of the Soret band of CoPPIX. Experimental complications and uncertainties have so
far left ambiguity as to whether direct electron transfer from ZnPCP to CoPPIX occurs, but
CoPPIX is being investigated as a possible path toward hydrogen production.
The MZH3 scaffold provides a starting point to begin to assemble a redox-active metal
cluster akin to the oxygen evolving complex of photosystem II. Photo-oxidation of tyrosine and
Fe(II) have already been demonstrated in this chapter, and this represents an important first
step toward a water oxidation catalyst. If oxidation of Mn(II) can be achieved, it may be possible
to use a photo-assembly mechanism to build a multinuclear metal center similar to the OEC of
photosystem II. The simple, robust reaction center maquette MZH3 could thus be used to
investigate the properties necessary to build a functional water-oxidizing metal cluster.
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Chapter 5: Oxygen binding and alternative heme ligations
Light-driven water oxidation and hydrogen evolution will require fine-tuning of the
properties of the various cofactors. One way to effect significant changes in heme redox
properties is by altering the ligand sphere (1). Wild type MZH3 ligates the heme B iron ion using
two histidine imidazole groups from His9 and His110 to form hexacoordinate iron. This bishistidine ligation scheme is similar to the heme coordination found in cytochromes b and b6 of
the cytochrome bc1 and b6f complexes, where the heme is used for electron transfer functions
(2, 3). Changes to the coordination in the MZH3 acceptor site could modulate heme B and
cobalt protoporphyrin IX (CoPPIX) midpoint potentials and possibly enable hydrogen evolution
activity from a cobalt tetrapyrrole.
Different heme ligation schemes in natural hemoproteins help to impart diverse
functions. For example, P450 enzymes ligate heme with a cysteine residue (4), bovine liver
catalase uses a tyrosinate ligand (5), cytochrome c and cytochrome b562 use a His-Met ligation
pattern (6, 7), and cytochrome f uses a histidine and an N-terminal amino group as heme ligands
(8). Myoglobin and hemoglobin ligate heme B with only one histidine, and the other site is left
open for a small molecule such as oxygen to bind (9, 10). This chapter will show heme B binding
by MZH3 mutants in which acceptor site histidine residues were changed to either tyrosine,
lysine, methionine, or alanine. The His110Ala mutant exhibits evidence of high-affinity oxygen
binding and a slow rate of autoxidation, similar to myoglobin and hemoglobin.
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5.1 MZH3 mutants bind heme B with ligands other than histidine
Wild type MZH3 ligates heme or CoPPIX in the electron acceptor site using His9 and
His110, and this section presents heme binding by MZH3 mutants His9Cys, His110Cys, His9Lys,
His9Tyr, His110Met, and His110Ala. All of these mutants retain the ability to bind heme B, as
evidenced by their ultraviolet/visible (UV/vis) spectra. Unbound ferric heme B in aqueous
solutions has a relatively weak, broad absorbance at about 390-395 nm, whereas all of the
MZH3 heme site mutants exhibit strongly absorbing Soret bands between 407 and 424 nm. In
addition, MZH3 heme site mutants bind heme B in vivo during overexpression in E. coli. Figure
5.1 shows absorbance spectra of MZH3 variants after cell lysis and purification by Ni-NTA
column; no heme was added to these spectra.

Figure 5.1: Heme B binds to MZH3 mutants His110Met and His110Ala in vivo
Conditions for wild type MZH3: 150 mM NaCl, 6 mM sodium phosphate, pH 7.4. Conditions
for MZH3-His110Met and His110Ala mutants: 100 mM NaCl, 600 μM EDTA, 30 mM Tris
buffer, pH 8.0. (His6 tags of the mutants had not yet been cleaved by TEV protease when
these spectra were collected, but the wild type MZH3 did have its His6 tag cleaved.
Subsequent studies showed that the His6 tag does not affect the spectrum).

Figure 5.2 shows the spectra of three more MZH3 variants with ferric heme bound.
These spectra were collected after adding heme B to the maquettes in vitro.
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Figure 5.2: Spectra of heme B bound to MZH3
mutants His9Lys, His9Cys, and His110Tyr
These purified MZH3 mutants were
reconstituted with ferric heme B in vitro. The
His9Lys and His9Cys spectra are shown in
comparison to wild type MZH3 (bis-His). The
MZH3-His9Cys UV/vis spectra were very similar
to MZH3-His110Cys and were very similar. The
MZH3-His110Tyr spectra are shown in the
oxidized state and ferrous state (reduced with
dithionite).

In Figure 5.1 and Figure 5.2, absorbance is shown in arbitrary units, because extinction
coefficients of heme B in MZH3 mutants have not been determined. Assuming similar heme
extinction coefficients in the different mutants, roughly 5-10% of samples of MZH3-His110Met
and His110Ala contained heme B from E. coli after lysis and purification by Ni-NTA column.
MZH3-His9Lys appeared to overexpress with approximately 15-20% heme B incorporation (data
not shown). The fact that MZH3 binds heme B in vivo similarly regardless of the ligation state
indicates that heme binding is not wholly dependent upon coordination by ligating amino acids;
other factors such as the shape of the binding pocket play a significant role in heme binding in
MZH3.
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Of particular interest is the fact that heme binds to MZH3-His110Ala, which only has one
histidine in the heme binding site. Previous maquettes from the Dutton group lacked the ability
to bind heme B using only one histidine instead of two, and this feature has been used to create
tetrapyrrole binding sites that select for zinc tetrapyrroles over iron tetrapyrroles (11, 12). In
addition, the heme B of MZH3-His110Ala remains in a reduced ferrous state even after several
hours of exposure to oxygen during cell lysis, Ni-NTA column purification, and dialysis. Ferric
heme B in MZH3-His110Ala has a Soret absorbance band at 415 nm, but Figure 5.1 (black trace)
shows that the Soret absorbance of MZH3-His110Ala is 425 nm immediately after purification,
which is consistent with an oxygen-bound oxyferrous state (1, 12). Other heme binding
maquettes, including other MZH3 variants, are rapidly oxidized in the presence of oxygen. The
oxyferrous MZH3-His110Ala species will be examined more closely in section 5.3.

5.2 Heme B midpoint potentials in MZH3 mutants
Alteration of heme-ligating amino acids can lead to new functions by changing the
midpoint potential of the heme. The midpoint potentials of iron porphyrins are particularly
sensitive to the ligating amino acids, presumably because the redox active electron in iron
porphyrins is localized to the iron ion; in some cases, amino acid substitutions can lead to
midpoint potential shifts of over 600 mV (13). Using a honeycomb spectroelectrochemical cell
(Pine Research Instrumentation), heme B midpoint potentials were determined for wild type
MZH3 and the mutants His9Lys, His9Tyr, His110Met, and His110Ala at pH 7.5. The methods
used for the spectroelectrochemical midpoint determinations are detailed in the appendix.
To demonstrate reproducibility, the midpoint potential of wild type MZH3 (with bis-His
heme ligation) was measured using the spectroelectrochemical honeycomb apparatus and the
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result was compared to the redox titration method described in section 2.2.9. The redox
titration previously showed a reversible one-electron transfer event at a midpoint of −180 mV
(Figure 2.22). Figure 5.3 shows that the results from the honeycomb spectroelectrochemical cell
are in agreement with the redox titration result. The heme redox spectrum from the

Figure 5.3: Spectroelectrochemical
midpoint determination of wild type MZH3
with heme B
The ferrous minus ferric heme redox
difference spectrum of wild type MZH3 was
the primary component of SVD analysis, as
shown in (A) the oxidizing and (B) reducing
directions. An n=1 Nernst curve (large blue
points) was fitted to the SVD component 1
population (small green points) in (C) the
oxidizing and (D) reducing directions. (E):
Absorbance spectra from the oxidizing scan
going from high potentials (ferric heme,
purple traces) to low potentials (ferrous
heme, green traces).
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spectroelectrochemical measurement was identified by SVD and fitted to a Nernst equation that
gave a one-electron reaction with a potential of about −183 mV in the oxidizing direction and
−195 mV in the reducing direction, demonstrating negligible hysteresis. The estimate of −190
mV using the spectroelectrochemical cell is within error of the −180 mV value from the redox
titration.
The spectroelectrochemical apparatus was used to determine midpoint potentials of
MZH3 mutants including MZH3-His110Ala (Figure 5.4). As with the wild type, MZH3-His110Ala
showed no sign of hysteresis, and Figure 5.4 shows the data from both the reducing and
oxidizing directions analyzed together. The low reducing potentials created an anaerobic
environment, and there was no sign of an oxygen-bound ferrous heme state in the reduced
spectra of Figure 5.4 (C); note the difference in Q-band shape between 500 and 600 nm in Figure
5.1 (black trace) compared to Figure 5.4 (C) (blue and purple traces). (This is shown more clearly
in Figure 5.5A). The midpoint potential of heme B bound to MZH3-His110Ala was estimated at
−110 mV vs. SHE.
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Figure 5.4: Midpoint potential of MZH3His110Ala with heme B
The MZH3-His110Ala spectroelectrochemical
curves were similar in the oxidizing and
reducing directions. The heme redox
spectrum of MZH3-His110Ala (A) was the
primary component of SVD analysis. (B): An
n=1 Nernst curve (large blue points) was
fitted to the SVD component 1 population
(small green points). Absorbance spectra
from the oxidizing scan going from low
potentials (ferric heme, red traces) to high
potentials (ferrous heme, purple traces).

In contrast to other mutants, heme B in MZH3-His110Met exhibited signs of hysteresis.
A partially reversible midpoint potential was observed at +70 mV vs. SHE, but in the reducing
direction, there was a second distinct midpoint at approximately −80 mV. This secondary −80
mV potential may represent a state similar to the MZH3-His110Ala ligation state in which the
protein contributes only one amino acid ligand and the potential is −110 mV. The fact that this
secondary low potential transition is only observed in the reducing direction may be because
methionine is a soft ligand that forms a stable interaction with the soft Lewis acid Fe(II) of
ferrous heme, but has a much weaker affinity for the hard Lewis acid Fe(III) of ferric heme. The
increased affinity of methionine ligands for ferrous heme over ferric heme has been shown to
stabilize the reduced state in other His-Met hemoproteins (14). The MZH3-His9Lys and His9Tyr
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mutants were found to have reversible Nernstian one-electron transfer events at midpoint
potentials of −65 mV and −180 mV, respectively. The MZH3 mutant spectroelectrochemistry
results are summarized in Table 5.1.

Table 5.1: Summary of heme B properties in different MZH3 mutants
The properties of heme B in MZH3 variants and natural proteins with similar ligation schemes
are compared. Table is adapted from Moser et al., 2016 (1).

5.3 Oxygen binding in MZH3-His110Ala
Many important medical procedures depend on blood transfusion to save lives and
improve health. The fact that this blood comes from voluntary donors means that healthcare
systems are susceptible to blood shortages, and blood transfusions present the risk of
transfusion-transmissible infections. An oxygen transport maquette that reproduces the
function of hemoglobin or myoglobin could potentially provide a safe, inexpensive blood
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substitute. This section examines the unexpected MZH3-His110Ala property of stable, highaffinity oxygen binding and the possibility of developing it into a novel blood substitute.

5.3.1 Introduction to oxygen transport proteins
Oxygen transport proteins including myoglobin and hemoglobin use ferrous heme B to
bind oxygen at the heme iron; the oxidized ferric state cannot form a stable interaction with
oxygen. The relatively low potential of heme B compared to oxygen means that the heme is
vulnerable to oxidation to the inactive ferric state, and the protein environment must modulate
the redox properties to prevent electron transfer. At room temperature, free heme B in
aqueous solutions autooxidizes within seconds, but myoglobin and hemoglobin autooxidation
takes hours or days (15, 16). Myoglobin and hemoglobin bind oxygen with dissociation
constants in the hundreds of nanomolar range: 830 nM for sperm whale myoglobin (17).
Oxygen binding has been observed in de novo-designed maquettes and redesigned
natural proteins. In these model systems, autooxidation is generally orders of magnitude faster
than in myoglobin or hemoglobin. In one example, human serum albumin (HSA) was redesigned
to introduce a heme B binding pocket. The modified HSA had an autooxidation lifetime of ~10
minutes, and its oxygen affinity in two different conformational states was 2.8 and 0.4% of the
myoglobin oxygen affinity (17, 18). In a series of maquettes from the Dutton group, an
oxyferrous state was identified with an autooxidation lifetime of seconds to tens of seconds at
16°C, and one maquette had an oxygen affinity that was 5% of the myoglobin oxygen affinity
(12, 17, 19, 20). These results demonstrate significant progress toward a designed oxygen
transport protein, but the oxyferrous stability and oxygen affinity must be increased significantly
before such a protein could become useful for medical applications.
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5.3.2 Oxygen binding results in MZH3-His110Ala
Natural oxygen transport proteins and previous oxygen binding maquettes show a clear
difference in the UV/vis absorbance spectra in the ferric, deoxyferrous, carboxyferrous, and
oxyferrous spectra. MZH3-His110Ala spectra at pH 7.5 (Figure 5.5A) are similar to those of the
earlier maquette BT6, which binds two hemes B via bis-histidine ligation and is able to bind
oxygen and carbon monoxide (Figure 5.5B) (12). In both MZH3-His110Ala and BT6, anaerobic
reduction of ferric heme (green traces) to deoxyferrous heme (blue traces) yields a significant
red shift in the Soret band from ~412-415 nm to ~426-431 nm and a significant sharpening and
increase in the intensity of the Q-bands at ~530 and ~560 nm. Exposure of the deoxyferrous
species to oxygen produces the oxyferrous state (red traces), and exposure to carbon monoxide
produces the carboxyferrous state (black traces). The oxyferrous and carboxyferrous spectra
have Soret bands that peak between the ferric and deoxyferrous Soret peaks and Q-bands that
are red-shifted and are more pronounced than the ferric Q-bands but less pronounced than the
deoxyferrous Q-bands. Further confirmation that MZH3-His110Ala binds oxygen comes from
comparison to spectra of bovine myoglobin (purchased from Sigma). Figure 5.5C shows the
deoxyferrous minus oxyferrous difference absorbance spectra of myoglobin (orange) and MZH3His110Ala (black). While the relative intensities of the absorption bands differ slightly, the
wavelengths of each band and the overall shapes of the spectra are similar.
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Figure 5.5: Ferric, deoxyferrous, carboxyferrous, and oxyferrous spectra
(A): MZH3-His110Ala spectra are shown with heme B in ferric (green), deoxyferrous (blue),
carboxyferrous (black), and oxyferrous (red) states. Samples were prepared in 50 mM NaCl,
10 mM MOPS buffer at pH 7.5 and are scaled to approximately the same concentration (~6
μM). Inset: Q-band region of MZH3-His110Ala spectra. (B): Reference spectra reproduced
from earlier bis-His two-heme maquette BT6 publication (Farid et al., 2013) (12), following
same color scheme as in (A). (The dotted red line is the oxyferrous species with only one
heme B bound to BT6 instead of two). (C): Deoxyferrous minus oxyferrous difference spectra
of myoglobin (orange trace) and MZH3-His110Ala (black trace).

The seconds to minutes lifetimes of oxyferrous states of earlier designed oxygen
transport proteins is too short for a blood substitute (12, 17-20), but the oxyferrous state of
MZH3-His110Ala is detectable for hours after cell lysis and protein purification (Figure 5.1). In
order to determine the rate of autooxidation, oxyferrous MZH3-His110Ala was prepared by
reduction of ~10 μM ferric MZH3-His110Ala with 10 mM ascorbate in 50 mM NaCl, 10 mM
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MOPS buffer at pH 7.5 at room temperature. Reduction with ascorbate was slow, probably
because of the relatively low heme B midpoint potential of MZH3-His110Ala of −110 mV vs SHE.
After one hour, reduction was complete, and ascorbate was removed by filtration through a PD10 desalting column (GE Healthcare Lifesciences). The ~6 μM sample was exposed to ambient
oxygen and UV/vis spectra were recorded every 0.25 to 4 hours for about 4 days. SVD fitting
identified two spectral components that were similar to the oxyferrous and ferric species shown
in Figure 5.5A. The oxyferrous lifetime was about 38 hours (Figure 5.6).

Figure 5.6: Autooxidation of oxyferrous
heme B in MZH3-His110Ala
(A): UV/vis spectra show the oxyferrous
state converts to the ferric state over days.
(B): SVD analysis identified components 1
(red, oxyferrous) and 2 (green, ferric). Inset:
Q-bands of SVD components. (C) The
population of SVD component 2 (ferric state,
green points) fitted to a simple exponential
function shows an oxyferrous lifetime of 38
hours.

There is no requirement for a blood substitute to use heme B, and other iron
tetrapyrrole cofactors might be preferable to heme B. MZH3 binds the higher potential Fe(III)
2,4-diacetyl deuteroporphyrin IX (Fe-DADPIX) with high affinity, as described in section 2.3.3. As
with heme B, MZH3-His110Ala is able to stabilize an oxyferrous state of Fe-DADPIX. A sample of
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30 μM MZH3-His110Ala bound to Fe-DADPIX was incubated with 150 μM ascorbate for several
hours to prepare the oxyferrous state, and ascorbate was removed using a PD-10 column. The
sample was kept exposed to ambient oxygen at room temperature at pH 7.5, and autooxidation
was monitored by the decay of the Fe-DADPIX oxyferrous Soret band at 447 nm for 6 days.
About ~8% of the MZH3-His110Ala sample contained heme B leftover from expression instead
of Fe-DADPIX, but the absorbance difference between the ferric and oxyferrous states of heme
B is very small at 447 nm. Fitting the autooxidation curve at 447 nm with a simple exponential
fit gave an Fe-DADPIX oxyferrous lifetime of ~80 hours, or 3.3 days (Figure 5.7).

Figure 5.7: Autooxidation of oxyferrous Fe-DADPIX in MZH3-His110Ala
Left: Absorbance spectra of MZH3-His110Ala with Fe-DADPIX at selected time points after
beginning the autooxidation reaction. Right: Absorbance at 447 nm fitted to a single
exponential curve gives oxyferrous Fe-DADPIX lifetime of roughly 80 hours or 3.3 days.

Carbon monoxide tends to bind to ferrous heme more tightly than oxygen, so
introduction of carbon monoxide should be able to convert oxyferrous MZH3-His110Ala to the
carboxyferrous state. The carboxyferrous and oxyferrous spectra are similar, but can be
distinguished by the large difference in the extinction coefficient of the Soret band (see Figure
5.5A, black and red traces, respectively). To test for the displacement of oxygen by carbon
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monoxide, a 1 mL sample of MZH3-His110Ala with ferric heme B was degassed and reduced
with dithionite. Addition of 15 μL of water containing ambient oxygen led to a mixture of ferric
and oxyferrous MZH3-His110Ala. About 10 mL of carbon monoxide gas was bubbled through
the anaerobic sample, and a slow increase in the Soret band at 425 nm was monitored over the
ensuing 40 minutes. After 40 minutes, more dithionite was added to sample to reduce the
oxygen and ferric heme B. The result was an immediate significant increase in the Soret
absorbance at 425 nm corresponding to rapid binding of carbon monoxide to ferrous heme B.
The result in Figure 5.8 shows that the presence of oxygen inhibited carbon monoxide binding to
MZH3-His110Ala, limiting its binding rate to tens of minutes. When oxygen was eliminated by
reduction with dithionite, carbon monoxide binding was complete within seconds.
Figure 5.8: Displacement of oxygen ligand by
carbon monoxide in MZH3-His110Ala with
ferrous heme B
UV/vis spectra show slow carbon monoxide
binding when oxygen is present and fast
carbon monoxide binding once oxygen is
reduced. Red trace: mixture of oxyferrous
and ferric heme B. Blue traces: after adding
carbon monoxide, Soret band slowly rose
over 40 minutes in the direction of the arrow.
Spectrum after 40 minutes is shown in
slightly darker blue. Black trace: addition of
dithionite reduced ferric heme B and
eliminated oxygen, allowing rapid carbon
monoxide binding in seconds or less.

Nature calibrated the dissociation constants of oxygen binding by myoglobin and
hemoglobin to be in the hundreds of nanomolar range (17, 21-23) so that these proteins can
bind oxygen from oxygen-rich environments and release it in oxygen-poor environments. To
probe the oxygen affinity of MZH3-His110Ala, a 5.6 μM sample in 50 mM NaCl, 10 mM MOPS
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buffer at pH 7.5 was degassed for 3.5 hours with argon that was bubbled through an acid
vanadyl sulfate-granular zinc oxygen scrubbing gas train (24). An ascorbate stock solution was
purged similarly, and ascorbate was added to the sample to a 500 μM final concentration at
time t=0 in Figure 5.9, below. The sample was purged continuously with argon throughout the
experiment. A peak began to increase at the oxyferrous Soret band wavelength of 425 nm. No
sign of a deoxyferrous state with a sharp Q-band feature at 560 nm was observed. Presumably,
oxyferrous formation was allowed by a slow leakage of oxygen into the cuvette. After 15 hours,
the rate of increase of absorbance at 425 nm had leveled off, and the cuvette was opened and
exposed to ambient oxygen. The oxyferrous spectrum decreased slightly, then increased to a
maximum after about 28 hours, showing that the oxyferrous spectrum depends on the presence
of oxygen.
Figure 5.9: Oxyferrous state formation
in MZH3-His110Ala during anaerobic
argon purging
500 μM ascorbate was added to MZH3His110Ala with ferric heme B at time
t=0. The absorbance difference of 424
minus 404 nm represents the rise of the
oxyferrous state. At the arrow, the
anaerobic cuvette was opened and the
sample was exposed to ambient
oxygen. Conditions: 50 mM NaCl, 10
mM MOPS buffer, pH 7.5.

In the first 15 hours of the experiment in Figure 5.9, the solution was purged
continuously with anaerobic argon, but the oxyferrous spectrum increased and was stable,
suggesting that the dissociation constant for the MZH3-His110Ala-heme B-oxygen complex was
less than the concentration of dissolved oxygen under these low-oxygen conditions. The
oxyferrous state was also stable for many hours if a glucose oxidase/catalase oxygen scrubbing
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system was introduced to the sample or if a weak vacuum was applied to the cuvette. These
results show that the affinity of MZH3-His110Ala for oxygen is greater than that of hemoglobin
or myoglobin, which release oxygen under low-oxygen conditions. Preliminary experiments
suggest that deoxyferrous MZH3-His110Ala is able to absorb oxygen from oxyferrous myoglobin.
This would indicate that the dissociation constant for oxygen binding by deoxyferrous MZH3His110Ala is less than hundreds of nanomolar. More work is need to determine a precise
dissociation constant.

5.3.3 Oxygen binding conclusions and future directions
The results presented here demonstrate that MZH3-His110Ala with heme B binds
oxygen. The stability of the oxyferrous state is 38 hours at room temperature at pH 7.5; the
autooxidation rate is orders of magnitude slower than the rates observed in earlier maquettes
and redesigned natural proteins (12, 18-20). This 38 hour lifetime at room temperature is
comparable to the hours to days lifetimes of various myoglobins and hemoglobins under similar
conditions (15, 16). For example, at pH 7.2 and 25°C, sperm whale oxymyoglobin is stable for
150 hours (16, 25), Aplysia kurodai myoglobin autooxidizes in 9 hours (25), and the chicken
gizzard oxymyoglobin lifetime is 59 hours (26). In addition, preliminary results suggest that the
oxygen affinity of MZH3-His110Ala appears to exceed that of maquettes, redesigned natural
proteins, and even natural myoglobins and hemoglobins by orders of magnitude. Extensive
purging with anaerobic argon does not convert oxyferrous MZH3-His110Ala to the deoxyferrous
state even over the course of hours.
It is not surprising that MZH3-His110Ala can bind oxygen; after all, several maquettes
and redesigned natural proteins have already demonstrated this ability, and MZH3-His110Ala
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has only one amino acid ligand available to ligate the heme iron, and the other site is left open.
However, the high oxygen affinity of MZH3-His110Ala and its oxyferrous state stability are very
much unexpected, and deserve explanation. The crystal structures of wild type MZH3, which
has bis-histidine heme B ligation, show low solvent access to the heme iron. It is likely that the
MZH3-His110Ala mutant is similar. A dry hydrophobic core might increase the oxygen affinity
because water molecules do not need to be displaced for oxygen to bind (15). The BT6
maquette and related mutants demonstrated that water access to the heme increases the rate
of autooxidation via water-catalyzed inner sphere electron transfer (12). However, solvent
inaccessibility alone cannot account for the extremely high affinity and stability observed in
oxyferrous MZH3-His110Ala.
Natural myoglobins and hemoglobins usually form a hydrogen bond between the
oxygen ligand and a distal histidine on helix E, HisE7 (27). This hydrogen bonding interaction
plays a pivotal role in stabilizing the oxyferrous state. The oxygen is the hydrogen bond
acceptor and the histidine donates a hydrogen bond from the protonated Nε atom. While
myoglobins tend to remain functional when HisE7 is replaced by glutamine, which may also
donate a hydrogen bond to oxygen, many substitutions to the E7 position result in a
catastrophic increase in autooxidation rate and decrease in binding affinity (15). For example,
the HisE7Gly mutation in sperm whale myoglobin accelerates autooxidation from a lifetime of
150 hours to 17 minutes (16) and decreases the oxygen affinity from 830 nM to 11 μM (17).
Similar results are observed for other mutations at the E7 position (15). These HisE7 mutations
weaken the oxygen binding and oxyferrous stability of myoglobin to the level of oxygen binding
maquettes and redesigned natural proteins, which have lifetimes and dissociation constants on
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the orders of seconds to minutes and tens of micromolar, respectively (12, 18-20). These
designed proteins are presumed not to have an oxygen-amino acid hydrogen bond.
Crystal structures of wild type bis-His MZH3 show that there are two hydrogen bond
donors in helix 2 that could potentially form a hydrogen bond to a bound oxygen molecule in
MZH3-His110Ala (Figure 5.10). The backbone amide of Gly92 and the hydroxyl group of Thr91
are both relatively close to where oxygen might be expected to bind (~3.5-4 Å). The Gly92
amide N-H group is perpendicular to the direction of the heme iron, and might not have the
proper geometry to form a stable hydrogen bond with a bound oxygen ligand. However, Thr91,
which makes a stable 2.8 Å hydrogen bond with heme-ligating His110 in wild type MZH3,
appears to have about the right distance and geometry to make a hydrogen bonding contact
with a bound oxygen molecule. The absence of a ligating His110 in MZH3-His110Ala might
result in a change in conformation that brings the threonine hydroxyl closer to the heme iron to

Figure 5.10: Possible H-bond to O2 in oxyferrous MZH3-His110Ala akin to HisE7-O2 H-bond of
myoglobin
Left: Wild type MZH3 crystal structure CS-D shown with His110 carbons in white and Thr91
and Gly92 carbons in yellow. Thr91 or Gly92 might form a hydrogen bond to bound oxygen in
MZH3-His110Ala. Right: Crystal structure of human myoglobin in oxyferrous state shows
HisE7 with yellow carbons making hydrogen bond to bound oxygen molecule. Structure is
from PDB-ID: 1MBO (9). Images rendered using The PyMOL Molecular Graphics System,
Version 1.7 Schrödinger, LLC.
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make a hydrogen bond closer to the His-O2 hydrogen bond length found in natural myoglobins
of ~2.8 Å (9, 28).
Future work on oxygen transport in MZH3 should be directed toward fine tuning the
dissociation constant for oxygen binding so that it better resembles natural myoglobins and
hemoglobins. The dissociation constant for MZH3-His110Ala should be determined precisely,
followed by mutagenesis studies to elucidate the source of the high oxygen affinity and long
oxyferrous lifetime. For example, study of a Thr91Val or Thr91Ala mutant might show whether
Thr91 plays an important role in stabilizing the oxyferrous state. Given the stability of the
complex and the fact that wild type MZH3 is readily crystallizable, it may be possible to solve the
structure of oxyferrous MZH3-His110Ala by X-ray crystallography.
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Chapter 6: Conclusion
In this thesis, a photosynthetic reaction center maquette has been designed that can
assemble iron and cobalt tetrapyrroles as electron acceptors, various zinc tetrapyrroles as
pigments, and tyrosine and metal ions as electron donors. MZH3 is a singularly structured and
highly stable canonical left-handed four-helix coiled coil with high affinity for all of its designated
cofactors. High resolution X-ray crystal structures show that all of the intended cofactors bind
to MZH3 simultaneously, and that MZH3 shares a high degree of structural similarity with the
natural four-helix bundle proteins cytochrome b and bacterioferritin, despite low sequence
identity. Transient absorption results indicate that MZH3 traps a charge separated state
involving ferrous heme B and a tyrosyl radical for up to 150 ms at pH 7.5. In addition, binding of
ferrous iron allows MZH3 to hold heme reduced for 300 ms at pH 7.5 before recombination. An
unexpected oxygen binding function was also detected in an MZH3 mutant. The MZH3His110Ala mutation led to a stable oxyferrous heme state with a lifetime comparable to natural
myoglobins and hemoglobins and with higher oxygen affinity than the natural proteins. These
results offer new perspectives on four-helix bundle design and advance the field toward more
sophisticated functions.

6.1 Four-helix bundle protein design strategy
Robertson et al. described the first de novo hemoprotein in 1994 (1). Since then, a
number of groups have pursued high resolution structural characterization of porphyrin binding
maquettes, and some have solved apo-state structures that lend insight into the structure213

function relationship of four-helix bundle heme maquettes (2-4). Until now, holo-state
structures have not been reported. Without experimental structures in the active state of the
maquette, it is difficult to identify essential structural elements that give rise to function or to
evaluate the degree to which maquettes fold into the intended structures.
The Dutton group has worked with a series of four-helix bundle maquettes designed by
simple binary patterning to achieve diverse functions including light-driven electron transfer,
iron-sulfur cluster assembly, inter-protein electron transfer, and oxygen binding (5-8). This
binary patterning is appealing as a way to simplify the design approach and minimize the
complexity of the sequence to tease out essential elements of the sequence-structure
relationship. However, simple binary patterning alone does not always lead to singularly
structured functional proteins, and it becomes less reliable in the design of increasingly complex
proteins. Furthermore, simple sequences do not necessarily translate into simple structures;
some maquettes lack the standard knob-into-hole interactions of coiled coils, fold with the
uncommon mixed parallel/antiparallel helical topology, and have a slight right-handed,
superhelical twist as opposed to the left-handed supercoil in normal coiled coils (2, 9). In
addition, heme binding in some maquettes triggers a significant structural change that rotates
the helices and buries glutamate residues (10). Many interesting functions have been achieved
in this type of heme maquette, but the unusual structural properties and lack of a high
resolution structure in the holo-state complicate our interpretation of the structure-function
relationship and sometimes make redesign difficult. A more robust design procedure was
necessary to design the multi-cofactor reaction center maquette MZH3.
In the successful design of MZH3, a broad and detailed view of the factors influencing
protein structure was used to strike a balance between the stability needed to decrease the
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entropic cost of cofactor binding, and flexibility, which is needed to decrease the enthalpic cost
of binding (11-13). The sequence of the metal binding section of MZH3 was taken from Due
Ferro proteins (14-16), but the tetrapyrrole binding section was designed from scratch. A
truncated version of MZH3 that only has a tetrapyrrole section, DDH2, is stable, helical, and
binds heme with high affinity. This shows that even in the absence of the Due Ferro section, the
tetrapyrrole section of MZH3 is functional. The design process relied on close attention to
interface widths, cofactor binding cavities, core packing using a layering approach, and negative
design by charge patterning. This is an empirical design method in the sense that it relies
primarily on takeaway messages derived from a variety of studies on natural and designed
proteins that have qualities in common with the desired design, as opposed to being an
intuition-driven approach guided by heptad repeat patterning. Ultimately, this method proved
to be fruitful, yielding the first high resolution structure of a maquette with tetrapyrroles bound
and the first maquette that separates charge for long enough for chemical reactions to occur.
This puts us on a path toward artificial photosynthesis in a de novo designed protein maquette.
Despite these successes, it is not clear whether the design strategy is robust. MZH3 and
DDH2 are promising results, but represent only two examples of proteins in which this empirical
approach to de novo four-helix bundle design has been used. Analysis of MZH3 crystal
structures in the apo-state suggests that interfacial leucine-leucine hydrophobic interactions
across g-g interfaces might be among the most stabilizing forces in MZH3, and they might play a
more important role in folding than layering of core amino acids or inter-helical charge pairing
interactions, which were originally expected to be the most important features of the maquette
sequence. In addition, the design strategy used for MZH3 is limited by its dependence on
observations of natural and designed protein structures and their modes of cofactor binding.
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MZH3 design was heavily influenced by the extensive literature on natural heme binding
proteins, carboxylate-bridged di-iron and di-manganese proteins, photosystem II, and a variety
of maquettes. An empirical approach to four-helix bundle design would not be suitable to the
design of a maquette that binds an unusual cofactor not found in nature or one that has an
atypical fold or function that has no precedent. However, when natural proteins that are
structurally similar to the target design exist, their structural attributes can serve to guide
design; MZH3 has striking structural similarities to cytochrome b and bacterioferritin despite
negligible sequence similarity. This shows that natural and designed protein structural features
can be readily included in the design of new maquettes with dissimilar sequences.

6.2 Light-driven electron transfer
Previous work has demonstrated light-driven oxidation of tyrosine side chains and metal
ions in redesigned natural proteins (17-22), but MZH3 is the first example of this function in a
maquette. The fact that MZH3 was designed from scratch gives it certain advantages. MZH3
was engineered to be highly stable, and the simplicity of its overall fold makes it amenable to
redesign. The maquette was specifically designed to arrange cofactors so that charge
separation can take place. Efficient redox-active triads have been synthesized chemically (23,
24), but the MZH3 triad is able to stabilize a charge separated state in an aqueous environment
for orders of magnitude longer than synthetic triads.
Transient absorption results support the conclusion that tyrosine and Fe(II) ions are
photo-chemically oxidized in MZH3 to stabilize the charge separated state. The MZH3-Y168L
mutant, which lacks a tyrosine, fails to stabilize a charge separated state, and the introduction of
hydrogen bonding networks involving the tyrosine in the MZH3-L71H and MZH3-L71H-L31D
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mutants significantly affects the yield and lifetime of charge separation. The crystal structure of
MZH3-L71H showed a 2.6 Å hydrogen bond between tyrosine 168 and histidine 71, similar to
the tyrosine-histidine hydrogen bonds of photosystem II. The L71H mutation results in a
pronounced increase in the yield of charge separation, and this yield is further increased by the
introduction of an aspartate predicted to be within hydrogen bonding distance of His71 in the
MZH3-L71H-L31D mutant. This histidine-aspartate interaction might play a role in tyrosine
oxidation that is similar to D1-Asn298 in photosystem II. Addition of Fe(II) in MZH3 enables
charge separation with a lifetime of 300 ms at pH 7.5 whether or not tyrosine is present. In
contrast, the MZH3-L71H-E34A mutant, which is deficient in its metal binding capacity, did not
exhibit a significant difference in charge separation behavior when Fe(II) was added. This shows
that bound Fe(II) is involved in charge separation.
These results provide compelling evidence of tyrosine oxidation and Fe(II) oxidation in a
working reaction center maquette, but further development is necessary to achieve the longterm goal of in vivo generation of oxygen and hydrogen. Direct evidence of tyrosine oxidation
might be derived from electron paramagnetic resonance (EPR) detection of the EPR-active
tyrosyl radical. Energy conversion might be made more efficient if the excited singlet state of
the zinc tetrapyrrole can be used for rapid electron transfer before it relaxes to the lower energy
triplet state. This would require the insertion of an additional cofactor close to the zinc
porphyrin, perhaps by using a modified version of the unexpected zinc porphyrin binding site at
the opening of the metal binding cavity observed in crystal structures CS-B and CS-C (Figure
3.16). In extending the electron transfer chain, a second electron acceptor cofactor might
further stabilize charge separation and expedite the slow cobalt porphyrin reduction that will be
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needed for hydrogen evolution. Future work is needed to establish manganese oxidation, which
would be a crucial step toward photoassembly of an oxygen evolving cluster in a maquette.

6.3 Oxygen binding
The MZH3-His110Ala mutation gave rise to a long-lived oxyferrous heme state. Other
heme maquettes and redesigned natural proteins have demonstrated oxygen binding capacity
(5, 6, 25, 26), but the MZH3-His110Ala oxyferrous lifetime is orders of magnitude longer at 38
hours, commensurate with the lifetimes of oxygen-carrying proteins in nature. Preliminary
results suggest that the oxygen affinity of MZH3-His110Ala exceeds the affinity of myoglobin
and hemoglobin, and that this affinity will need to be decreased in order to create a potential
blood-substitute protein.
Oxygen binding in MZH3-His110Ala was not unexpected, given that it has a vacant
coordination site on the heme iron and a proximal histidine ligand similar to myoglobin, but the
stability and oxygen affinity are remarkable. Unanticipated specific interactions may be
responsible for the serendipitous oxygen-carrying properties of MZH3-His110Ala. The hydroxyl
group of threonine 91 might be poised to make a hydrogen bond with bound oxygen, thereby
stabilizing the oxygen in the manner of HisE7 in myoglobin and hemoglobin (27). The backbone
amide nitrogen of glycine 92 might also be close enough to make a hydrogen bonding contact
with oxygen. Given the long lifetime of the oxyferrous state and the fact that MZH3 is readily
crystallizable, it may be possible to resolve these questions by X-ray crystallography of the
MZH3-His110Ala mutant in the oxyferrous state. Mutagenesis studies may also be able to
determine whether Thr91 plays a role in oxygen binding, and could allow the fine-tuning of the
maquette to make its oxygen binding behavior more similar to natural proteins.
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6.4 Summary
This thesis demonstrates the design, structure and action of a working photosynthetic
reaction center maquette. The design procedure applied detailed design rules laid out by
decades of research on the sequence-structure relationship in four-helix bundle proteins. High
resolution X-ray crystallographic structures revealed the assembly of multiple redox cofactors
into an electron transfer chain that can separate charge for hundreds of milliseconds, as verified
by transient absorption spectroscopy. Without copying natural sequences, the maquette folds
into a structure that strongly resembles structures of natural proteins that were used to guide
the design. Ultraviolet/visible spectroscopy showed that this maquette binds oxygen in a
complex with a stability comparable to oxygen transport proteins in nature. There is still a vast
divide between the range of functions expertly covered by natural proteins and the developing
field of de novo protein design. This thesis helps to narrow the gap and advance protein design
toward the goal of artificial photosynthesis to serve human energy needs.
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Chapter 7: Appendix
7.1 Protein expression and purification
A gene encoding MZH3 including an N-terminal His6-tag and TEV protease cleavage
sequence was purchased from DNA2.0 in a pJexpress414 vector with codons optimized for
expression in E. coli. After finding that TEV cleavage was slow due to the proximity of a proline
to the TEV cleavage site, Gly22 in the sequence below was inserted using site-directed
mutagenesis. The TEV protease cleavage site is between Q21 and G22; G22 becomes G1 in the
protein used for experimental studies in this thesis. Primers for mutagenesis were purchased
from Invitrogen, and mutant plasmids were PCR amplified using AccuPrime™ Pfx SuperMix
(Invitrogen). Other mutations including Y168L, L71H, L31D, E34A, and H124M were prepared
similarly. The final amino acid sequence of the protein expressed for experimental studies was:

MGKGGHHHHHHGGDGENLYFQGSPELRQEHQQLAQEFQQLLQEIQQLGRELLKGELQGIKQLREASEKAR
NPEKKSVLQKILEDEEKHIELLETLQQTGQEAQQLLQELQQTGQELWQLGGSGGPELRQKHQQLAQKIQQLL
QKHQQLGAKILEDEEKHIELLETILGGSGGDELRELLKGELQGIKQYRELQQLGQKAQQLVQKLQQTGQKLW
QLG

The plasmids were transformed into BL21-(DE3) competent cells (New England Biolabs),
and bacteria were grown to 0.6 OD at 600 nm. Expression was induced with between 40 μM
and 1 mM IPTG for 4 hours at 37˚C. The cells were pelleted by centrifugation, resuspended in 20
mM sodium phosphate buffer at pH 7.4 with 500 mM NaCl, 40 mM imidazole, 1% w/v
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octylthioglucoside, ~0.1 mg/mL DNAse, and lysed by homogenization or sonication. The lysate
was centrifuged at 25,000 g for 30 minutes, and the supernatant was applied to a 5 mL Ni-NTA
HisTrap FF prepacked column (GE Healthcare Life Sciences) on an Akta FPLC. The protein was
treated with TEV protease and incubated at 4°C for up to 2 weeks, applied to an Ni-NTA column
again, and finally purified by size exclusion chromatography (SEC) using an XK 16/70 column (GE
Healthcare Life Sciences) packed with 110 mL of Superdex 75 prep grade gel filtration medium
(GE Healthcare Life Sciences). Where noted, an additional purification step by high performance
liquid chromatography (HPLC) was done with a Waters reverse-phase HPLC system using a C4 or
C18 HPLC column (Grace Davison Discovery Sciences). HPLC-pure samples were lyophilized and
resuspended in >6.5 M GdnHCl, refolded by dilution, and the monomeric MZH3 protein was
isolated by SEC. Sample purity and molecular weight estimations were made using denaturing
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).

7.2 Ultraviolet/visible spectroscopy
Ultraviolet/visible spectroscopy (UV/vis) was performed using a Varian Cary-50
spectrophotometer at room temperature. Cofactor binding titrations were performed by
preparing a 1 mL protein sample near 1 μM in a quartz cuvette, unless otherwise noted.
Concentrations were determined using an extinction coefficient of ε280nm=12490 M−1cm−1 for
MZH3, based on the predicted absorbance of the two tryptophan and one tyrosine amino acids.
A stock solution of cofactor was titrated into the protein solution until at least three equivalents
of cofactor per protein had been added. Cofactor was typically added in steps of 0.1 equivalents
of cofactor per protein until after the binding capacity of the protein appeared to have been
reached, at which point 0.2 equivalents of cofactor per protein were added for each step. At
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least 10 minutes were allowed for equilibration before adding the next aliquot. Heme B stock
concentrations were measured by hemochrome assay (1). Stock concentrations of other
tetrapyrrole cofactors and Co(NO3)2 were estimated by mass measurements. Soluble cofactor
stocks were prepared in water, and insoluble tetrapyrrole stocks were prepared in dimethyl
sulfoxide. Tetrapyrrole stock solutions were 100-200 μM and the Co(NO3)2 stock was 17 mM in
water.
Estimates of the amounts of heme B incorporated into MZH3 during overexpression
were made by UV/vis measurements. The heme concentration was determined from the
absorbance at 415 nm using an extinction coefficient of 115,000 M−1cm−1, and the protein
concentration was estimated by the difference in the absorbance between 280 nm (where apoMZH3 absorbs with an extinction coefficient of 12490 M−1cm−1) and 317 nm. The low
absorbance of heme B at 317 nm serves as a baseline for the protein peak at 280 nm, because
heme B absorbance is similar at 280 and 317 nm.

7.3 Circular dichroism
Circular dichroism measurements were made using an Aviv Model 410 instrument. Far
UV CD spectra were measured from 190 to 260 nm and were performed in a 0.1 cm path length
quartz cuvette. Thermal denaturation was measured at 222 nm for 5 seconds with a 2 nm
bandwidth, and data were collected every 2°C with a heating rate of 10°C/min followed by a 4
minute incubation time. The mean molar ellipticity per residue, θMMR, was calculated by dividing
the measured ellipticity by 196 residues. Measurements of exciton coupling in the Soret region
of the spectrum were made at 25°C from 370 nm to 470 nm in either a 1 cm or 0.1 cm path
length cuvette, as noted. Spectra were collected with a 1 nm bandwidth every 1 nm for 5
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seconds per data point, and each reported spectrum was the average of three spectra that were
measured consecutively.

7.4 Redox titration
A redox titration was performed as described previously (2). A sample of 7 mL of ~40
μM MZH3 with heme B was prepared in 15 mM NaCl and 10 mM sodium phosphate, pH 7 in a
cuvette modified for this technique. The sample was kept anaerobic by continuously flushing
with argon scrubbed with an acid vanadyl sulfate/granular zinc bubble train, as described
previously (3). Changes in the absorption of the Q-bands of heme B were monitored as a
function of solution potential, which was measured by a calomel electrode (Radiometer
Analytical). The solution potential was lowered by addition of 1 μL aliquots of dithionite
(reducing direction) or 5 μL of ferricyanide (oxidizing direction). The Nernst curves in both
directions were compared to look for hysteresis. Redox mediators are needed to bring the
measuring electrodes into equilibrium with the redox state of the cofactor, because biological
redox centers usually cannot transfer electrons to and from the electrode because the protein
shields the cofactor (2). The following redox mediators were used: duroquinone (25 μM),
pyocyanine (10 μM), indigotrisulfonate (10 μM), 2-hydroxy-1,4-naphthoquinone (10 μM),
phenazine (10 μM), anthroquinone-2-sulfonate (20 μM), and benzyl viologen (10 μM).

7.5 Crystallography methods and crystal structure statistics
Protein samples for crystallography were purified as described in section 7.1 . Protein
samples for crystal structures CS-F and CS-G were purified by HPLC using a C4 column, followed
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by lyophilization, denaturation by GdnHCl, refolding, and SEC. No other samples were purified
by HPLC, lyophilized, or denatured. All crystals of MZH3 were grown in hanging drops at 4°C.
MZH3 stock solutions contained 20-40 mM NaCl and 10-20 mM piperazine-N,N′-bis(2ethanesulfonic acid) (PIPES) buffer at pH 6.5, and were stored at 4°C.
Addition of heme B was done after the final SEC purification step. In order to prevent
aggregation and precipitation of heme B, the MZH3 sample was diluted to ≤100 μM and was
kept stirring at room temperature. Heme B was added dropwise from a stock solution of ≤1 mM
heme in dimethyl sulfoxide (DMSO) up to 0.9 equivalents of heme per protein. At this point, a
more dilute heme B stock solution, typically ≤200 μM, heme B was titrated into the MZH3
solution until 1.0 equivalents heme B per protein had been added. Full occupancy of heme B
was verified by diluting the sample to ~2 μM and adding ~0.1 equivalent of heme B per protein.
If the difference spectrum showed signs of additional heme binding, more heme was added to
the MZH3 stock until binding stopped. A similar method was used for the addition of ZnPCP.
Sample buffers were exchanged to the low salt PIPES buffer using 5 kDa MWCO Vivaspin Turbo
15 concentrators (Sartorius AG) by centrifuging to concentrate the sample and diluting with the
new buffer several times. Table 7.1 gives the MZH3 stock concentrations, cofactors bound to
MZH3 in the stock solution, well solutions for the hanging drop experiments at 4°C, drop
volumes, and cryoprotectant for each crystal structure. Crystal structures CS-B and CS-C were
grown from crystal seeds starting from crystals that lacked ZnPCP using a Seed Bead kit
(Hamilton). Crystal structure CS-H used streak seeding with a cat whisker.
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Crystal
Structure

Cofactors

Well solution

Heme B,
ZnPCP, 1.5
mM ZnCl2
Heme B,
ZnPCP, ~35
mM MnCl2
Heme B,
ZnPCP, 2 mM
MnCl2
Heme B, 1.5
mM ZnCl2

3.6 M NaCl, 100
mM NaAc pH 4.5

540

Heme B, 1 mM
MnCl2

1.2 M Li2SO4, 0.5 M
(NH4)2SO4, 150 mM
Na citrate, pH 5.9

1 μL:1 μL

CS-F
(Tray 32,
B6)

500

Heme B,
ZnPCP, 1.5
mM ZnCl2

1 μL:1 μL

CS-G
(Tray 21,
D4)
CS-H
(Tray 73,
A5)

560

Heme B, 1.5
mM ZnCl2

630
(L71H
mutant)

Heme B

19.5% w/v PEG
8000, 100 mM
CdCl2, 100 mM
NaAc pH 4.2
24% w/v PEG 1500,
100 mM CdCl2, 100
mM NaAc pH 4.8
24% w/v PEG 1500,
70 mM CdCl2, 100
mM NaAc pH 4.6

CS-A
(Tray 7,
D5)
CS-B
(Tray 54,
A2)
CS-C
(Tray 52,
D5)
CS-D
(Tray 1,
B2)
CS-E
(Tray 53,
B4)

MZH3
stock
(μM)
550

600

600

630

3.0 M NaCl, 100
mM NaAc pH 4.9
3.0 M NaCl, 100
mM NaAc pH 4.8
2.7 M NaCl, 100
mM NaAc pH 4.5

Drop volumes
(well solution:
protein stock)
1 μL:1 μL

1.2 μL:2.5 μL
and 0.5 μL seed
stocka
1.2 μL:2.5 μL
and 0.5 μL seed
stockb
1 μL:1 μL

Cryoprotectant

30% glycerol, 3.5 M
NaCl, 100 mM NaAc
pH 4.4
30% glycerol, 3.5 M
NaCl, 100 mM NaAc
pH 4.4
30% glycerol, 3.5 M
NaCl, 100 mM NaAc
pH 4.4
30% glycerol, 3.5 M
NaCl, 100 mM NaAc
pH 4.4
28% glycerol, 1.25
M Li2SO4, 0.5 M
(NH4)2SO4, 100 mM
Na citrate, pH 5.85
40% v/v glycerol,
100 mM CdCl2, 100
mM NaAc pH 4.2

1 μL:1 μL

2-methyl-2,4pentanediol

5 μL: 1 μL,
seedsc

40% v/v glycerol, 70
mM CdCl2, 100 mM
NaAc pH 4.6

Table 7.1: Crystallization conditions used to obtain MZH3 crystal structures
Crystals were quickly dipped in the indicated cryoprotectant for no more than 30 seconds
immediately prior to flash freezing in liquid nitrogen or a nitrogen gas stream at 100 K. PEG
8000 and PEG 1500 stand for polyethylene glycol with an average molecular weight of 8000
and 1500 g/mol, respectively. NaAc stands for sodium acetate.
a

Seed stock was prepared from similar crystals grown with heme, ZnPCP, and 2 mM MnCl2
over 3.0 M NaCl, 100 mM NaAc, pH 4.8, which in turn were grown from the seed stock used
for CS-C (see note b)
b
Seed stock was prepared from crystals grown with heme and 1 mM MnCl2 over 2.8 M NaCl,
100 mM NaAc, pH 4.7 that did not contain ZnPCP
c
Streak seeded with cat whisker from crystals grown with the same protein stock solution
hanging over 25% PEG 1500, 80 mM CdCl2, pH 4.6

All X-ray crystallographic data sets were collected from single crystals at 100 K. X-ray
diffraction data for crystal structures CS-A and CS-D were collected at the National Synchrotron
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Light Source, beamline X6A using an ADSC Q270 CCD x-ray area detector. X-ray diffraction data
for crystal structures CS-B, CS-C, CS-E, CS-F, CS-G, and CS-H were collected using a Rigaku
Micromax-007 HF rotating copper anode X-ray generator and VariMax HF optics with a Rigaku
Saturn 944 HG CCD detector.
Multiwavelength anomalous dispersion (MAD) data was collected to solve crystal
structure CS-A. Data were integrated with XDS (4) and initial phases were calculated using
SOLVE (5). All other crystals used the CS-A crystal structure as a model for molecular
replacement using Phaser (6). Software packages CCP4i (7) and PHENIX (8) were used
throughout the structure solution and refinement process. Intensities were scaled using SCALA
(9). Refinement was done using REFMAC5 (10), phenix.refine (11), and PDB_REDO (12). Real
space refinement was done by manually fitting models into electron density maps in Coot (13).
Model bias removal was done using prime-and-switch phasing (14) and density modification was
done with RESOLVE (15).
Statistics for the three data sets collected for MAD to solve crystal structure CS-A are
given in Table 7.2.
Measurement
Zn K edge
Zn K inflection point
Remote energy
Wavelength
1.2824 Å
1.2831 Å
1.0781 Å
Space group
P41212
P41212
P41212
Resolution
2.1 Å
2.1 Å
2.0 Å
Completeness
99.1%
99.1%
99.4%
I/σ
18.15
19.53
16.8
Rmerge
6.6%
6.3%
8.5%
Rmerge (outer shell)
49.9%
53%
97%
Table 7.2: Multiwavelength anomalous dispersion (MAD) statistics for crystal structure CS-A

Data collection and refinement statistics for all eight crystal structures reported in this
thesis are given in Table 7.3.
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Crystal
Resolution, high (Å)
Resolution, low (Å)
Wavelength (Å)
X-ray Source
Space group
Cell dimensions:
a (Å)
b (Å)
c (Å)
α (°)
β (°)
γ (°)
Total reflections
Unique reflections
Redundancy:
All data:
Outer shell:
Completeness (%):
All data:
Outer shell:
I/σ(I):
All data:
Outer shell:
Rmerge (%):
All data:
Outer shell:
Final refinement:
Rwork (%)
Rfree (%)
Rwork (last shell) (%)
Rfree (last shell) (%)

CS-A
2.0
61.43
1.0781
NSLS
P41212

CS-B
2.02
61.17
1.54178
Cu Kα
P41212

CS-C
2.10
38.90
1.54178
Cu Kα
P41212

CS-D
1.45
61.38
1.0781
NSLS
P41212

CS-E
1.90
59.64
1.54178
Cu Kα
P41212

CS-F
2.01
19.58
1.54178
Cu Kα
C2

CS-G
1.78
18.36
1.54178
Cu Kα
C2

CS-H
2.02
71.54
1.54178
Cu Kα
P21

43.749
43.749
245.74
90
90
90
130,054
17,105

44.14
44.14
244.7
90
90
90
205,441
16,830

44.243
44.243
244.95
90
90
90
198,057
15,112

43.747
43.747
245.52
90
90
90
382,473
43,568

44.968
44.968
238.29
90
90
90
253,427
20,059

91.777
25.206
73.165
90
102.12
90
71,446
10,978

89.692
23.693
72.756
90
99.93
90
47,861
14,127

44.467
25.872
73.623
90
103.67
90
72,034
10,744

7.6
7.4

12.2
4.3

13.1
10.8

8.8
5.2

12.6
5.2

6.5
2.3

3.4
1.7

6.7
3.3

99.4
98.8

99.2
89.1

99.7
96.1

99.7
96.1

98.4
86.6

96.5
61.8

95.1
68.9

97.3
71.0

16.80
2.52

18.32
1.58

22.65
4.63

15.30
1.26

22.22
1.66

15.47
3.40

17.12
3.79

25.98
9.46

8.5
97.0

10.4
97.2

8.6
54.6

9.9
133.7

8.9
105.3

7.9
22.8

4.7
17.5

5.1
10.1

22.5
27.2
35.5
40.7

22.4
27.1
37.1
43.7

22.6
28.0
26.9
30.3

20.4
23.7
35.2
39.0

22.4
25.5
38.4
35.9

23.9
30.0
30.6
49.9

19.8
23.3
21.6
21.0

20.7
25.5
20.7
29.7

Table 7.3: Data collection and refinement statistics

7.6 Transient absorption
Transient absorption experiments were performed at 20°C with a 10 Hz Q-switched
frequency-doubled Nd:YAG laser (532 nm, DCR-11 Spectra Physics). The laser pulse duration
was 2 ns long. A Xe flash lamp emitted probe beams of white light into split fiber optic cables at
times t after the laser flash to measure the change in absorbance spectra as a function of time
after the laser flash. The gate width of the Xe flash was either 600 ns or 1 μs, with the exposure
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beginning at time t. The split fiber optic cables were used to direct one probe beam through the
laser-pumped (experimental) region and the other probe beam through the dark (reference)
region of the sample in the cuvette. Each probe beam was collected by a fiber optic bundle and
flattened into a line of fibers at the entrance slit of an Acton SP-2156 spectrograph. The images
from the exit slit of the monochromator were focused onto a Princeton Instruments PiMax-3
ICCD camera. Delay times t were set by a Stanford Research System DG 535 digital delay
generator. A ThorLabs beam shutter allowed the 10-Hz laser repetition rate to be lowered to
seconds for measurements at times t longer than 100 ms.

7.7 Singular value decomposition (SVD)
Absorbance spectra were collected at varying times or potentials, depending on the
experiment, and the raw absorbance data were compiled into a matrix A. Matrix A contained
one spectrum per column so that each column had λ absorbance values and there were t
columns, where t is the number of spectra collected. Singular value decomposition was
performed using the built-in “SingularValueDecomposition” function in Mathematica 10.3.
Calling the function with matrix A as the input variable returned three output matrices U, S, and
V, such that A = USVT. Matrix U had dimensions λ by λ, V had dimension t by t, and S was a
diagonal matrix with dimensions λ by t.
The V matrix was used to fit a kinetics model in which ordinary differential equations are
used to describe the development of the electron transfer system with time. In the monad case,
where a pigment (P) is alone in the maquette, the model includes the rate of decay of the
excited state (P*) to the ground state. In this case, the P* minus ground state difference
spectrum is the only spectrum of interest, and model fitting gives this spectrum and its rate
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constant. In the dyad case, rates of electron transfer from P* to the electron acceptor (A) and
from A- to P+ are included in the model. (It is assumed that P+ goes back to the ground state
when it accepts the electron from A-, because the return to the P* state is negligible). The dyad
model therefore includes two difference spectra: P* minus the ground state and P+/A- minus
the ground state. In the triad case, when an electron donor (D) is included, the model includes
electron transfer from D to P+ and from P to D+. If the rate of electron transfer from D to P+ is
significantly faster than from P to A, then the population of the D/P+/A- state will not be
observable and the D to P+ rate constant will not be resolved.
Model fitting followed a variation of the methods of Henry and Hofrichter (16). The
model described above was used to calculate an expected population matrix P with maximum
dimensions t by t. A square transformation matrix C with maximum dimensions t by t was
applied to P, and the mean square difference between V and the CP product was minimized
using the “FindMinimum” function in Mathematica 10.3. Electron transfer rates and the
elements of matrix C were allowed to vary during minimization. The minimization followed a
quasi-newton procedure starting with various initial estimates of the rates and C matrix
elements. The best initial estimates were identified by comparing the residuals of the
minimization procedures. The final values of the rates and the C matrix elements were used to
reconstruct the elemental spectra from the raw data and the electron transfer kinetics that best
explain the absorbance measurements.

7.8 Spectroelectrochemistry
Midpoint potential measurements of heme B in MZH3 variants were made using a
spectroelectrochemical setup. A CH Instruments Electrochemical Analyzer was used to set
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electrode potentials in a honeycomb spectroelectrochemical cell (Pine Research
Instrumentation). The sample was placed in the 0.18 cm path length cuvette with a fine gold
honeycomb working electrode modified with cystamine to prevent protein adsorption to the
electrode. The reference electrode was Ag/AgCl (3 M NaCl), which has a potential of 209 mV
with respect to the standard hydrogen electrode (SHE). Ultraviolet/visible absorbance spectra
were collected using an Ocean Optics DH-2000 Deuterium-Halogen Light Source that emitted
light through a fiber optic cable through the honeycomb working electrode and through another
fiber optic cable to an Ocean Optics spectrometer. To speed redox equilibration, redox
mediators were added to the sample including 1,2-naphthoquinone (25 µM), 2,3,5,6tetramethylphenylenediamine (25 µM), phenazine methosulfate (20 µM), phenazine ethosulfate
(20 µM), duroquinone (50 µM), phenazine (20 µM), pyocyanine (10 µM), 2-hydroxy-1,4naphtoquinone (25 µM), anthraquinone-2-sulfonate (20 µM), indigo trisulfonate (6 µM), and
benzyl viologen (20 µM) (2).
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